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Abstract 
This thesis presents structural and biochemical studies of a phytochrome, Agp1, a bilin-
binding red-light receptor protein. Crystallographic studies were undertaken in order to 
obtain structural insight into the mechanism of photoconversion and signal transduction 
from the sensor domain to the signalling domain, the latter hypothesised to be 
universally conserved among two-component histidine kinases. Using Agp1 from a 
non-photosynthetic plant pathogen, Agrobacterium tumefaciens as a model 
phytochrome, structural determination of both Pr and Pfr-forms was attempted, in order 
to permit unbiased structural comparison of the two. Application of the surface entropy 
reduction strategy led to determination of the structure of Agp1 in its Pr-form and 
crystals of Agp1 in the Pfr-like form were obtained for the first time. 
Biochemical studies were undertaken to probe the conformational differences between 
Agp1 as apoprotein, Pr-form, and Pfr-like form. Limited differences in secondary 
structure exist between the forms of Agp1. Conformational differences between the Pr 
and the Pfr-like form seem to underlie the fact that the space group of Agp1 crystals in 
the Pfr-like form is different from that of Agp1 in the Pr-form. The ability of the Agp1 
apoprotein to form a dimer via a disulphide bond at the N-terminal chromophore-
binding cysteine residue implies flexibility of the N-terminal region which allows for 
the initial bilin incorporation during holoprotein formation. 
  
 4 
 
Acknowledgements 
First and foremost, I would like to express my utmost gratitude to Dr Norbert Krauß for 
his supervision. Without his guidance and encouragement, my Ph.D. project would not 
have been realised and reached the current stage. I would also like to thank his wife Dr 
Kristina Zubow for the efforts she has paid in setting up the lab as well as invaluable 
technical advices. 
I would also like to thank the Ph.D. panel members, Professor John Allen, Dr James 
Sullivan, and Dr Robin Maytum for their advices. I thank Professor Richard Pickersgill 
for the helps I received throughout the project. I thank Dr Jon Nield for offering to 
include his research results in my thesis. 
I am thankful to our collaborators, without whom the project would not have been 
realised. I thank Dr Patrick Scheerer for technical advices and invaluable suggestions. I 
thank Professor Tilman Lamparter, Dr Inga Oberpichler, Dr Benjamin Zienicke, Dr 
Ibrahim Njimona, and Dr Gregor Rottwinkel for their hospitality during my visit to the 
Karlsruhe Institute of Technology and the plasmids I have received. I would like to 
thank Professor Katsuhiko Inomata for supplying the precious locked chromophore. I 
thank Dr David von Stetten for his kind help we received at the ESRF synchrotron, 
Grenoble. 
I am indebted to my friends for their critical opinions, collaborations, and friendships. 
Thank you, Allan Pang, for being a fantastic lab mate to work with for a long time. I 
thank Iskander Ibrahim for our collaboration on the chloroplast sensor kinase project. I 
thank Dennis Nürnberg for our collaboration.  
I acknowledge Queen Mary University of London for the collage studentship. The work 
presented in the present study has been supported by the University of London central 
research fund. I thank the British Crystallographic Association and International Centre 
for Diffraction Data for supporting my attendances at the BCA spring meetings. I thank 
the Collaborative Computational Project No. 4 for awarding the bursary for the CCP4 
study weekend 2012. 
Finally I would like to thank my parents who taught me the value of perseverance, 
without which I would not have been able to come this far. 
 5 
 
Abbreviations 
Abbreviation Description 
a anti conformation of a single bond in a bilin. 
Agp1 or 2 Agrobacterium tumefaciens phytochrome 1 or 2. 
APS Ammonium persulphate. 
AU Spectrophotometric absorption unit. 
BphP Bacteriophytochromes. 
BSA Bovine serum albumin. 
BV Biliverdin IX 
CA Catalytic and ATP-binding domain. 
CBD Chromophore binding domain, a part of the N-terminal 
signalling domain of phytochromes, consisting of PAS and 
GAF domains. 
Cph1 or 2 Synechocystis PCC6803 phytochrome 1 or 2. 
DEPC Diethylpyrocarbonate. 
DHp Dimerisation and histidine phosphorylation domain. 
DLS Dynamic light scattering. 
DrBphP Deinococcus radiodurans phytochrome. 
DTT Dithiothreitol. 
E trans configuration of a double bond in a bilin. 
EPR Electron paramagnetic resonance. 
GAF cGMP phosphodiesterase/adenylcyclase/FhlA domain. 
HEWL Hen egg white lysozyme. 
HIC Hydrophobic interaction chromatography. 
HK Histidine kinase. 
Hpt Histidine-containing phosphotransfer domain. 
HSA Human serum albumin. 
IEX Ion exchange chromatography. 
max The wavelength with the maximum absorption in the 
absorption spectrum. 
M15 Agp1 fragment containing the entire PCM, containing PAS, 
GAF, and PHY domains (1-504). 
M15s M15 construct without the first nine amino acid residues (10-
504). 
M20 Agp1 fragment containing the entire CBD, containing PAS 
and GAF domains (1-313). 
M20s M20 construct without the first nine amino acid residues (10-
313). 
mAU Milli absorption unit (spectrophotometric). 
NMR Nuclear magnetic resonance. 
PB Phytochromobilin. 
PaBphP Pseudomonas aeruginosa phytochrome. 
PAS Per/Arndt/Sim domain. 
PCB Phycocyanobilin. 
PCM Photosensory core module, the entire N-terminal signalling 
domain of phytochromes, usually consisting of PAS, GAF, 
and PHY domains. 
PEB Phycoerythrobilin. 
Pfr-form The far-red light absorbing form of phytochromes. 
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PHY Phytochrome specific domain. 
pI Isoelectric point. 
Pr-form The red-light absorbing form of phytochromes. 
RpBphP1, 2, 3, 4, or 5 Rhodopseudomonas palustris phytochrome 1, 2, 3, 4, or 5. 
RR Response regulator. 
s syn conformation of a single bond in a bilin. 
SAXS Small angle X-ray scattering. 
SDS Sodium dodecyl sulphate. 
SEC Size exclusion chromatography. 
SER Surface entropy reduction strategy, or prefix of the codename 
given to constructs modified according to the strategy.  
SK Sensor kinase. 
SyB-Cph1 Synechococcus OS-B′ phytochrome. 
TCS Two-component signal transduction system. 
TEMED N,N,N′,N′-Tetramethylethylenediamine. 
Tm Melting temperature of a primer (°C). 
Tris Tris(hydroxymethyl)aminomethane. 
WT Wild type. 
Z cis configuration of a double bond in a bilin. 
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Chapter 1: Introduction 
1.1 Photoreception 
In the vast majority of ecosystems, light is the sole ultimate energy source, being 
converted into chemical potential energy by the primary producers. This energy is then 
distributed to other organisms at higher trophic levels, except in the case of 
chemoautotrophic organisms. During the course of evolution, life has developed a 
multitude of implementations to utilise light, for example as an energy source or for 
sensory purposes. The emergence of photosynthesis in evolution allowed more complex 
organisms to emerge, and light perception plays vital roles in spatial recognition in both 
aquatic and terrestrial organisms of a wide range of complexity. Light has been and will 
continue to be the essential factor for the maintenance of life on the Earth. 
Light-sensitive proteins include photosynthetic machineries, opsins, photolyases, 
cryptochromes, phytochromes and phototropins, to name a few. Obviously research on 
phytochromes is just one out of many areas of photobiology, but studying them is of 
intrinsic value and may lead to identification of commonalities with other signalling 
proteins. Detailed understanding of such common mechanisms will have wide 
implications.  
1.2 Two-component signal transduction systems 
1.2.1 Introduction 
Two-component signal transduction systems (TCS) provide a ubiquitous mechanism to 
respond to the environmental stimuli and are found in all domains of life except for 
animals (Casino et al., 2009). Cellular responses including chemotaxis, osmoregulation, 
anaerobic respiration, photosynthesis, nitrogen and phosphate acquisition, sporulation, 
host recognition by pathogens, antibiotic production, the cell cycle, and viability are 
controlled by histidine kinases (Karniol and Vierstra, 2004, Stock et al., 2000). The 
name of the system was introduced in 1986 (Nixon et al., 1986) and refers to a 
conserved group of proteins of two types which together are involved in a 
phosphotransfer cascade, the activity of which depends on the response to the 
environmental trigger and modulates the physiological activity (Bourret and Silversmith, 
2010). In its most basic form, a TCS consists of a pair of proteins: the sensor kinase 
(SK) and the response regulator (RR), but more extensive forms of TCS include other 
Chapter 1: Introduction 
20 
 
intermediate phosphotransfer proteins (Fig. 1.1). A bacterial genome can encode many 
TCS to facilitate response to various aspects of the ever-changing environment. A single 
bacterial cell can contain between 200 and 300 pairs of SK-RR (Laub and Goulian, 
2007). The genes of the SK and the cognate RR may be found within the same operon 
(Szurmant and Hoch, 2010). The interaction between the SK and its cognate response 
regulator is usually specific (Capra et al., 2010), but cases of promiscuous interaction 
(Ninfa et al., 1988) or a case where two SKs appears to have redundant roles (Bick et al., 
2009) have been reported. The gene of a TCS protein may not be in an operon with the 
cognate partner, and is then referred to as an “orphan” (Szurmant and Hoch, 2010). 
Components in a TCS ultimately translate external stimuli into physiological 
modulation via a phosphotransfer cascade. In brief, the external stimulus is sensed by 
the sensor domain of the SK, and the kinase activity of the SK is modulated according 
to the concentration of the stimulus. Some elaborate TCSs, however, for example the 
chemotactic signal transduction pathways in Escherichia coli and Salmonella 
typhimurium, enable the cell to respond to changes in stimuli concentration. Chemotaxis 
enables the cell to move towards higher concentration of attractants, but eventual 
methylation of the membrane receptor protein attenuates the attractant signal to 
prestimulus levels (p89-97, Hoch and Silhavy, 1995). 
Sensor kinases autophosphorylate a histidine residue typically found in the histidine 
kinase (HK) domain. The phosphoryl group is then transferred to a conserved aspartate 
residue in the receiver domain of the RR, which then modulates the physiology with its 
C-terminal output domain often featuring a DNA-binding domain that functions as a 
transcriptional regulator. The amount of phosphorylated RR ultimately determines the 
degree of physiological modulation. In addition to the kinase activity of the SK, the 
concentration of phosphorylated RR may be regulated by dephosphatase activities 
which may occur at a number of points in a pathway. A phosphorylated receiver domain 
may be dephosphorylated by either the phosphatase activity of the SK or other 
accessory proteins (Kenney, 2010) or by the inherent catalytic activity of the receiver 
domain to autodephosphorylate (Hess et al., 1988, Keener and Kustu, 1988). 
Additionally, intermediate phosphotranfer proteins may be subjected to 
dephosphorylation, for example an intermediate RR Spo0F phosphotransfer protein is 
dephosphorylated by the RapH protein (Parashar et al., 2011). As a result, physiological 
modulation is imposed as a gradient over a range of activity instead of discrete on/off 
response. Hence, the kinase assay used to quantify the degree of phosphorylation of a 
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protein is the sum of kinase and phosphatase activities over a period of time under 
particular experimental conditions. 
The core components of the TCS are the C-terminal kinase domain of the HK and the 
N-terminal receiver domain of the RR. There is a high degree of homology among 
TCSs, but the N-terminal sensor domain of the SK and the C-terminal output domain of 
the RR are not conserved, which reflects the diversity of the external stimuli for the SK 
and the types of modulation that the RR can carry out. There are two major variations of 
intermediate phosphotransfer proteins. In the sporulation phosphotransfer pathway of 
Bacillus subtilis, the phosphoryl group is passed down in the order of KinA, Spo0F, 
Spo0B, and Spo0A. KinA is the SK, and Spo0A is the RR, the final recipient of the 
phosphoryl group. Spo0F and Spo0B, the intermediate phosphotransfer proteins, are 
structurally homologous to the receiver domain of a response regulator and a HK 
domain, respectively (Zapf et al., 2000). The crystal structure of the complex between 
Spo0B and Spo0F shows that Spo0B forms a dimer like a typical HK domain, and 
Spo0F is associated with Spo0B with a stoichiometric ratio of 1:1. The phosphotransfer 
protein can be of another type, exemplified by the phosphotransfer domain of the E. coli 
ArcB domain (Kato et al., 1997). If only the fact is considered that ArcB forms a 4-helix 
bundle, ArcB may be regarded as being analogous to the dimerisation and histidine 
phosphorylation (DHp) domain of a HK domain or helical dimerisation regions of 
Spo0B, but key differences exist between those two classes. The DHp domain of a HK 
domain or helical dimerisation regions of Spo0B form symmetrical dimers with one 
histidine residue per monomer, but the histidine phosphotransfer domain of ArcB is a 
monomer consisting of a 4-helix bundle with only one histidine per structural unit 
(Tomomori et al., 1999). In addition to these variations of the components that can be 
found in a TCS system, the variation is further expanded such that some proteins form 
fusion proteins (Fig. 1.1). 
Given a typically large number of TCS proteins in a single cell, the interaction between 
the SK and the RR must be specific in a given TCS pathway, otherwise the cell will not 
be able to adapt to the environment by responding to the stimuli properly. Structural and 
molecular studies have shown that the fidelity between an SK and its cognate RR is 
maintained via numbers of residues at the interaction interface between two proteins 
which co-vary to avoid cross-talk with other TCS proteins (Capra et al., 2010, Skerker 
et al., 2008). An exceptional case where cross-talk is present between two pathways has 
also been documented (Ninfa et al., 1988). CheA and NRII, the SKs that regulate the 
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chemotaxis and transcription of nitrogen-regulated genes, respectively, were found 
capable of phosphorylating the cognate RR of each other. The case is particularly 
interesting because NRII and CheA are Class I and II SKs, respectively (Section 1.2.2). 
 
Figure 1.1 Some combinations of phosphotransfer proteins found in TCS pathways which have been 
documented to date. By no means are the combinations shown herein complete. Proteins are labelled 
and depicted schematically as monomers regardless of their biological oligomeric state in situ. For 
each given combination, an example pathway is given. H represents the conserved phosphoryl group 
accepting histidine residues in SK or phosphotransfer proteins, while D indicates the conserved 
aspartate in RR. Identical colour and shape signify the homology of the components. a, E. coli 
osmoregulation system; b, Bacillus subtilis sporulation pathway; c, Saccharomyces cerevisiae 
osmosensor system; d, Fremyella diplosiphon chromatic adaptation system; e, E. coli anaerobic 
control system. Figure adapted from Kato et al. (1997). 
 
1.2.2 Classification of the TCS components 
Diversity of each component protein involved in the TCS allows the organism to 
respond to a multitude of external stimuli and to elicit different types of responses. For 
this reason, as of present there is no universal classification method that addresses every 
attribute of sensor kinases. There are nevertheless numbers of ways to classify sensor 
kinases. These are described below. 
The HK domains in SKs are identified on the basis of amino acid sequence similarities 
at five regions termed the N, G1, F, G2 and the H box, the last of which contains the 
histidine residue that is the substrate for phosphorylation (Parkinson and Kofoid, 1992). 
The relative positions of these elements are different among SKs, and SKs can be 
classified into either Class I or II accordingly (Fig. 1.2).  
Chapter 1: Introduction 
23 
 
Class I SKs contains the H-box in the dimerisation domain adjacent to the catalytic and 
ATP-binding (CA) domain, hence it is referred to as dimerisation and histidine 
phosphorylation (DHp) domain (Song et al., 2004). Class II SKs, exemplified by the 
chemotaxis regulation protein CheA, have a different relative domain orientation. The 
most significant difference is that the H-box is not present in the dimerisation domain, 
but it is found in the N-terminal P1 domain, featuring a HPt domain-like histidine-
containing phosphotransfer domain with a 4-helix bundles per polypeptide. The 
phosphoryl group is transferred from the N-terminal H-box to the response regulator via 
specific recognition mediated by the P2 domain.  
 
Figure 1.2 Two classes of SK protein. SK can be classified according to the position of the H-box 
relative to the catalytic and ATP-binding domain. Red arrows indicate the catalytic activity exerted 
to the histidine residue in the H-box, the substrate. Black arrows indicate the phosphotransfer from 
the HK domain to the response regulator. Black diagonal lines in the Class II indicate the specific 
interaction between the proteins involved in the system. Figure adapted from Bilwes et al. (1999).  
 
An SK protein can either be membrane associated or found in the cytoplasm. 
Additionally, the position of the sensory domain relative to the transmembrane regions 
can vary in cases of membrane associated SKs (Cheung and Hendrickson, 2010). A 
prototypical SK possesses the sensor domain in between two transmembrane regions 
such that it protrudes into the periplasmic space. However variations of SKs include 
those without an obvious sensor domain, but instead the sensor domain is embedded 
within the transmembrane region (Fig. 1.3). 
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Figure 1.3 Variations in the position of the sensor domain relative to the transmembrane regions in 
Class I SKs. A) The sensor domain is located between two transmembrane regions, hence the former 
protrudes into the periplasmic space. B) The sensor domain is imbedded within the transmembrane 
regions. The sensor domain is N-terminal C) or C-terminal D) to the transmembrane regions, and the 
sensor domain is located at the cytoplasm. E) The transmembrane region is absent for a cytoplasmic 
histidine kinase. Transmembrane segments labelled as TM1 and TM2 may consist of several 
transmembrane segments, but its number will always be an odd number. Figure adapted from 
Cheung & Hendrickson (2010). 
 
Moreover, detailed analyses of the sequences led to the classification of members of the 
SK superfamily into three superclusters which are subdivided into twelve families 
including a recently identified unique class of HK domain termed “HWE kinase” 
(Karniol and Vierstra, 2004). HWE kinases are characterised by the lack of an F-box, 
the presence of a histidine in the N-box and a tryptophan-x-glutamate motif in the G1-
box. HWE kinases are found in - and -proteobacteria, but concentrated in the 
Rhizobiaceae family. HWE kinases are often found as a fusion protein with the 
response regulator attached to the C-terminus of the HK domain. 
In addition to the above-mentioned diversity of SK, some signalling proteins with SK 
ancestry do not function as a HK. Examples include chloroplast sensor kinases (CSK, 
Puthiyaveetil et al., 2008), ethylene receptors (Moussatche and Klee, 2004), and plant 
phytochromes (Chen et al., 2004). In the latter two, the HK-like domains have evolved 
to function as Serine/Threonine kinases. 
Detailed account of the modular nature of the signalling proteins other than SKs in 
bacteria lies outside the scope of this introduction. Nonetheless, an example where 
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diversity is found in the C-terminal signalling domain relative to the conserved N-
terminal sensor domain is briefly described here. Six bacteriophytochrome genes are 
present in the genome of Rhodopseudomonas palustris CGA009 (Giraud et al., 2005, 
Larimer et al., 2004). These encode proteins of which all but RpBphP1 have a histidine 
kinase at the C-terminus (Fig. 1.4). The C-terminal output transducing domain (OTD) of 
RpBphP1 comprises a PAS/PAC domain followed by a 2-helix output sensor (HOS) 
domain (Bellini and Papiz, 2012b). This observation highlights the plasticity of the 
bacterial genomes and their ability to carry out horizontal gene transfer (Dobrindt and 
Hacker, 2001). 
 
 
Figure 1.4 Homologues of bacteriophytochromes found in the genome of Rhodopseudomonas 
palustris CGA009. The translated coding sequences were submitted to the SMART domain 
prediction server with the PFAM option enabled. The accession code of the genome sequence used 
is NC_005296 (Larimer et al., 2004), and the gene locus for each protein is as follows; RpBphP1 – 
rpa1537 (frame shift mutation corrected by inserting a guanine base at 430th position, Braatsch et 
al., 2007), RpBphP2 – rpa3015, RpBphP3 – rpa3016, RpBphP4 – rpa1490, RpBphP5 – rpa0122, 
RpBphP6 - rpa0990. Accession numbers are as mentioned in Rockwell et al. (2006). All but 
RpBphP1 possess a histidine kinase with canonical domain organisation except for RpBphP6 which 
is a fusion protein typical for a HWE histidine kinase. RpBphP1 has no histidine kinase, and 
illustrates the fact that the modularity is not limited to histidine kinases, but is widespread among 
many bacterial signalling proteins. The scale shown at the top indicating the number of amino acid 
residues applies to all the schematic diagrams.  
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1.2.3 Structures of sensor kinases 
A wealth of structural information for TCSs has now accumulated. Structurally 
analysed histidine kinases and phosphotransfer proteins are listed in Table 1.1.  
A canonical Class I histidine kinase consists of a DHp domain and a CA domain (Fig. 
1.5), and must form a parallel dimer to function as a kinase. A DHp domain consisting 
of two -helices forms a four-helix bundle upon dimerisation (Tomomori et al., 1999). 
The CA domain is a member of the GHKL (GyraseB, Hsp90, histidine kinase and 
MutL) superfamily (Dutta and Inouye, 2000). The members of this family assume a 
common ATP-binding Bergerat fold, the core of which minimally consists of a mixed 
/ sandwich with 4 anti-parallel -strands and 3 -helices. In addition to the variable 
N-terminal sensor domain and the conserved C-terminal histidine kinase domain, a 
HAMP (Histidine kinase, adenylyl cyclase, MCP and phosphatase) linker may be found 
between the two. A HAMP domain is found in over a fifth of SKs and two-thirds of 
chemotaxis receptors. It consists of two parallel -helices connected by a long linker, 
and these two parallel helices are off-set in the longitudinal direction by a single turn of 
an -helix. The HAMP domain dimerises in solution to form four-helix bundles (Fig. 
1.5, Hulko et al., 2006). 
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Source organism Protein PDB accession code Reference 
Histidine kinase domain / HK+RR complex 
Thermotoga maritima CheA 1B3Q Bilwes et al. (1999) 
Thermotoga maritima HK853 2C2A Marina et al. (2005) 
Geobacillus stearothermophilus KinB with 
Sda 
3D36 Bick et al. (2009) 
Thermotoga maritima HK853 and 
RR468 
3DGE (3DGF, 3GL9) Casino et al. (2009) 
Thermotoga maritima ThkA with 
TrrA 
3A0R Yamada et al. (2009) 
Escherichia coli QseC 3JZ3 Xie et al. (2010) 
Dimerisation domain 
Escherichia coli EnvZ 1JOY Tomomori et al. (1999) 
Escherichia coli CheA Preliminary study Park et al. (2011) 
Catalytic and ATP-binding domain 
Escherichia coli EnvZ 1BXD Tanaka et al. (1998) 
Escherichia coli PhoQ 1IDO Marina et al. (2001) 
Thermotoga maritima CheA 1I58, 1I59, 1I5A, 
1I5B, 1I5C, 1I5D 
Bilwes et al. (2001) 
Escherichia coli NRII (NtrB) 1R62 Song et al. (2004) 
Salmonella typhimurium PhoQ 3CGZ, 3CGY Guarnieri et al. (2008) 
Aquifex aeolicus VF5 HksPr Preliminary study Horita et al. (2011) 
 PrrB ** E. Nowak, S. Panjikar & P. Tucker, unpublished work 
Phosphotransfer protein complex 
Bacillus subtilis Spo0F and 
Spo0B 
1F51 Zapf et al. (2000) 
Saccharomyces cerevisiae YPD1 and 
SLN1-R1 
1OXB, 1OXK Xu et al. (2003) 
Bacillus subtilis Spo0F and 
Spo0B 
2FTK Varughese et al. (2006) 
Saccharomyces cerevisiae YPD1 and 
SLN1-R1 
2R25 Zhao et al. (2008) 
Bacillus subtilis Spo0F and 
RapH 
3Q15 Parashar et al. (2011) 
Phosphotransfer protein 
Escherichia coli ArcB 1A0B Kato et al. (1997) 
Bacillus subtilis Spo0B 1IXM Varughese et al. (1998) 
Saccharomyces cerevisiae YPD1 1C02, 1C03 Song et al. (1999) 
Saccharomyces cerevisiae YPD1 1QSP Xu, Porter and West (1999) 
Salmonella typhimurium CheA 1I5N Mourey et al. (2001) 
Thermotoga maritima CheA 2LD6 Vu et al. (2011) 
Miscellaneous 
Thermotoga maritima CheW Preliminary study Park and Crane (2011) 
Table 1.1 Information about structural studies carried out on TCS component proteins to date 
except for RRs. ** Unpublished work on PrrB was mentioned in Horita et al. (2011). 
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Figure 1.5 Domains of histidine kinase. A) HAMP domain of Af1503 of Archaeoglobus fulgidus 
shown as a dimer with each monomer coloured differently. PDB accession code: 1ASX (Hulko et 
al., 2006). B) DHp domain of EnvZ of E. coli shown as a dimer with each monomer coloured 
differently. PDB accession code: 1JOY (Tomomori et al., 1999). C) CA domain of EnvZ. Three -
helices that are conserved among the GHKL superfamily are presented transparently to aid the 
visibility of -strands. PDB accession code: 1BXD (Tanaka et al., 1998). The 1BXD structure was 
solved as a complex with AMP-PNP, a non-hydrolysable structural analogue of ATP. The ATP lid 
in this structure is thought to correspond to the open conformation of the proteins of the GHKL 
superfamily (Dutta and Inouye, 2000). D) PAS–HK (ThkA) and RR (TrrA) complex of Thermotoga 
maritima. The domains of a ThkA monomer are coloured as follows: PAS (red), DHp (blue), and 
CA (green). One TrrA monomer is coloured in cyan. The symmetry related ThkA and TrrA 
molecules are coloured grey. PDB accession code: 3A0R (Yamada et al., 2009).  
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1.2.4 Mechanism of signal transduction 
To date the mechanism by which the external stimulus, perceived by the sensor domain, 
is translated into modulation of the kinase activity and the extent of conservation of the 
mechanism is not fully understood. The motivations for understanding the mechanism 
of signal transduction are manifold, of which two major ones are as follows. Firstly, 
TCSs as potential targets of antimicrobial drugs have previously been discussed 
(Matsushita and Janda, 2002). A TCS functions to sense numerous external stimuli and 
to elicit responses, some of which are involved in controlling the virulence in bacteria, a 
notable example being quorum sensing. Means by which to intervene with signal 
transduction may render pathogenic bacteria unable to coordinate their pathogenic 
activities. Since a TCS is not found in mammals, potential side effects from a 
compound targeted to a TCS are expected to be minimal. Secondly, the modular nature 
of SKs has enabled production of functional chimera as described later. Characterising 
the mechanism of signal transduction will enable a more rational approach in designing 
a component of a synthetic biological circuitry.   
As previously described, an SK must form a dimer to be catalytically active. The notion 
that dimerisation of an SK is an absolute prerequisite for its functionalities is in 
accordance with observations that the HK domains, HAMP domains, and some sensor 
domains form dimers, as well as with the proposed mechanism of autophosphorylation 
occurring in trans, i.e. monomers in a dimer phosphorylate each other. However, recent 
evidence has shown that at least some SKs undergo intramolecular phosphorylation by a 
cis mechanism (intra-molecular autophosphorylation), which still requires dimerisation 
(Casino et al., 2009).  
Regarding the mechanism of signal transduction along transmembrane -helices, the 
following four models have been proposed: A) Horizontal translation along the plane of 
the membrane, B) piston movement along the axis normal to the membrane, C) pivot 
movement along the axis parallel to the membrane, and D) rotation along the axis 
perpendicular to the membrane (Matthews et al., 2006). An adaptation of these models 
to SKs with a transmembrane -helix is depicted in Fig. 1.6. These models of signal 
transduction were proposed for transmembrane -helices, but they do not necessarily 
exclude soluble SKs. According to those models, the signal is transduced by movements 
of monomers relative to each other. Alternatively, Möglich and co-workers propose 
another model whereby the signal transduction takes place by the rotation of the linker 
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between the sensory and the signalling domain, and the signal is transduced by the 
change in the relative position of two domains (2009). To date a number of functional 
chimeric SKs have been generated that may suggest that the mechanism of inter-domain 
signal transduction is conserved, not just within the closely related SKs, but also within 
diverse signalling proteins.  
The conservation of a signal transduction mechanism could be anticipated for closely 
related SKs with similar domain organisations and, indeed, functional chimeric SKs 
have been created by fusing similar parental SK domains (Baumgartner et al., 1994, 
Feng et al., 1997, Krikos et al., 1985, Perraud et al., 1998, Utsumi et al., 1989, Ward et 
al., 2002, Weerasuriya et al., 1998, Zhu and Inouye, 2003). Experimental evidence for a 
signal transduction mechanism was lacking until 2006 when the structure of a HAMP 
domain was solved (Hulko et al., 2006). Based on the coiled-coil structure of 4-helix 
bundles with unusual “knobs-to-knobs” packing (rather than the usual “knobs-into-holes” 
packing), helix rotation was proposed to occur as a result of switching between two 
isoenergetic packing modes, rather like cogwheels. Evidence in agreement with the 
rotation model came from a study utilising a chimeric SK where insertions and deletions 
were introduced at the linker region between the sensor domain and the HK domain. 
The length of the linker region affects how the kinase activity is modulated by the 
sensory domain. Moreover, the stimuli-response pattern exhibited a heptad periodicity 
as insertions/deletions were introduced to the linker (Möglich et al., 2009). Data in 
partial agreement with the above-mentioned rotation model was presented in a study 
with Tez1, a chimeric protein with the periplasmic and transmembrane regions of Tar1 
fused to the HAMP domain and the HK domain of EnvZ (Zhu and Inouye, 2003). 
Therein, the number of alanine residues inserted at the HAMP domain affected the 
ability of Tez1 to modulate the kinase activity in response to the stimulus. Inasmuch as 
the stimuli-response pattern was affected by the number of residues in the linker region, 
this observation is in accordance with the rotation model. However in the same study, 
the type of mutation introduced in the HAMP domain also had a profound effect on the 
kinase response to the stimulus, implying that it is not just the length (which affects the 
rotational orientation of the HK domain), but also the properties of the linker region that 
play a key role in signal transduction. It must be noted that the study was carried out 
prior to the structural information of the HAMP became available, and some of the 
mutations resulted in disruption of the heptad periodicity of hydrophobic residues that is 
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proposed to be essential in the rotation model (Hulko et al., 2006). Therefore the 
rotation model is not entirely refuted by Zhu and Inouye (2003).  
Examples of functional chimeras created from more diverse proteins include a fusion of 
the sensor domain of a soluble SK (Synechocystis PCC6803 phytochrome 1, Cph1) and 
the HAMP domain and the HK domain of E. coli EnvZ, a membrane associated SK 
(Levskaya et al., 2005) and a fusion of the LOV domain of YtvA and the HK domain of 
FixL (Möglich et al., 2009). The notion that these diverse proteins function by the same 
signal transduction mechanism is still plausible given the variation of modular proteins 
observed in nature. The phytochrome homologues RpBphP1 and RpBphP2 for example 
possess different output domains despite having similar sensor domains (Fig. 1.4). One 
the other hand, a wide variety of SKs share common HK domains despite their diverse 
N-terminal sensor domains. 
A functional chimera termed “AIR” was created by fusing the periplasmic and 
transmembrane regions of E. coli Tar (referred to as aspartate receptor, AR therein) and 
the human insulin receptor (IR). The signal transduction mechanism was suggested to 
be conserved even between bacterial and human receptor proteins (Moe et al., 1989). 
The original assumption was that AR and IR share a similar topology and may therefore 
operate by a similar mechanism. This study must be approached carefully since it was 
carried out prior to the detailed structural determination of the human IR becoming 
available (Lawrence et al., 2007) which demonstrated gross architectural differences 
between human IR and bacterial signalling proteins. As far as is known, this 
controversial hypothesis of a universally conserved signal transduction mechanism has 
not been tested experimentally to a degree comparable with the “rotation model” for the 
SK by Hulko et al. (2006) and Möglich et al. (2009). Another chimera termed “IAR” 
features an alternative combination between IR and AR, and it failed to exhibit kinase 
activity in response to the stimulus (Ellis et al., 1986). The apparently functional “AIR” 
chimera may therefore be an artefact and it alone is insufficient to prove the notion of a 
universal mechanism for receptor proteins. 
It is clear that a conserved mechanism exists between various receptor proteins to a 
certain extent, but the exact boundary of conservation of the mechanism is currently 
unknown. Questions remain over the appropriateness of the “rotation model” for some 
SKs whose sensor domain fragments assume the monomeric form (Cheung and 
Hendrickson, 2010) or signalling proteins with an atypical domain arrangement. If the 
Chapter 1: Introduction 
32 
 
sensor domains of these proteins do not form a molecular contact in a dimer, the 
rotational force will not be transferred to the signalling domain, because the rotational 
force generated by the sensor domain will result in its own rotation relative to the HK. 
The soluble SK RpBphP4 could correspond to such a hypothetical case. RpBphP4 was 
shown to assume a Y shaped global conformation in solution where the N-terminal 
sensor domains were interpreted as being far apart (Evans et al., 2006). Af1503 of 
Archaeoglobus fulgidus exemplifies another unusual case because the HAMP domain is 
its sole cytoplasmic part (Hulko et al., 2006). It seems unlikely for these unusual 
proteins to operate by the same mechanism as SKs with a canonical domain 
organisation.  
The mechanism of signal transduction by helical rotation seems to be widespread, but 
other models of signal transduction cannot be excluded. Whether other models also play 
roles in the signal transduction in SKs, and if so, how widespread such mechanisms are 
is yet to be seen. 
 
 
Figure 1.6 Four hypothetical mechanisms of signal transduction from the N-terminal sensor domain 
to the C-terminal HK domain in a membrane associated Class I SK. A) Piston movement, B) 
Horizontal translation, C) Pivot movement, and D) Rotation model. The colour scheme is as follows 
Periplasmic sensor domain: Green, transmembrane region: Orange, DHp domain: Blue, and CA 
domain: Red. These motions will cause movements relative to each monomer. 
A B 
C D 
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1.3 Phytochrome 
1.3.1 Diversity and evolutionary perspectives 
Phytochrome was originally identified in plants as being a light sensitive pigment that 
absorbs light most effectively in the red region (Butler et al., 1959). Phytochromes are 
light-sensitive proteins that reversibly interconvert between two thermostable forms 
termed Pr-form, the red-light absorbing form, and Pfr-form, the far-red light absorbing 
form. Phytochromes regulate numerous light dependent physiological responses 
(Scheerer et al., 2010). Since the original discovery, phytochromes have been identified 
in cyanobacteria, photosynthetic bacteria, non-photosynthetic bacteria, filamentous 
fungi, slim moulds, and diatoms (Lamparter et al., 1997, Jiang et al., 1999, Davis, 1999, 
Blumenstein et al., 2005, and as reviewed in Vierstra and Zhang, 2011). Additionally, 
variants of phytochrome with unusual domain organisation (Ulijasz and Vierstra, 2011) 
and photoreceptors that are related to phytochrome, but with a distinctly different 
photocycle, have been identified (Rockwell et al., 2011).  
The diversity of phytochromes has led to at least two hypotheses being put forward 
regarding their evolutionary path. The plant phytochrome was originally thought to 
have been inherited from cyanobacteria during the process of endosymbiosis. The 
theory is based on similarities between the plant and the cyanobacterial phytochromes 
in their cognate bilin chromophore and the location of the covalent bond forming 
cysteine residue (Herdman et al., 2000, Lamparter et al., 2003). An alternative theory 
hypothesises that the plant and the cyanobacterial phytochromes are distantly related to 
each other based on sequence alignments carried out independently on the N-terminal 
and the C-terminal parts of phytochromes (Lamparter, 2004). This result led to a 
proposition that plant cells already possessed bacteria-type phytochromes prior to the 
acquisition of plastids. The endosymbiosis resulted in the introduction of biliverdin 
reductase from the cyanobacteria to the plant, which explains the similarity between 
their cognate bilin chromophore. The reduction of the bilin changed the preferred site 
for the covalent bond-forming cysteine residue, and the seemingly conserved cysteine 
residue in plant and cyanobacterial phytochromes is therefore the result of convergent 
evolution. Neither of these hypotheses have become the consensus, but the presence of 
bacterial-type phytochromes in both cyanobacteria and plants may be interpreted in 
favour of the latter hypothesis (Quest and Gärtner, 2004). 
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1.3.2 Bilin and the mode of attachment 
Phytochrome’s sensitivity to light originates from a covalently bound chromophore, 
which is a bilin, a linear tetrapyrrole. The bilin is covalently attached to a conserved 
cysteine residue, and the process of autocatalytic attachment is a characteristic feature 
of bona fide phytochrome, which is unusual among phycobiliproteins (Scheer and Zhao, 
2008). The type of the covalently bound bilin chromophore differs among the lineages 
of phytochromes. In general plant phytochromes bind to phytochromobilin (PB), 
cyanobacterial phytochromes bind to phycocyanobilin (PCB), and bacterial and fungal 
phytochromes bind to biliverdin (BV). BV is the immediate breakdown product of haem 
by haem oxygenase (Lamparter, 2004). BV binds to the cysteine residue in the N-
terminal region upstream of the PAS domain via its vinyl side chain (Lamparter et al., 
2003). In case of plant and cyanobacterial phytochromes, BV is reduced to produce 
PB and PCB in plant and cyanobacteria, respectively. These two bilins have an 
ethylidene side chain at the A-ring in common, and covalently bind to the cysteine in 
the GAF domain (Lamparter, 2004). 
The GAF domain is the minimum lyase domain required for the formation of the 
covalent bond between the cysteine residue and the bilin in plant and cyanobacterial 
phytochromes (Wu and Lagarias, 2000). For bacteriophytochrome that binds to a BV 
via its N-terminal region, the PAS domain is required for the covalent bond to form 
between the BV and the cysteine residue. Bacteriophytochromes have been shown to 
bind to a PCB non-covalently, but the covalent bond will form if a cysteine is present in 
the GAF domain at the position homologous to the plant/cyanobacterial phytochromes 
(Lamparter et al., 2002, Wagner et al., 2007). Whether an isolated GAF domain of a 
bacteriophytochrome with a cysteine introduced at the homologous location forms a 
covalent bond with PCB has yet to be shown. 
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Figure 1.7 Domain organisations of phytochromes. A) Three main classes of phytochromes and 
their cognate bilin chromophores. Homologous domains are coloured the same. The bilins are shown 
in their free form. The bilin side chains that form covalent bonds with conserved cysteine residues 
are highlighted with colours - red for vinyl side chain of BV, and blue for ethylidene side chains of 
PCB and PB. The cysteine residues where the covalent bonds form are indicated in yellow. B) 
Fragments of the Agp1 phytochrome used in the present study. 
  
A 
B 
The cysteine residue which forms a covalent bond with a bilin chromophore 
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1.3.3 Photochromicity 
Binding of a bilin, including the formation of a covalent linkage, to its cognate apo-
phytochrome causes a change in the absorption spectrum characterised by an increase in 
the extinction coefficient and the max in the Q-band region. Similar changes are also 
observed for non-covalent adduct formation (Lamparter et al., 2002). Formation of the 
covalent bond also has an effect on the absorption spectrum, as the non-covalent Cph1-
PCB adduct is red-shifted with respect to the covalently bound adduct (Borucki et al., 
2003). The max (Q-band) of holoprotein adducts of plant and cyanobacterial 
phytochromes are, in general, roughly 50 nm lower than those of bacterial 
phytochromes (Lamparter, 2004). An increase in absorption in the Q-band region 
enables the assignment of “Specific Absorbance Ratio (SAR)” (Scheerer et al., 2006), 
which is calculated according to the equation below. 
                                    
Here AbsorbanceQmax is the absorbance at the max in the Q-band region. The SAR value 
enables the evaluation of the proportion of holoprotein in a given sample relative to 
other samples of the same protein. 
Absorption spectroscopy and resonance Raman spectroscopy allowed for the 
identification of several intermediate stages of the photocycle of phytochromes (Fig. 
1.8). In the Pr-form all the pyrrole ring nitrogens are protonated. Upon absorption of a 
photon, isomerisation occurs around a double bond between the C and the D rings of the 
bilin, leading to the formation of the Lumi-R form within a picosecond timescale. Lumi-
R (max = 688 nm), with a partially bleached absorption spectrum, then undergoes 
thermal relaxation into Meta-Ra, with max at 663 nm, on a microsecond timescale. The 
subsequent formation of Meta-Rc (max = 725 nm) on a micro- to millisecond timescale 
is associated with deprotonation of a pyrrole ring nitrogen. Finally, the thermal 
relaxation steps are completed with the formation of the Pfr-form with fully protonated 
pyrrole ring nitrogens. These relaxation stages induce conformational changes in the 
protein that ultimately result in modulation of the activity of the C-terminal kinase 
domain. The Pfr-form can revert back into the Pr-form either by a spontaneous process 
of dark reversion or by absorbing far-red light, the latter proceeding at the faster rate. 
Some phytochromes referred to as bathy-phytochromes (Karniol and Vierstra, 2003) 
will undergo dark reversion in the opposite direction such that the Pfr-form is the dark-
adapted form. Neither PfrPr pathways are well understood (Wagner et al., 2008). To 
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date, photocycles of the classical (stable in the Pr-form) and the bathy-phytochromes 
(stable in the Pfr-form) have not been fully established as proceeding by the same 
pathways, although some similarities including the initial D-ring flip have been reported 
(Yang et al., 2011, and as reviewed in Scheerer et al., 2010).   
The changes that occur in the bilin chromophore during photoconversion have been a 
subject of intense investigation by a multitude of techniques. The current consensus for 
the first stage is that the D-ring flips via an isomerisation around the double bond 
between the C and the D-rings (Rockwell and Lagarias, 2010, Song et al., 2011, Yang et 
al., 2011). The first crystallographic evidence for this came from crystal structures of 
the PaBphP Q188L mutant. Crystal structures of a mutant with markedly decreased rate 
of dark-reversion were deemed to be in a mixed state of a Pfr/Pr-form as judged by 
absorption spectroscopy (Yang et al., 2011). The electron densities of the bilin 
chromophore and the surrounding residues were broad and this was interpreted to be the 
result of the simultaneous presence of BV in two different configurations – one, as in 
the wild type PaBphP crystal structure, which is in a pure Pfr-form (Yang et al., 2008) 
and the other, as in the DrBphP crystal structure, which is in a pure Pr-form (Wagner et 
al., 2007). More explicit evidence was obtained from a “trap–pump–trap–probe” 
experiment carried out on PaBphP, where the data suggest that the configurational 
change is initially confined in the D-ring, but later the changes extends to the B- and 
then to the A-ring (Yang et al., 2011). Collectively, the data supports the “flip-and-
rotate” model proposed for the overall movement of the bilin during the 
photoconversion (Yang et al., 2009). The initial D-ring flip is followed by a clockwise 
in-plane rotation of the entire bilin moiety relative to the GAF domain (view direction 
onto the -face of the bilin). With regards to the initial D-ring flip, the directions of the 
rotation of the D-ring in the plant/cyanobacterial and bacterial phytochromes were 
proposed to be the opposite. The D-ring of the BV in bacteriophytochromes and the D-
ring of the phytobilin (PB and PCB) in plant/cyanobacterial phytochromes were 
proposed to rotate anti-clockwise and clockwise, respectively, as the bilin is viewed in 
parallel to the planar B- and C-rings with the D-ring in the foreground (Rockwell et al., 
2009). 
A surprising observation has been reported where the primary movement of the bilin 
occurs at the A-ring in the GAF domain fragment of SyB-Cph1 from Synechococcus 
OS-B’. Comparison of the solution structures of SyB-Cph1 in the Pr- (PDB code 2KOI) 
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and the Pfr-form (PDB code 2KLI) showed the rotation to occur at the A-ring around 
the axis of C4=C5 atoms by about 90. The bilin structures were significantly 
remodelled in the refined structures of SyB-Cph1 in the Pr- (2LB9) and the Pfr-form 
(2LB5). Changes include the positions of the bilin moieties relative to the GAF domains 
in both forms. Additionally, the movement of the A-ring as inferred from the refined 
structures in the Pr- and the Pfr-forms is qualitatively different from the original 
proposal. Nonetheless the conclusion that the A-ring is the major location of the 
conformational change during the photoconversion remains the most favourable 
outcome from the comparison of the revised structures. This finding was commented as 
controversial and difficult to reconcile with the existing data (Hughes, 2010), but given 
the recent discovery of more diverse members of the phytochrome family, some of 
which undergo complex photocycles involving two cysteine residues (Rockwell et al., 
2011), it could be hypothesised that the molecular trajectories during the 
photoconversion may not be conserved among all classes of phytochrome and related 
proteins. Additionally, there is always a concern when comparing structures solved by 
crystallography and by nuclear magnetic resonance (NMR) spectroscopy. Indeed, 
effects of crystal packing on the global conformation have been described previously for 
Cph1 (Mailliet et al., 2011) and are as well described for Agp1 in the present study 
(Section 3.10.2). It is possible that the process of crystallisation led to accumulation of 
structurally homogeneous species of phytochrome molecules whereas data from NMR 
spectroscopy may be reflecting the simultaneous presence of more diverse species at 
different points in the photocycle. It will be interesting to obtain the crystal structures of 
SyB-Cph1 and compare the solution and crystal structures for any differences between 
them. 
Configurations of the bilins in phytochrome holoproteins are difficult to study, because 
of their movement during the photocycle under ambient condition. To this end, 
synthetic, locked chromophores with additional carbon chain(s) that maintain the 
predetermined configurations were devised (Figure 1.9). The holoprotein adducts with 
locked chromophores were analysed for their resemblance to the natural holoproteins. 
UV-vis spectra collected from phytochrome adducts with singly locked chromophores 
termed 15Za and 15Ea strongly suggest that the structures of these synthetic molecules 
to resemble BV in the Pr- and the Pfr-forms, respectively in both Agp1 and Agp2, and 
these are consistent with the configurations of the BVs found in the crystal structures of 
DrBphP (5Zs/10Zs/15Za, Wagner et al., 2007) and PaBphP (5Zs/10Zs/15Ea, Yang et al., 
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2008) . Analyses on Agp1 and Agp2 holoprotein adducts with the locked chromophores 
5Za and 5Zs indicated that the holoproteins with 5Zs have absorption spectrum that 
more closely resembles that of the natural holoprotein in the Pr-form. However, the 5Za 
holoprotein was found to resemble the Pfr-form more closely than the 5Zs holoprotein 
upon photoconversion, thus indicating the C5-C6 single bond to be in the anti 
conformation in the Pfr-form. Motion around the A-ring in the photocycle is consistent 
with the mechanism proposed for SyB-Cph1 (Ulijasz et al., 2010). However, the anti 
conformation around the C5-C6 bond is inconsistent with the syn conformation 
suggested for the Pfr-form of Cph1 (Hahn et al., 2008, Rohmer et al., 2008) and found 
in the PaBphP crystal structure (Yang et al., 2008). A relatively broad electron density 
calculated from a low resolution dataset may not exclude the possibly of an alternative 
configuration of the BV in the structure in the latter case.  
Additionally, the identity of the photocycle between the classical and the bathy-
phytochrome has not been fully established. A notion that the C5-C6 bond assumes the 
anti conformation is further supported by a study employing four doubly locked 
chromophores in a study to determine the stereochemistry between the A- and the B-
rings (Inomata et al., 2009). The absorption spectra of Agp1 and Agp2 holoproteins 
with the doubly locked chromophores in the 5-anti conformation resemble those of the 
natural holoproteins, but those of chromophores with the 5-syn conformation do not. 
Out of two doubly locked chromophores with the 5-anti conformation, the Agp2 
holoprotein with 5Ea15Ea conclusively resembled the Pfr-form more than did the 
holoprotein with 5Za15Ea, but the resemblance was not so clear in case of Agp1. 
Because of the ambiguity concerning the correct stereochemistry between the A- and 
the B-rings it seems possible that the stereochemistry of the bilins is different among 
phytochromes. In a recently study, synthetic locked chromophores termed 15ZaPCB 
and 15EaPCB were used, and those PCB chromophores resemble the configurations of 
15Za and 15Ea, respectively (Yang et al., 2012). The 15EaPCB adduct of plant 
phytochromes exhibited Pfr-like properties during in vitro and in vivo studies, thus 
supporting the notion of conserved chromophore motion for phytochromes with 
canonical domain organisation. 
Clearly more research is required to establish the exact molecular trajectory of 
stereochemical changes at the bilin in phytochrome during the photocycle and also the 
extent of conservation of the mechanism in the phytochrome family. 
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Figure 1.8 Schematic diagram of the photocycle of a classical phytochrome. Diagram adapted from 
Wagner et al., 2008. The wavelength of the absorption maximum in the Q-band of the Pr- and the 
Pfr-forms are of Agp1 M15-BV. 
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Figure 1.9 All locked chromophores that were tested on bacteriophytochromes to date. The numbers 
in their names indicate the number of the carbon atom where the single and the double bonds have 
been locked in a certain stereochemistry. Z and E represent the configuration of the double bonds, 
respectively, whereas s and a represent syn and anti conformations of single bonds, respectively. 
Note all the doubly locked chromophores feature ethyl (instead of vinyl) side chains, therefore 
would not allow the formation of covalent adducts with bacteriophytochromes. Figures adapted from 
Inomata et al. (2005); Inomata et al. (2006); Inomata et al. (2009). 
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1.3.4 Phytochrome structures 
Phytochrome domain organisation has been known based on sequence alignment prior 
to any structure determination (Montgomery and Lagarias, 2002). The N-terminal 
sensor domain of phytochromes, referred to as the photosensory core module (PCM, 
Yang et al., 2009), consists of a PAS, a GAF, and a PHY domain (Fig. 1.7), all of which 
were found to possess a conserved fold (Essen et al., 2008, Yang et al., 2008). The N-
terminal regions of phytochromes are characterised by an unusual knot consisting of a 
region upstream of the PAS domain and a loop extending from the GAF domain 
(Wagner et al., 2005). The C-terminal region is a signalling domain, and cyanobacterial 
and bacterial phytochrome feature a HK domain. HK domains of phytochromes are 
expected to be similar to structurally well characterised Class I SKs based on the similar 
domain organisation and the sequence identity, for example the sequence identity 
between Agp1 HK and TM0853 (PDB code: 2C2A, Marina et al., 2005) is 30.32%. The 
C-terminal signalling domain of plant phytochromes has evolved to become a Ser/Thr 
kinase (Chen et al., 2004). Additionally, plant phytochromes feature two tandem PAS 
domains termed “Quail module” between the N-terminal PCM and the C-terminal 
signalling domain (Hughes, 2010).  
The first structure determination of a phytochrome was reported in 2005 when the 
structure of the chromophore binding domain (CBD, Wagner et al., 2005) 
encompassing the PAS and GAF fragment of D. radiodurans phytochrome (DrBphP) 
was described. Since then many more phytochrome structures have been determined 
which are summarised in Table 1.2. Each phytochrome structures differ by variables 
such as the source organism, the type of the chromophore, the form in which its 
structure was determined, and the primary structure. A major breakthrough was made 
when the structures of the entire photosensory core modules (PCM) of phytochromes 
comprising the PAS, GAF, and PHY domains were simultaneously published in 2008. 
The structures of Synechocystis PCC6808 phytochrome 1 (Cph1) and P. aeruginosa 
phytochrome (PaBphP) were solved in their dark stable forms which are the Pfr- and the 
Pr-form, respectively (Essen et al., 2008, Yang et al., 2008). Cph1 and PaBphP 
crystallised as parallel and anti-parallel dimers, respectively. In the present thesis, the 
mode of dimerisation according to this nomenclature is described in Fig. 1.10. It is 
noted that the first report of crystallisation of a PCM fragment of a phytochrome was 
reported in 2006 by Scheerer et al., and a preliminary structure of Agrobacterium 
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tumefaciens phytochrome 1 was modelled based on the datasets described in the study 
from 2006 (Scheerer et al., 2010, Scheerer et al., 2006). 
Despite the initial anticipation that elucidating the mechanism of photoactivation and 
signal transduction should be possible by comparing the structures of different 
phytochromes in the Pr and the Pfr-forms, it was soon realised that conformational 
differences cannot immediately be attributed to such differences due to numerous 
differences of variables between them. Cph1 is a classical phytochrome from a 
cyanobacterium with PCB as the chromophore, whereas PaBphP is a bathy-
phytochrome from a -proteobacterium with BV as the chromophore. Conformational 
differences between Cph1 and PaBphP can be explained by any of the following 
variables, such as low identity of the primary structure (31.25%), genuine differences 
between Pr and Pfr-form, or structural features specific to the lineage of each 
phytochrome. The latter variable can be further divided into two types of classification - 
bacterial and cyanobacterial phytochromes, and the classical and the bathy-
phytochromes.  
Under natural conditions, there is a correlation between the type of covalently bound 
chromophore, the type of the phytochrome, and the position of the conserved cysteine 
residue (Section 1.3.2). It is possible however, to obtain an unnatural holoprotein with a 
covalently bound non-cognate bilin by introducing appropriate mutations. For example 
the Agp1 C20A/V249C mutant binds covalently to PCB, and crystallisation of such a 
holoprotein has been described (Scheerer et al., 2010). Structural information for this 
unnatural holoprotein may help to disentangle the specific effect the bilin imposes on 
the structure of the holoprotein. 
At the start of this project, the source organisms from which the structures of 
phytochrome PCMs had been solved were limited to Synechocystis PCC 6803 and P. 
aeruginosa, therefore it has not been possible to disentangle the correlation between the 
variables and structural features. Subsequently more structural studies have been 
published, including the structures of SyB-Cph1 in both Pr- and Pfr-forms, and PaBphP 
in the mixed Pfr/Pr-forms. Both studies have some limitations, however. In case of the 
former, the SyB-Cph1 structures in solution were solved as the GAF domain fragment, 
and it is not ideal for deducing how the initially localised molecular changes are 
ultimately translated into the modulation of the kinase activity. For the latter, a logical 
question may be posed regarding crystal structures of a protein in mixed states. One 
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question could be that since some conformational change should be expected to occur 
during a photoconversion, how could then the simultaneous presence of two forms in a 
crystal have resulted in the refinement of a single entity? Should no conformational 
change be expected, then what is the mechanism of signal transduction from the N-
terminal sensor domain to the C-terminal HK domain? Yang et al. (2009) interpreted 
the broad electron density map as the result of simultaneous presence of two forms, but 
working with such maps could lead to over-interpretation. While it is clear that each and 
every one of these studies have contributed to accumulation of our knowledge, it is still 
highly desirable for other phytochrome PCM structures to be solved, because the 
availability of multiple representatives for each type of phytochromes (classical and 
bathy) will enable the disentanglement of the variables contributing to conformational 
differences. Furthermore, structures of a single phytochrome in both Pr- and Pfr-forms 
are required in order to reveal the molecular trajectories during the photoconversion 
process. Structural information of a single phytochrome in both photochromic states 
will enable to carry out structural comparison without bias, and thus help to clarify the 
effect of photoconversion which culminates in signal transduction to the C-terminal 
histidine kinase. 
 
Figure 1.10 Two modes of dimerisation in crystal structures of phytochrome PCMs. PCM structures 
of Cph1 (PDB code: 2VEA) and PaBphP (PDB code: 3C2W) in ribbon presentation. PAS, GAF, 
and PHY domains as defined by the SMART server are in red, blue, and green, respectively. In the 
present thesis, a parallel dimer is defined by the corresponding domains at the longitudinal termini 
of two monomers in a dimer being in cis orientation. An anti-parallel dimer is defined by the 
corresponding domains at the longitudinal termini of two monomers in a dimer being in trans 
orientation. 
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1.3.5 Signalling mechanism of phytochrome 
Signal transduction mechanisms of SK in general were discussed in Section 1.2.4, but 
here phytochrome will be treated specifically. 
Similar to SKs in general, our current understanding of signal transduction in 
phytochromes is rudimentary. This is partially due to the fact that only a few of the 
phytochromes have been characterised for their kinase activity in three different forms - 
as apoprotein, the Pr-form, and the Pfr-form. Such analyses have been carried out on 
Agp1, Agp2, Cph1, and PaBphP, and the consensus seems to be that the relative kinase 
activity is the highest for the apoprotein. As for the holoprotein, the dark adapted form 
has the higher kinase activity (Inomata et al., 2005, Karniol and Vierstra, 2003, 
Lamparter et al., 2001, Njimona and Lamparter, 2011, Psakis et al., 2011, Tasler et al., 
2005). Originally PaBphP was reported to exhibit higher kinase activity in the Pfr-form 
(the dark adapted form), but the difference in kinase activities in the Pr- and the Pfr-
forms were marginal (Tasler et al., 2005). The work by Tasler and co-workers is 
regarded as controversial, because an independent investigation using a mutant of 
PaBphP that cannot form the Pr-form concluded the Pr-form to have a higher kinase 
activity (Yang et al., 2011). At least one conclusion which can be drawn from the 
currently available observations is that the relative kinase activity, with respect to the 
bathochromic state, is different among phytochromes.  
The modulation of kinase activity of a chimeric SK, created by fusing Cph1 and EnvZ 
(Levskaya et al., 2005), in response to light is seemingly paradoxical. The parental SK, 
Cph1 has higher kinase active in the Pr-form. The chimera is also more active in the Pr-
form, but importantly the chimera contains a HAMP domain between the sensor and the 
HK domains. From its structure, the HAMP domain was implied to inverse the signal by 
reversing the direction of rotation of the linker helices (Hulko et al., 2006). This may be 
rationalised by the rotation model of signal transduction (Section 1.2.4), because 
according to the model the number of residues at the linker plays a key role in 
determining the kinase activity in response to the stimuli. 
Whether the signal transduction mechanism is conserved between the plant 
phytochromes and bona fide SK-type (cyanobacterial and bacterial) phytochromes is 
unknown. The signal transduction in plant phytochromes may not be confined to the 
SK-type mechanism as some activity modes of plant phytochromes are not found in SK-
type phytochromes, for example the reversible interaction between the Quail module of 
Chapter 1: Introduction 
48 
 
Arabidopsis PhyB and PIF3 (Ni et al., 1999).  
It is established for SK that the formation of a parallel dimer is required for its kinase 
functionality. As of now no full-length structure of a phytochrome with canonical 
domain organisation has been determined. The full-length structure of RpBphP1 has 
been determined (Bellini and Papiz, 2012b), but its off-set anti-parallel dimer mode is 
unlikely for canonical phytochromes for two reasons. Firstly, RpBphP1 is an atypical 
bacteriophytochrome which does not have a HK domain at its C-terminus. Experimental 
evidences support the canonical phytochromes to form a parallel dimer (Evans et al., 
2006, Li et al., 2010). Secondly, no plausible mechanism can be proposed for HK 
activity for an anti-parallel phytochrome dimer, given that the formation of a dimer at 
the HK domain is a prerequisite for a kinase activity even for the ones that undergo cis 
autophosphorylation (Casino et al., 2009). 
Two modes of inter-domain orientation have been proposed for the PCM and the HK 
domains in phytochromes. The HK domains of each monomer may be orientated either 
in cis or trans relative to the PCM dimer (Fig. 1.11). Indirect support for the cis 
orientation comes from a crystal structure of TM0853 including a HK with a PAS 
domain at its N-terminus (Fig. 1.5, Yamada et al., 2009). As described, the PAS domain 
shares a common fold with the GAF and PHY domains, therefore an analogy may be 
drawn between phytochromes and TM0853 regarding their domain orientations. Low 
resolution structures obtained by cryoelectron microscopy on DrBphP (Li et al., 2010) 
and small-angle X-ray scattering (SAXS) on RpBphP4 (Evans et al., 2006) do not rule 
out the possibility of inter-domain orientations in trans. 
With regards to the orientation of the Quail module (two PAS domains) relative to the 
PCM, the near-full length crystal structure of RpBphP1 may be regarded as a proxy. The 
crystal structure includes the PCM followed by a PAS/PAC domain but does not include 
the C-terminal HOS domain (Bellini and Papiz, 2012b). 
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Figure 1.11 Two hypothetical modes of inter-domain orientations for the PCM and the HK domains 
in a full-length phytochrome. Structures are shown as cartoons. The preliminary structure of the WT 
M15-BV (Scheerer et al., 2010) is used as the N-terminal PCM and the C-terminal HK is from 
TM0853 (2C2A). A hypothetical full-length model of PaBphP with cis orientation has been 
presented in Yang et al. (2008). In Li et al. (2010) the cis and the trans orientations are referred to as 
mode I and II, respectively. 
 
1.3.6 Applications of phytochromes in the future 
Numerous applications of phytochromes have been suggested and demonstrated to date. 
Firstly, understanding the mechanistic details of phytochrome will lead to a better 
mechanistic understanding of the SK superfamily of TCS in general (Hughes, 2010). A 
system that can be reversibly switched on and off represents an improved model system 
compared to other chemical receptor SKs whose HK activity are modulated by 
diffusion-dependent stimuli. 
Phytochromes are already known to control many physiological roles in plant, for 
example draught resistance (Gonzalez et al., 2012). It is anticipated that further insights 
into the molecular mechanism of phytochromes will enable more rational approaches to 
be pursued by genetic engineering to improve food and biofuel production (Ulijasz et al., 
2010). 
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Structural studies in addition to biochemical characterisation of phytochrome mutants 
revealed the residues essential for the photoconversion. Fluorescent phytochromes with 
chromophores that do not permit photoconversion have been documented, for example 
an adduct with Phycoerythrobilin (PEB) or adducts with locked chromophores 
(Zienicke et al., 2011). Alternatively, experiments using holoproteins which has bound 
natural chromophore, but contains mutations at key residues, have also been shown to 
result in fluorescent phytochromes, possibly due to the loss of conformational freedom 
of the bilin chromophore around the D-ring (Samma et al., 2010). Fluorescent 
phytochromes display a maximum in the fluorescence spectrum towards the near-infra 
red (IR) region, therefore they are an attractive fluorophore for in vivo imaging because 
BV, the required cofactor, is available in the cell and light in the near-IR wavelength 
penetrates tissues more efficiently than light in the visible region (Lecoq and Schnitzer, 
2011). Characterisation and expression of mutated phytochrome-based fluorophore in 
mammals have already been reported (Filonov et al., 2011, Shu et al., 2009). 
Finally, the ability of phytochrome to translate the light signal into a biochemical signal 
has attracted its use as a component in the growing field of synthetic biology and 
optogenetics. The modular nature of SKs has enabled the creation of a chimeric SK 
from fragments of Cph1 and EnvZ as described in Section 1.2.4, which enabled the 
construction of a biological photographic system (Levskaya et al., 2005). In another 
example the ability of Arabidopsis thaliana PhyB is utilised to reversibly recruit 
phytochrome interacting factor 6 (PIF6) to spatially and temporally control a protein-
protein interaction by light (Levskaya et al., 2009). Unique features of phytochrome will 
help to create diverse synthetic biological circuitries in the future along with a growing 
catalogue of biological parts (Registry of Standard Biological Parts, 
http://partsregistry.org/). A light-switchable promoter system has also been described 
(Shimizu-Sato et al., 2002). An increase in the overall structural information will 
undoubtedly help progress within the field of optogenetics (Moglich and Moffat, 2010). 
1.3.7 Phytochromes in Agrobacterium tumefaciens 
Agrobacterium tumefaciens is a non-photosynthetic plant pathogen, the causative agent 
of crown gall tumour in plants. Its use as means to transform plants has been established 
in the field of plant biotechnology (Christou, 1996), and its importance lead to the 
genome of C58 strain being sequenced, based on which two papers were published 
simultaneously(Goodner et al., 2001, Wood et al., 2001). Discovery of phytochrome 
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genes in a genome of a non-photosynthetic bacterium was a surprise, because initially 
no light was thought to be present in the natural sub-terrestrial habitat of A. tumefaciens. 
Later sunlight was found to be conducted by plant stem and roots (Sun et al., 2003) and 
it is also possible for A. tumefaciens to be exposed to the sun when on the surface of the 
soil (Scheerer et al., 2010). Discovery of phytochrome homologues in bacteria greatly 
accelerated biochemical characterisations of phytochromes as these are more amenable 
to overproduction with E. coli (Rockwell et al., 2006). 
Phytochrome homologues from A. tumefaciens have been utilized as model 
phytochromes since their discovery, as in the present study. In this thesis a phytochrome 
termed Agp1 (alternatively referred to as AtBphP1, Karniol and Vierstra, 2003) is used 
as a model phytochrome, due to it being suitable for several reasons. It possesses a 
canonical domain organisation as well as being a classical phytochrome with standard 
photochemistry with the Pr-form being the dark adapted form (Lamparter et al., 2003). 
Additionally, the presence of another phytochrome Agp2 in the A. tumefaciens genome 
makes the system an interesting target for characterising the physiological roles in vivo, 
because Agp1 and Agp2 have antagonistic spectral properties and Agp2 possesses an 
atypical HK domain termed HWE-HK (Karniol and Vierstra, 2003, Karniol and 
Vierstra, 2004). Furthermore, as a HWE histidine kinase, Agp2 has with an RR domain 
at the C-terminus, which is in contrast to Agp1 with its typical domain organisation of a 
soluble SK. 
Physiological roles of Agp1 and Agp2 in A. tumefaciens have been studied. Plant 
infectivity of A. tumefaciens was not altered by single or double knockout mutations of 
Agp1 and Agp2, regardless of the light condition. The growth rate of A. tumefaciens is 
reduced in both light and dark conditions when both phytochrome genes were knocked 
out (Oberpichler et al., 2006). In the following study, A. tumefaciens and other 
Rhizobiaceae species were found to exhibit the scotophobic (fear of darkness) response. 
Increased motility in darkness was found to originate from upregulation of flagella 
component proteins (FlaA and FlaB), but single or double knockout mutants of Agp1 
and Agp2, as well as a knockout mutant of PhrA, a photolyase, exhibited identical 
swimming behaviour as the wild type, suggesting either the presence of an additional 
photoreceptor in the A. tumefaciens genome or phytochromes and photolyase to 
compensate for the absence of each other (Oberpichler et al., 2008). The future answer 
to this question may be related to the presence of PhrB, another homologue of 
photolyase which has been identified in A. tumefaciens genome (Oberpichler et al., 
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2011). Recently, a study suggested the physiological role of Agp1 to be a temperature 
sensor as well as a light sensor (Njimona and Lamparter, 2011). The kinase activity of 
Agp1 decreased in response to increasing temperature while in general maintaining the 
relative order of kinase activity in decreasing order of apo-form, Pr-form, and Pfr-form. 
This reduction in kinase activity was not attributed to the denaturation of the protein as 
judged by the integrity of the absorption spectra obtained for the investigated range of 
temperatures. Furthermore, the temperature dependent formation of a novel Prx-form 
with a unique absorption spectrum was observed. 
1.3.7.1 Start codon ambiguity 
When interpreting the structural and biochemical data using the recombinant Agp1, it 
must be noted that there is an ambiguity regarding the location of the exact start codon. 
Subcloning of the Agp1 gene into an expression vector was first documented by 
Lamparter (2002) and the pair of primers used for amplification from the A. tumefaciens 
C58 genome is shown in Fig. 1.12. 
Primer 1 
N-                             M  Q  R  E  R  L  E -C 
5-GGAATTCATTAAAGAGGAGAAATTAACTATGCAAAGAGAGCGGCTGGAG-3 
   EcoRI                      Agp1 sequence 
Primer 2 
5-GGGAGATCTGGCAATTTTTTCCTCTTCAACTTTC-3 
3-CCCTCTCGACCGTTAAAAAAGGAGAAGTTGAAAG-5 
C-   L  D  P  L  K  K  R  K  L  K   -N 
      BglIIAgp1 sequence 
 
Figure 1.12 Primers used during the amplification of the Agp1 coding sequence from A. 
tumefaciens C58 genome in Lamparter et al. (2002). The nucleotide sequence following the first 
ATG codon will translate as MQRERLE. Bases coloured in blue and yellow are protein coding 
sequences and restriction sites, respectively. Bases highlighted in green represent additional base 
pairs to be added to the end of recognition site to ensure efficient restriction digestion. The 
complementary bases are added for the second primer to aid viewing. 
 
Upon checking the open reading frame Atu1990, which corresponds to Agp1 in the 
circular chromosome of A. tumefaciens C58 from two independent genome projects 
published simultaneously (Goodner et al., 2001, Wood et al., 2001), it is clear that the 
position of the presumed start codon in Lamparter et al. (2002) is actually occupied by 
the codon TTG which is normally translated into leucine (Fig. 1.13). The annotated 
protein coding sequence starts from another downstream methionine which corresponds 
to Met10 according to the numbering by Lamparter et al. (2002) and as far as is 
understood, all subsequent studies using Agp1.  
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A 
 
B 
 
Wood et al., 2001 
GenBank accession code: AE007869.2 
Goodner et al., 2001 
GenBank accession code: NC_003062 
Figure 1.13 Sequences of the circular chromosome of A. tumefaciens C58 viewed with Artemis 
13.2.1 (Rutherford et al., 2000). Sequences from two independent genome projects indicate the 
presence of a codon TGG in the position of the presumed start codon in Lamparter et al. (2002). 
 
It is not unknown for a start codon to be TTG. In fact, about 3% of the start codons are 
TTG in case of E. coli K-12 (Blattner, 1997). No publication is yet available to justify 
the assignment of the TTG codon as the start codon of Agp1. Judging the exact location 
of the start codon from the sequence alone is more difficult than the stop codons.  
Biochemical verification proved inconclusive. The absence of the first nine amino acids 
was shown not to drastically affect the overall properties of an Agp1 fragment termed 
M15 encompassing the PCM (Noack et al., 2007), which makes it difficult to judge 
whether the first nine amino acids according to the nomenclature of Lamparter et al., 
2002 is a legitimate part of the endogenous protein. Crystallisation of a BV adduct of 
the M15 fragment of Agp1 yielded a slightly better result with the protein lacking the 
first nine residues (P. Scheerer, personal communication). 
The most decisive way to clarify the issue will be to analyse the endogenously 
expressed Agp1 protein from A. tumefaciens C58 with Edman degradation or mass-
spectrometry. Such work may be technically difficult owing to the low level of Agp1 
being expressed in A. tumefaciens C58, which is estimated to be about ten molecules 
per cell (Oberpichler et al., 2006). Taking all the aforementioned factors into account, 
clarification of this issue does not justify the required resources in the present study. 
The majority of the crystallisation and biochemical analyses were carried out with the 
Chapter 1: Introduction 
54 
 
constructs lacking the first nine amino acid residues unless otherwise stated, and they 
are identified by the suffix of “s” after the name of the constructs (e.g. M15s). For the 
sake of consistency, the residue numbering in the present study will correspond to the 
nomenclature originating from Lamparter et al., 2002 (i.e. the chromophore-binding 
Cys residue in Agp1 is at the 20
th
 position). 
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1.4 Aim of the project and thesis outline 
The aim of this project was to obtain functional insights into phytochromes using 
structural information obtained via X-ray crystallography. Herein Agp1 was utilised as 
the model phytochrome. Agp1 was deemed a suitable target for crystallographic studies 
for several reasons. Firstly, Agp1 along with Agp2 have been subjects of intense 
biochemical and crystallographic analyses, and much data have already been 
accumulated for these proteins. Crystallisation of Agp1 PCM has been reported 
(Scheerer et al., 2006), and it is anticipated that the present study will be able to build 
upon the previous efforts. The new crystallographic structure obtained in the present 
study will be better rationalised and reconciled with data that have already accumulated 
for Agp1. Secondly, Agp1 is a classical bacteriophytochrome with a photocycle 
common to majority of phytochrome, hence its structural data is of wide relevance to 
other phytochromes. Moreover, at the start of the present study, Agp1 would have been 
the first classical bacteriophytochrome to be structurally determined as a PCM 
fragment, to the best of the author’s knowledge. This is significant as the Agp1 structure 
has added substantial information to the combination of variables as found in the 
already known structures of phytochrome PCM. At the start of the present study, only 
two phytochrome PCM structures were available (2VEA, Essen et al., 2008; 3C2W, 
Yang et al., 2008). Two phytochrome structures were different in many aspects, but such 
structural difference could not simply be rationalised as the difference in the Pr and the 
Pfr-forms, because many other variables that contribute to the structure of those proteins 
were different too. The variables are for example the type of the chromophore (BV or 
PCB) and the lineage (cyanobacterial or bacterial). Hence it posed difficulty over 
assigning the specific effect each variable had on the structures of two different 
phytochromes. Structure of Agp1, a bacteriophytochrome with biliverdin in the Pr-form, 
will help to disentangle how each variable affects the structure of phytochromes. 
To date, no phytochrome has had its structures of both Pr and Pfr forms solved. 
Structural comparison of two phytochrome PCM structures available at the start of the 
present study (Cph1 and PaBphP) reveals many differences between them, but 
ultimately it is not possible to deduce if the differences reflect the structural changes 
during a photoconversion in one phytochrome or if the differences are simply due to the 
low sequence identity. Whether the structure of Agp1 will turn out to resemble Cph1, 
PaBphP, or look like a mixture of both is impossible to predict from the sequence alone 
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as the sequence identities between all of them are similar (Table 1.4). 
 Agp1 Cph1 PaBphP 
Agp1  35.43% 33.33% 
Cph1   31.25% 
Table 1.4 Amino acid sequence identities between three phytochrome PCMs. Since the sequence 
identities are similar, it is difficult to predict whether the Agp1 structure will more closely resemble 
the Cph1 or the PaBphP structure. Sequences from the first residues (Met 1) to the last residues of 
the PHY domain as identified by the SMART server were aligned, and the residue numbers were as 
follows; Agp1 (1-504), Cph1 (1-513), PaBphP (1-498). Sequence identity was calculated with the 
number of aligned residues excluding deletions in the denominator. 
Solving the structures of Agp1 in both Pr- and Pfr-forms will enable an unbiased 
structural comparison to be made in order to deduce the molecular trajectories during 
the photoconversion. Additionally, the molecular movement which induces the signal 
transduction, eventually culminating in histidine kinase activity modulation, might also 
be understood. 
In the present study, structural biological studies have been associated with biochemical 
analyses to further characterise the difference between the Pr- and the Pfr-forms of 
Agp1. Recent publications now discuss the structures of phytochromes in detail 
especially in the context of photoconversion, but thus far apo-phytochromes have not 
been discussed in great detail. Analyses on apo-phytochrome fragments are also 
described in this thesis, because information regarding apo-phytochromes could 
describe how phytochromes acquire the ability to sense light. In this present study, 
Agp1 protein products of differing lengths were subjected to various biochemical 
analyses to pinpoint the location of conformational change as well as the quality of 
change. Additionally, since dimerisation is thought to be an essential prerequisite for a 
sensor kinase to carry out its kinase activity, the oligomerisation propensity of Agp1 
was investigated. 
This thesis is presented in a way such that after detailing the material and methods 
(Chapter 2), the structural analysis of Agp1 in the Pr-form is described in Chapter 3, 
followed by Chapter 4 that describes the attempts to structurally determine Agp1 in the 
Pfr-form. Next, the effects of the “Surface Entropy Reduction” strategy used during 
crystallisation of Agp1 in both Pr- and Pfr-forms are discussed in Chapter 5. 
Biochemical analyses to characterise the structural differences of Agp1 in different 
forms are presented in Chapter 6. Finally the overall summary is given in Chapter 7. 
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Chapter 2: Material and methods 
2.1 Materials and instrumentation 
2.1.1 Water 
Water for most biochemical analyses was sourced from Purelab DV35 (ELGA), which 
supplies water of Type 2 quality of as defined by ASTM® 
(http://www.millipore.com/lab_water/clw4/tutorial&tabno=4). Water of further 
stringent quality for molecular biological applications was obtained from Purelab Ultra 
(ELGA), which was further treated with diethylpyrocarbonate (DEPC, Sigma) to 
minimise the effect of nucleases to the DNA samples. 
2.1.2 Polymerase chain reaction 
DNA was amplified by PCR using the C1000 thermal cycler from Biorad. 
Phusion® high-fidelity DNA polymerase (Finnzymes) was used throughout the present 
study to amplify DNA, and was always used in combination with the HF buffer 
included in the kit. DMSO was used where indicated. 
All primers were purchased from Eurofins.  
2.1.3 DNA purification 
The peqGOLD plasmid mini kit I C-line (Peqlab) was used to isolate plasmid DNA 
from overnight cultures of E. coli. The peqGOLD cycle-pure kit (Peqlab) was used to 
isolate plasmids or amplified DNA from PCR reactions. 
2.1.4 DNA ligation 
Blunt end DNA ligation was carried out with T4 DNA ligase (AppliChem). 
2.1.5 Restriction endonucleases 
All type-two restriction endonucleases used in the present study (NdeI, BamHI, and 
XhoI) were sourced from New England Biolabs. 
2.1.6 Agarose gel electrophoresis 
TAE buffer was used as a component of an agarose gel and the electrophoresis buffer. 
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10 × TAE buffer Tris-HCl: 0.4 M 
 Glacial acetic acid: 1.142% (v/v) 
 EDTA: 0.01 M 
 
2.1.7 Polyacrylamide gel electrophoresis 
2.1.7.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
4 × Tris / SDS solution Tris-HCl: 1.5 M (pH 8.8) 
 SDS: 0.02% (w/v) 
 
4.2% Stacking gel 30% Acrylamide / 0.8% Bisacrylamide: 14% (v/v) 
 4 × Tris / SDS solution: 25% (v/v) 
 
4 × SDS loading solution Tris-HCl: 200 mM (pH 6.8) 
 DTT*: 400 mM 
 SDS: 8% (w/v) 
 Bromophenol blue: 0.4% (w/v) 
 Glycerol: 40% (v/v) 
*DTT was omitted from 4 × SDS(non-reducing) loading solution for non-reducing SDS-PAGE. 
10 × SDS Running buffer Tris-HCl: 0.25 M 
 Glycine: 1.9 M 
 SDS: 0.5% (w/v) 
2.1.7.2 Native polyacrylamide gel electrophoresis 
4 × Tris solution Tris-HCl: 1.5 M (pH 8.8) 
 
4.2% Stacking gel 30% Acrylamide / 0.8% Bisacrylamide: 14% (v/v) 
 4 × Tris solution: 25% (v/v) 
 
Native-PAGE loading solution Sucrose: 68% (w/v) 
 
Detergent-free buffer Tris-HCl: 0.05 M 
 Glycine: 0.4 M 
 EDTA: 0.001 M 
 
2.1.7.3 Staining and de-staining of polyacrylamide gels 
Coomassie staining solution* Coomassie brilliant blue R250: 0.194 (w/v) 
 Ethanol: 50% (v/v) 
 Glacial acetic acid: 7% (v/v) 
*Undissolved Coomassie brilliant blue was removed by Whatman No. 1 filter paper. 
Destaining solution  Ethanol: 10% (v/v) 
 Glacial acetic acid: 7% (v/v) 
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2.1.7.4 Molecular weight markers 
Protein marker I (14-116, AppliChem) was used as the molecular weight standards in 
reducing and non-reducing SDS-PAGE. SN marker was also used, and it consisted of 
M15 (55.8 kDa) and M20 (34.7 kDa) apoproteins at the final concentration of 1 mg/ml. 
SN2 marker was identical to SN marker except for the constituting proteins were M15s 
(54.9 kDa) and M20s (33.5 kDa) apoproteins. 
2.1.8 pH measurement 
The pH of solutions was determined by a pH 210 microprocessor pH meter (Hanna). 
Alternatively, pH indicator strips (pH 0-14, VWR) were used to determine the pH of a 
small amount of solution. 
2.1.9 Media for bacterial growth 
All liquid media were sterilised by autoclaving prior to use. An antibiotic was added to 
the liquid media once it has cooled, prior to use.  
LB and RB media 
LB media Tryptone: 1% (w/v) 
 Yeast extract: 0.5% (w/v) 
 NaCl: 0.5% (w/v) 
For rich broth (RB), 0.2% (w/v) of D-glucose was added to the above. 
SOC media 
SOC media Tryptone: 2% (w/v) 
 Yeast extract: 0.5% (w/v) 
 NaCl: 0.058% (w/v) 
 KCl: 2.5 M 
 Glucose: 0.4% (w/v) 
 
Agar plate 
Agar plates were used to obtain colonies of E. coli cells where an antibiotic may be 
added to select the cells bearing a plasmid that confers cells resistance, thereby allowing 
their growth. 
Agar was added to LB media at a concentration of 1.5% (w/v) prior to sterilisation with 
an autoclave. Where required, an antibiotic was added to the media after the media has 
been autoclaved and cooled to 50-60 °C.  
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Antibiotics 
All the plasmids used in the present study contain a gene encoding for -lactamase, 
conferring host E. coli cell resistance to ampicillin, which was used as the selective 
antibiotic. 
Ampicillin sodium salt was solubilised in 50% ethanol to the final concentration of 100 
mg/ml. The working concentration of the ampicillin was 100 g/ml. 
2.1.10 Cell disruption 
Collected E. coli cells were disrupted for protein extraction either by freeze/thaw cycles, 
sonication, or by sing a cell homogeniser, or a combination of those methods. 
Sonication was carried out with a Vibra cell sonicator (Sonics). Cells were homogenised 
with an EmulsiFlex C3 cell homogeniser (Avestin). 
2.1.11 Centrifugation 
The following centrifuges were used to centrifuge samples at required centrifugal forces. 
Desktop centrifuge: PerfectSpin 24 (Peqlab) 
Medium volume centrifuge: 5840R (Eppendorf) 
High speed/Large volume centrifuge: Avanti J-301 (Beckman Coulter) 
Following rotors were used under appropriate situations in combination with the latter 
of the aforementioned centrifuges. 
Large volume: JA-10 (Beckman Coulter) 
High speed: JA-25.50 (Beckman Coulter)  
2.1.12 Lyophilisation 
Dehydration of samples was carried out with a Univapo 100H vacuum concentrator 
(Montreal Biotech Inc.). 
2.1.13 Chromatography 
Proteins were purified with the following fast protein liquid chromatography systems. 
 ÄKTA FPLC with Frac-950 fraction collector, controlled by Unicorn 4. 
 ÄKTA purifier with Frac-950 fraction collector, controlled by Unicorn 5.31. 
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All the buffers used during chromatography were filtered and degassed by a bottle top 
filter (Nalgene) and ME24 filter (Whatman) using a vacuum pump (Edwards). 
Sep-Pak® Plus C18 cartridges (Waters) were used to buffer exchange biliverdin to 
remove HCl. 
2.1.14 Protein concentration 
Vivaspin 20 10,000 MWCO PES (Satorius) were used to concentrate protein samples. 
2.1.15 Spectroscopy 
2.1.15.1 UV-visible absorption spectroscopy 
U-3010 UV-visible absorption spectrometer in combination with UV solutions 2.0 
(Hitachi) was used to measure the absorption either as spectra or at a single wavelength. 
A quartz cuvette (Hellma) was used for measuring absorption of DNA and protein 
samples, while polystyrene cuvettes (VWR) were used for measuring the optical density 
of E. coli culture. 
2.1.15.2 Circular dichroism spectroscopy 
CD spectroscopy was carried out with a Chirascan (Applied photophysics). Data was 
manipulated with Pro-Data viewer (Applied photophysics). 
2.1.16 Dynamic light scattering 
Dynamic light scattering (DLS) experiments were carried out with a Dyna Pro 
controlled by the UV solutions 2.0 software (Protein Solutions). A 45 l sample cell 
was used to hold the sample during measurements. 
2.1.17 Safe light 
 “Safe lights” were used to secure the visibility while preventing the photoconversion of 
phytochrome samples. Safe lights consist of either green filters or green LEDs, and are 
detailed in Appendix 1.  
2.1.18 Protein crystallisation 
Protein crystallisation screening plates were set up with a Mosquito robot (TTP labtech) 
controlled by the Mosquito software. Crystallisation screening kits were sourced from 
Molecular Dimensions, Hampton research, and Jena Biosciences. Either 2-drop 96-well 
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MRC plates or 3-drop polystyrene plates (Molecular Dimensions), both in sitting drop 
configuration, were used for screening crystallisation conditions. 24-well XRL plates 
(Molecular Dimensions) were used for optimisation of crystallisation conditions. All 
PEG precipitants were purchased from Molecular Dimensions. Crystallisation plates 
were incubated either in a temperature controlled room at 19 °C, or in either a 
temperature controlled incubator (Binder) or MD5-501 incubator (Molecular 
Dimensions). Crystallisation plates were inspected with a SM2-168 stereo microscope 
(Motic). Crystals were vitrified in liquid nitrogen using LithoLoops (Molecular 
Dimensions). 
2.1.19 X-ray diffraction image collection 
X-ray diffraction images were collected either with an in-house rotating anode X-ray 
generator or at the ESRF synchrotron, Grenoble. 
The set-up for in-house experiments consisted of an RU-H3R RINT2000 series CE 
marking horizontal type rotor flex (RIGAKU, Japan), a Mar345 image plate scanner 
(Marresearch, Germany), and a cryostream cooler (Oxford cryosystems, UK). The 
rotating anode generator was operated at 50 kV and 100 mA. 
For data collections at the ESRF synchrotron, the following beamline and detectors 
were used. ID14-4, Q210 CCD detector (ADSC); ID14-4 and ID23-1, Q315r CCD 
detectors (ADSC).  
2.2 Methods 
2.2.1 Water preparation 
For molecular biological applications, the water obtained from Purelab Ultra (ELGA) 
was treated by DEPC. DEPC was added to the water at a concentration of 0.1% (v/v) 
and incubated for 3 hours at 37°C. The DEPC was inactivated by autoclaving the 
solution for 15 minutes at 121 °C. 
2.2.2 Plasmid construct preparation 
2.2.2.1 Polymerase chain reaction 
PCR was used to synthesise the pNM19a-M20 construct for expressing the M20s gene 
(Agp1 10-313 and a hexahistidine tag) in E. coli. The entire template plasmid termed 
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pNM19a (Table 3.1) which bears the coding sequence of agp1 M15s (DNA 28-1512) 
was amplified, except for the sequence coding for the PHY domain to be omitted. 
Lyophilised primers were solubilised in DEPC-treated water to a final concentration of 
100 M. Working solutions were made by further dilution with DEPC-treated water to 
the final concentration of 10 M. All primer solutions were stored at -20 °C 
Primers 
The following primers were used for the generation of the pNM19a-M20 plasmid 
(Section 3.3.1). 
Name Sequence Tm (°C) 
pNM19a-M20F 5’CACCACCACCACCACCACTGAGATCCGGCTGC 3’(32 bp) >75 
pNM19a-M20R 5’CTGGGAACTCTGCTCCATCGCGATCCGCATCG 3’(34 bp) 74.6 
 
PCR reaction mixture 
The following composition was used for the generation of the pNM19a-M20 plasmid 
(Section 3.3.1). 
Component Volume (l) 
DEPC treated water Adjusted for the reaction to be 50 l 
5 × HF buffer 10 
dNTPs (10 mM) 1 
Template parental plasmid Adjusted to be 5 ng 
Forward primer (10 M)  1 
Reverse primer (10 M) 1 
Phusion polymerase (2 U/l) 0.5 
Thermal cycles 
The following thermal cycles were used to amplify the pNM19a-M20 plasmid (Section 
3.3.1). 
Stage Temperature (°C) Time (seconds) Cycles 
Initial denaturation 98 120 1 
Denaturation 98 10 
25 Annealing 65 15 
Extension 72 180 
Final extension 72 600 1 
Storage 10 Hold  
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2.2.2.2 PCR product purification 
Amplified PCR product or plasmid DNA were treated with the peqGOLD cycle-pure kit 
(Peqlab) to remove oligonucleotides and the polymerase as well as to exchange the 
buffer. DNA samples in solution were subjected to the protocol specified by the kit. The 
DNA sample was always eluted from the column with DEPC-treated water, rather than 
the elution buffer, in order to make the sample more amenable to downstream 
applications. 
2.2.2.3 Ethanol precipitation 
Ethanol precipitation was used to purify plasmid DNA (Sambrook et al., 1989). 
3.0 M of sodium acetate solution was added to the DNA sample in solution to the final 
concentration of 0.3 M and mixed. 2 volumes of ice-cold 100% ethanol were added and 
the solution was mixed. The solution was incubated at 4 °C for 30 minutes to allow for 
the DNA to precipitate. The sample was centrifuged at 12,000 × g for 10 minutes at 
4 °C. The supernatant was removed, and the sample tube was filled with a half volume 
of 70% ice-cold ethanol. The sample was centrifuged again with the same parameters, 
and the supernatant was removed. The tube was allowed to dry at room temperature 
with the lid open until no trace of liquid was identified. The DNA pellet was dissolved 
with 50-100 l of DEPC-treated water. 
2.2.2.4 Miniprep 
Plasmids were purified predominantly from E. coli XL1-blue strain cells, bearing the 
plasmid of interest. 1-5 ml of overnight culture was centrifuged at 10,000 × g for 1 
minute at the room temperature. The collected cell pellet was subjected to the alkaline 
lysis protocol given in the peqGOLD plasmid mini kit (Peqlab). The plasmid DNA was 
always eluted from the column with DEPC-treated water, rather than the supplied 
elution buffer. 
2.2.2.5 Restriction digestion 
Restriction digestion of DNA was carried out under the presence of the appropriate 
NEB buffer, and the DNA sample was supplemented with bovine serum albumin (BSA) 
where necessary (BglI, NEB3; DpnI, NEB4; NheI, NEB2, +BSA; XhoI, NEB4, +BSA). 
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2.2.2.6 T4 Ligation 
Blunt end ligation was carried out with T4 ligase. The reaction was carried out for 1:30 
hours at 20 °C with the following composition. 
Component Volume (l) 
DNA sample 25 
10 × Buffer 3 
T4 ligase (1,000 units/ml) 2 
 
2.2.2.7 Agarose gel electrophoresis 
The length and the quantity of double-stranded DNA fragments were estimated by 
agarose gel electrophoresis. Agarose (Merck) was dissolved in 1 × TAE buffer to a 
concentration of 0.7% (w/v), and ethidium bromide solution (Fisher) was added to the 
final concentration of 50 g/ml. The agarose solution was cast into a tank with a comb 
(Biorad) until set. DNA samples were supplemented with 6 × DNA loading buffer 
(Peqlab) and subjected to electrophoresis at a constant voltage of 2 V/cm until sufficient 
separation was achieved. Bands in gels were visualised under an illumination with UV 
light platform (Uvitec). 
2.2.2.8 DNA quantification 
The absorption at 260 nm allows the quantitation of DNA in the sample, where an OD 
of 1 equals to 50 ng/l for double-stranded DNA (Sambrook et al., 1989). The 
Absorption at 280 nm was also measured to calculate the A260/A280 ratio used to 
quantify the sample purity. The typical ratio ranged from 1.7 to 2.0. 
2.2.2.9 QuikChange™ mutagenesis 
Site-directed mutagenesis was carried out according to the QuikChange™ mutagenesis 
protocol (Agilent Technologies) albeit individual enzymes were purchased separately 
from different manufactures (DNA polymerase: Finnzymes, DpnI endonuclease: New 
England Biolabs).  
To facilitate the conformation of successful mutation, the following recognition sites for 
restriction enzymes were additionally incorporated. SER2, NheI; SER3, BglI; SER6, 
BglI (Table 2.1).  
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Name Sequence Tm 
(°C) 
GC 
(%) 
SER2 F 5’ccgcctggtattccggcgCTgCTagcaatttccgatatgcc 3’ 79.28 58.54 
SER2 R 5’ggcatatcggaaattgctAGcAGcgccggaataccaggcgg 3’ 79.28 58.54 
SER3 F 5’cgatatgcctgggccgCaGCgGCactcgatgtttcggcgc 3’ 81.82 65.91 
SER3 R 5’gcgccgaaacatcgagtGCcGCtGcggcccaggcatatcg 3’ 81.82 65.91 
SER6 F 5’ggccgccgccgCGGCatgggttgatggcctgc 3’ 79.94 78.13 
SER6 R 5’gcaggccatcaacccatGCCGcggcggcggcc 3’ 79.94 78.13 
Table 2.1 List of primers used during QuikChange mutagenesis to generate expression plasmids 
with SER mutations. Primer type is indicated after the name given to each mutant. F, forward 
primer; R, reverse primer. Region highlighted in yellow is where the mutations have been 
introduced. Underlined regions correspond to the recognition sites of the restriction enzymes 
introduced additionally to the designed mutations. SER2, NheI (G/CTAGC); SER3/6, BglI 
(GCCNNNN/NGGC). 
 
Mutagenesis reaction was always performed at 50 l per reaction. Composition of the 
reaction is as follows.  
Component Volume (l) 
DEPC treated water Adjusted for the reaction to be 50 l 
5 × HF buffer 10 
10 mM dNTPs (10 mM) 1 
Template parental plasmid Adjusted to be 50 ng 
DMSO (100%) 1.5 
Forward primer (10 M)  1 
Reverse primer (10 M) 1 
Phusion polymerase (2 U/l) 0.5 
 
The thermal cycle used for mutagenesis is as follows. 
Stage Temperature (°C) Time (seconds) Cycles 
Initial denaturation 98 120 1 
Denaturation 98 10 
25 Annealing 55 60 
Extension 72 206 
Final extension 72 600 1 
Storage 10 Hold  
 
Since site-directed mutagenesis was always carried out on variations of the pNM19a 
plasmid, the extension time is the same for all the mutants.  
2.2.2.10 DNA sequencing 
Despite a proof-reading capability of Phusion polymerase, it is possible for a mutation 
to be inadvertently introduced as a result of replication error. In order to verify the 
correctness of the sequence of gene of interest in the plasmid, or to confirm the success 
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of site-directed mutagenesis, dideoxy chain termination sequencing was carried out. 
Plasmid DNA samples were prepared according to the recommendation of Eurofins (15 
l of 50-100 ng/l in double distilled water or Tris-HCl [pH 8.0 – 9.0]) before being 
shipped. Primers used for sequencing offered by Eurofins are designed to anneal to 
either the T7 promoter or the T7 terminator sequence of pET plasmids, and will be 
referred to as T7 forward and T7 reverse, respectively. 
2.2.3 Protein production 
2.2.3.1 Overnight culture 
1-10 ml of LB media, containing appropriate antibiotic if necessary, was inoculated 
with either a single colony of E. coli cells, a glycerol stock or another liquid culture. 
The culture was incubated overnight at 30-37 °C while shaken at 200-220 rpm. 
2.2.3.2 Chemically competent cell preparation 
Various strains of E. coli cells were made chemically competent with divalent cations, 
rendering them amenable to be transformed. 100 ml of LB media containing appropriate 
selected antibiotic was inoculated with an overnight culture at a 1/200 dilution. Cells 
were allowed to grow at 37 °C with 200 rpm shaking until OD600 = 0.5. Cells were 
collected by centrifugation at 5,000 × g for 10 minutes at 4 °C. Cells were resuspended 
in 80 ml of ice-cold 100 mM MgCl2 solution, and were centrifuged again. Pelleted cells 
were resuspended in 40 ml of ice-cold 50 mM CaCl2 solution and incubated on ice for 
30 minutes. Cells were centrifuged, and finally the cells were suspended in 4 ml of ice-
cold solution containing 50 mM CaCl2 and 15% (v/v) glycerol. Resuspended cells were 
aliquoted into 100 l portions and flash frozen in liquid nitrogen. Frozen cells were 
stored at -80 °C. 
2.2.3.3 Transformation 
Chemically competent E.coli cells were transformed by heat-shock to introduce a 
plasmid into the cell. An aliquot of chemically competent cells was thawed on ice. 1 pg-
100 ng of plasmid DNA in 1-5 l volume was added to the cells and gently mixed with 
pipette tips on ice. The mixture was incubated on ice for 30 minutes. The mixture was 
heat-shocked at 42 °C for 90 seconds, and then cooled on ice for 2 minutes. 1 ml of 
SOC media without an antibiotic was added and the culture was incubated at 37 °C for 
1 hour while shaken at 220 rpm. The culture was centrifuged at 3,000 × g for 3 minutes, 
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and 200 l of the supernatant was pipetted and discarded. Additional 200 l of fresh 
SOC media was added, and the cell pellet was resuspended, and plated onto LB agar 
plate containing the appropriate selective antibiotic. 
2.2.3.4 Glycerol stock preparation 
Glycerol stocks of E. coli cells were created to be maintained indefinitely. An overnight 
culture was supplemented with 20% (v/v) glycerol prior to flash freezing in liquid 
nitrogen. The glycerol stocks were stored at -80 °C. 
2.2.3.5 Preparation of bilin chromophore 
2.2.3.5.1 Biliverdin 
Biliverdin hydrochloride is supplied in an acidic form that upon addition of biliverdin 
solution in organic solvent to protein solution causes the Agp1 to precipitate irreversibly, 
possibly due to the denaturation of the protein. Therefore, it was necessary to remove 
the acid by exchanging the buffer. 
C18 column (Waters) was equilibrated with 5 ml of methanol. Roughly 5 mg of 
biliverdin was dissolved in 200 l methanol, and was applied to the column. The 
column was washed with 30 ml of H2O to remove HCl. The H2O was then removed 
from the column by blowing air through it with a syringe. Biliverdin was eluted from 
the column with methanol. Eluted biliverdin in methanol was dried by a vacuum 
concentrator, and the dry pelleted biliverdin void of HCl was dissolved in DMSO, and 
stored at -80 °C. 
2.2.3.5.2 15Ea 
A synthetic bilin compound termed 15Ea which has the same stereochemistry between 
the C- and the D-rings as the natural bilin chromophore in the Pfr-form was assembled 
with the Agp1 apoprotein to create a holoprotein with similar biochemical 
characteristics to that of Agp1 in the Pfr-form (Inomata et al., 2005). 
15Ea was supplied as dry powder. The sample was dissolved in DMSO and stored at -
80 °C.  
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2.2.3.6 Production of recombinant proteins 
2.2.3.6.1 Small scale test expression  
Small scale test expressions were often carried out prior to large scale protein 
production. 1 – 10 ml of LB-Amp was inoculated with an overnight culture of the 
appropriate E. coli strain bearing the plasmid construct with 1/200 dilution. The cells 
were grown at 37 °C and 200 rpm until A600 reached 0.6. The culture was cooled at the 
target temperature, typically at 18 °C, for 1 hour while continued to be shaken. Protein 
expression was induced with 100 M IPTG unless otherwise specified. The culture was 
incubated for 18 hours, and the cells were collected by centrifugation at 5,000 × g for 15 
minutes. 1 g of collected cells was suspended in 10 ml of Basic buffer (300 mM NaCl, 
50 mM Tris-HCl pH 7.8 at 20 °C, 5 mM EDTA). Cells were lysed either by 3 cycles of 
freeze-thaw and/or 5 cycles of sonication at 10 W for 30 seconds followed by a cooling 
period for 30 seconds. The cell lysate was clarified by centrifugation at 12,000 × g for 
15 minutes. The supernatant was transferred into a fresh tube, and the insoluble pellet 
was resuspended in 500 l of 4 ×SDS loading solution by vortexing. The resuspended 
pellet was heated at >80 °C for 5 minutes in a hot water bath. Soluble and insoluble 
fractions were analysed by SDS-PAGE. 
2.2.3.6.2 Large scale growth and induction 
Typically, 800 ml of LB media with appropriate antibiotic were prepared in 2L baffled 
flasks. The media was inoculated with an overnight culture at 1/200 dilution. The 
culture was incubated at 30-37 °C with 180-200 rpm until the OD600 reached 0.6. The 
cultures were cooled for 1 hour at target induction temperature of 16-18 °C while 
continued to be shaken. Expression of the gene of the target protein was induced with 
IPTG at the final concentration of typically 50 M. The culture was incubated for 
further 18 hours. 
E. coli cells from large scale cultures were collected by centrifugation at 6,000 × g for 
20 minutes at 4 °C. Collected cells were typically stored at -80 °C. 
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2.2.3.7 Purification and assembly of recombinant proteins 
2.2.3.7.1 Cell disruption and lysate clarification 
Target proteins in the cytoplasm of E. coli cells were extracted by mechanical disruption 
methods. Pelleted cells were suspended in 60 ml Affinity buffer A (300mM NaCl, 50 
mM Tris-HCl pH 7.8 at 20 °C, 10 mM Imidazole) and were disrupted by three passages 
though a cell homogeniser (twice at 5000 psi and once at 10,000 psi). The cell lysate 
was clarified by two rounds of centrifugation at 18,000 × g at 4 °C. 
2.2.3.7.2 Affinity chromatography 
As a first step of purifying the target protein, affinity chromatography was carried out. 
All isolated proteins in the present study have a C-terminal 6 histidine tag, and are 
purified by Ni
2+
 affinity chromatography. 
Clear lysate was applied to a pre-equilibrated HiTrap IMAC HP 5ml column (GE 
Healthcare) loaded with Ni
2+
 using a P1 peristaltic pump (GE Healthcare). Weakly 
bound protein was removed by applying Affinity buffer A until the OD280 of the flow-
through reached below 0.1 or the total volume of flow-through reached 10 CV. 
Proteins strongly bound to the column were eluted by applying Affinity buffer B 
(300mM NaCl, 50 mM Tris-HCl pH 7.8 at 20 °C, 250 mM Imidazole) until the OD280 
of the flow-through dropped below 0.1 or the total volume of flow-through reached 6 
CV. 
In order to remove imidazole from the protein eluate, the protein was precipitated by 
adding three parts of Ammonium sulphate buffer (3.3M (NH4)2SO4, 20 mM Tris-HCl 
pH 7.8 at 20 °C, 5 mM EDTA) to two parts of eluted protein. The precipitated protein 
was collected by centrifugation at 6,000 × g for 15 minutes at 4 °C. Protein was 
solubilised with very small amounts of Assembly buffer (300 mM NaCl, 50 mM Tris-
HCl pH 7.8 at 20 °C, 5 mM EDTA, 10% Glycerol). Any remaining insoluble matter 
was removed by centrifugation with the same parameters as mentioned above. The 
apoprotein was aliquoted in 0.5-1.0 ml portions, and flash frozen in liquid nitrogen and 
stored at -80 °C.  
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2.2.3.7.3 In vitro assembly of the Agp1 holoprotein 
One of the defining features of bona fide phytochrome is autolyase activity to form a 
covalent bond with a bilin chromophore (Rockwell et al., 2006). Since Agp1 is a 
bacterial phytochrome that naturally uses biliverdin as the chromophore, it was possible 
to assemble the Agp1 holoprotein using commercially available biliverdin (Section 3). 
The Agp1 apoprotein was assembled with 15Ea to form the holoprotein in a Pfr-like 
form. 
DTT was added to the Agp1 apoprotein to the final concentration of 10 mM and 
allowed to incubate on ice for 15 minutes. Protein was assembled with chromophores 
with molar ratios of 1:1.2 and 1:1 for BV and 15Ea, respectively. A bilin solution in 
DMSO was pipetted into protein solution, and mixed by pipetting up and down. In vitro 
assemblies and all subsequent downstream processes were carried out under the 
minimum exposure to the safelight. The assembly was allowed to proceed at 4 °C for 1 
hour and 14 hours for BV and 15Ea adduct, respectively. 
2.2.3.7.4 Ion exchange chromatography 
Where the in vitro assembly of the Agp1 holoprotein was not efficient, apoprotein and 
holoprotein were separated by ion exchange chromatography (IEX). The buffer of a 
protein sample was exchanged to IEX buffer A (20 mM Tris-HCl pH 7.8 at 20 °C, 1 
mM EDTA) by dialysis to ensure efficient binding of the protein to the stationary phase 
by lowering salt concentrations. Salt concentrations were further lowered by diluting the 
dialysed sample with IEX buffer A until to the volume of 10 ml. 
Protein was bound to a pre-equilibrated HiTrap Q HP 5 ml column (GE Healthcare) 
using either a peristaltic pump or the sample injection loop of the FPLC. Protein was 
eluted by a linear gradient from IEX Buffer A to IEX buffer B (500 mM NaCl, 20 mM 
Tris-HCl pH 7.8 at 20 °C, 1 mM EDTA) over 15 CV and 30 CV for analytical and 
preparative purpose, respectively. Flow rate of the FPLC was set at 0.4-0.5 ml/min or 3 
ml/min for preparative and analytical purpose, respectively. Eluted proteins were 
collected by a fraction collector. 
For some chromatographic analyses, the quantities of protein samples were unified on 
the basis of absorption at 280 nm. The absorption of the sample was multiplied by its 
volume (ml) to derive a value with a unit of “mAU×ml”, where the length of the cuvette 
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(d) is constant at 1 cm. This approach enables to unify the areas of the elution peaks in 
chromatograms. 
2.2.3.7.5 Hydrophobic interaction chromatography 
As an alternative way of separating holoprotein from apoprotein, hydrophobic 
interaction chromatography (HIC) was used. The concentration of ammonium sulphate 
in the protein sample was adjusted to 500 mM by adding the Ammonium sulphate 
buffer (Section 2.2.3.7.2). Protein was applied to a pre-equilibrated HiTrap Phenyl HP 5 
ml column (GE Healthcare) either by a peristaltic pump or by using the sample injection 
loop of the FPLC. Protein was eluted with a linear gradient from HIC buffer A (500 
mM (NH4)2SO4, 300 mM NaCl, 20 mM Tris-HCl pH 7.8 at 20 °C, 1 mM EDTA) to 
HIC buffer B (20 mM Tris-HCl pH 7.8 at 20 °C, 1 mM EDTA) over 15 CV at 3 ml/min. 
2.2.3.7.6 Size exclusion chromatography 
Either HiPrep 16/60 Sephacryl S-200 High Resolution column or Superdex 200 10/300 
GL column (GE Healthcare) were used for size exclusion chromatography (SEC). The 
former was predominantly used for the preparative purpose, and the latter was used for 
both preparative and analytical purposes. Protein samples were always subjected to SEC 
regardless of the preceding purification steps. The aims are to exchange the sample 
buffer, remove contaminations with different molecular weights, and to isolate a 
conformationally homogeneous species of the eluate.  
The protein sample volume was adjusted to the volumes of the sample injection loop, 
which were either 100 l or 2 ml. The sample was applied to the column with a sample 
injection loop and the protein was purified using an isocratic elution with a flow rate of 
0.5 ml/min. Unless otherwise specified, the SEC buffer (20 mM Tris-HCl pH 7.8 at 
20 °C, 1 mM EDTA) was used during SEC runs. 
2.2.3.8 Concentration of protein 
The membrane of a Vivaspin concentrator was pre-rinsed using H2O to remove traces of 
glycerol and sodium azide. The concentrator was equilibrated with a suitable buffer 
prior to use. The maximum volume was 14 ml for the use with a centrifuge with a fixed 
angled rotor. The concentrator was centrifuged at 3,000-8,000 × g until the target 
concentration of the protein was achieved. 
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2.2.4 Biochemical analyses 
2.2.4.1 Polyacrylamide gel electrophoresis 
In polyacrylamide gel electrophoresis (PAGE), a negatively charged proteins migrate 
through a porous matrix of polymerised acrylamide and bisacrylamide gel, and the rate 
of migration is determined predominantly by the molecular weight of the sample. The 
gels were invariably stained by Coomassie brilliant blue to visualise the protein 
following the electrophoresis. 
2.2.4.1.1 Reducing SDS-PAGE 
Reducing SDS-PAGE was used to estimate the molecular weight of a target protein and 
the purity of the sample. Under the presence of saturating SDS, SDS binds to 
polypeptide chains at 1.4 g per gram of polypeptide. Uniform negative charge linearises 
the polypeptide chain to destroy the tertiary structure as well as the intermolecular 
aggregation. SDS binds almost proportionally to the length of the polypeptide 
regardless of the protein, so the resulting mass/charge ratio is almost always constant, 
thus making the length of polypeptide the dominant factor in determining the rate of 
migration through the gel. Furthermore, the reducing agent will break intra/inter-
molecular disulphide bond(s). 
Gel cast assembly was set up according to the manufacturer’s instruction. In essence the 
protocol was in accordance with the standard procedure (Sambrook et al., 1989). The 
target concentrations of acrylamide/bisacrylamide in the resolving layer of gels were 
achieved according to Table 2.2. The samples were heated at 80 °C for 5 minutes in 1 × 
SDS loading solution. The electrophoresis was carried out at a constant voltage of 15 
V/cm for 1 and a half hours under the presence of SDS running buffer. 
 Final concentration of bis/acrylamide in separating gel (%) 
Stock solution 8 9 10 11 12 
30% Acrylamide 
0.8% Bisacrylamide 
1.33 1.5 1.67 1.83 2 
4 × Tris/SDS solution 1.25 1.25 1.25 1.25 1.25 
H2O 2.42 2.25 2.08 1.92 1.75 
Table 2.2 Solutions and their volume for the resolving layer of SDS-PAGE gels with varying final 
concentration of bis/acrylamide. Volumes of the solutions are indicated in ml. 
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2.2.4.1.2 Non-reducing SDS-PAGE 
Normally a reducing agent is included in the sample loading solution in SDS-PAGE, 
which breaks intra/inter-molecular disulphide bonds. By omitting the reducing agent 
from the loading solution, disulphide bonds are conserved and the rate of migration will 
be affected by disulphide bonds. SDS that linearises polypeptide chains still ensure that 
the rate of migration is mostly determined by the molecular weight of the polypeptide. 
The protocol was identical to that for SDS-PAGE (Section 2.2.7.1.1), except that the 
reducing agent was omitted from the sample loading solution (Section 2.1.7.1) and the 
sample was not heated. 
2.2.4.1.3 Native-PAGE 
A native polyacrylamide gel electrophoresis may be carried out without the presence of 
neither SDS nor the reducing agent, thus the tertiary/quaternary structures of the protein 
is preserved during the separation. The resulting separation may be difficult to interpret 
since the rate of migration depends on the surface charge of the protein under the pH of 
the buffer when the separation is carried out, which is inconsistent among different 
proteins. Preservation of quaternary structure allows one to observe the oligomerisation 
of proteins under a condition closer to that in the in vivo environment. Therefore a 
native-PAGE may be used to study the conformational homogeneity of the protein. 
A native-PAGE gel was casted with the same protocol as for an SDS-PAGE gel except 
for the lack of SDS and the presence of glycerol in the resolving layer (Table 2.3). The 
stacking layer of a native-PAGE gel was more alkaline than that for an SDS-PAGE gel 
(Section 2.1.7.2). The sample and native-PAGE loading solution were mixed at a 
volume ratio of 2:1. The electrophoresis was carried out at a constant voltage of 15 
V/cm for 1:30 hours under the presence of Detergent-free buffer.  
 Final concentration of bis/acrylamide in separating gel (%) 
Stock solution 8 9 10 11 12 
30% Acrylamide 
0.8% Bisacrylamide 
1.33 1.5 1.67 1.83 2 
4 × Tris solution 1.25 1.25 1.25 1.25 1.25 
100% Glycerol 0.5 0.5 0.5 0.5 0.5 
H2O 1.92 1.75 1.58 1.42 1.25 
Table 2.3 Solutions and their volume for the resolving layer of native-PAGE gels with varying 
final concentration of bis/acrylamide. Volumes of the solutions are indicated in ml. 
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2.2.4.2 UV-visible absorption spectroscopy 
Absorption of translucent materials was quantified with UV-visible absorption 
spectroscopy, from which the molar concentration could subsequently be calculated 
with the extinction coefficient and the Beer-Lambert’s law equation. 
          
Where A is the absorbance in absorption unit,  is the extinction coefficient in M-1cm-1, 
c is the concentration in M, and l is the path length in cm. 
2.2.4.3 Calculation of bilin chromophore concentration 
The absorption at the following wavelengths and coefficients were used for calculating 
bilin concentration in HCl (5%)/methanol. 
Compound Wavelength (nm)  (mM
-1
cm
-1
) Reference 
BV 696 30.80 Lamparter et al., 2001 
15Ea 679 51.30 Zienicke et al., 2011 
 
2.2.4.4 Calculation of protein concentration 
Extinction coefficients shown in Table 2.4 were used for calculating protein 
concentration. For the apoprotein without any disulphide bond, the calculated extinction 
coefficient without any disulphide bond from the Protein calculator server 
(http://www.scripps.edu/~cdputnam/protcalc.html) was used. The extinction coefficient 
of a holoprotein was derived by adding the 280 of the appropriate bilin chromophore to 
the 280 of the apoprotein. Absorption spectra of BV and 15Ea chromophores were 
taken in order to determine their 280 (Fig. 2.1). 
The extinction coefficient at the reference wavelength was scaled according to the 
absorption measurement at 280 nm and the reference wavelength. 
The absorption value at 280 nm and that of the wavelength from which the reference 
extinction coefficients have been quoted were used to calculate the extinction 
coefficient for both BV and 15Ea. 
In the present study the effect of covalent bond formation between protein and 
chromophore to A280 was neglected. 
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Protein / 
compound 
Protein description 280 nm (mM
-1
cm
-1
) 
Full-length 1-745 + ArgSer (BglII site) + hexahistidine tag 98290 
M15 1-504 + hexahistidine tag 77950 
M15s 10-504 + LeuGlu (XhoI site) + hexahistidine tag 77950 
M15 C20A 1-504 C20A + LeuGlu (XhoI site) + hexahistidine tag 77950 
M20 1-313 + hexahistidine tag 34280 
M20s 10-313 + hexahistidine tag 34280 
SER2 M15s E86A/E87A 77950 
SER3 M15s E96A/K97A/K98A 77950 
SER6 M15s E336A/K337A 77950 
SER26 M15s E86A/E87A/E336A/K337A 77950 
SER36 M15s E96A/K97A/K98A/E336A/K337A 77950 
SER23 M15s E86A/E87A/E96A/K97A/K98A 77950 
SER236 M15s E86A/E87A/E96A/K97A/K98A/E336A/K337A 77950 
BV  20.963 
15Ea  11.013 
Table 2.4 Extinction coefficients () at 280 nm of proteins and compounds used in the present study.  
 
 
 
Figure 2.1 Absorption spectra of BV and 15Ea. Absorption spectra were obtained by diluting the 
bilin solution in DMSO to an arbitrary concentration with HCl (5%)/MeOH. A280/AQmax ratios were 
obtained from spectra and were used to calculate extinction coefficients at 280 nm. A280/AQmax for 
BV and 15Ea were 0.681 and 0.215, respectively. The extinction coefficients at 280 nm for BV and 
15Ea were 20.963 and 11.013 mM
-1
cm-1, respectively. 
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2.2.4.5 Circular dichroism spectroscopy 
The secondary structure content of a protein was probed with CD spectroscopy, based 
on which comparative studies may be carried out to deduce photochromic state (Pr and 
Pfr) dependent conformational differences.  
The buffer of protein samples were exchanged to CD buffer (20 mM Na phosphate pH 
7.8, 0.5 mM EDTA) either by dialysis or with Vivaspin protein concentrators (Satorius). 
Protein concentration was adjusted to 0.1 mg/ml for the CD measurement and the 
concentration was quantified prior to the CD measurement in order to enable the 
calculation of molar circular dichroism after the measurement. The cuvette with a path 
length of 0.1 mm holding the protein sample was constantly orientated in the same 
direction in the sample chamber of CD spectrometer in order to minimize the variation 
being introduced during an experiment. Three independent measurements were carried 
out where the delta absorbance was measured between 190-260 nm. The spectra were 
subsequently averaged and the averaged spectrum of the CD buffer was subtracted. The 
spectra were adjusted for the reading at 260 nm to be 0 mdeg, and finally the spectra 
were smoothed with window value of 10 nm. 
The spectra in mdeg as a function of wavelength were converted to mean residue 
ellipticity with the following equation. 
       
        
             
 
where MRW is the mean residue weight in Daltons, P is the path length in cm, CONC is 
the concentration in mg/ml, and 3298 is a specific constant. 
Secondary structure content was calculated from CD spectra using Dichroweb server, 
using the CDSSTR algorithm, with reference set 4 optimised for 190 – 240 nm 
(http://dichroweb.cryst.bbk.ac.uk/html/home.shtml, Whitmore and Wallace, 2004). 
2.2.4.6 Determination of protein solubility 
The solubility of Agp1 proteins was measured using a method similar to that described 
in Trevino et al., (2007). The solubility of the BV adducts was measured instead of that 
of the apoproteins, because Agp1 apoproteins were found to dimerise via a disulphide 
bond, which may affect their solubility (Section 6.5.1). Maintaining the monomeric 
state of apoproteins requires reducing agents, for example DTT, which may interfere 
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with spectrophotometric measurements. The BV adduct is suspected to be the 
predominant form of phytochromes in A. tumefaciens (Section 6.7.4), therefore 
characterisation of BV adducts was deemed more physiologically relevant. 
7.27 l of the ammonium sulphate buffer (3.3 M (NH4)2SO4, Section 2.2.3.7.2) was 
added to 12.72 l of Agp1 holoproteins in SEC buffer (Section 2.2.3.7.6) to obtain 20 
ml of holoprotein in 1.2 M (NH4)2SO4. Only highly concentrated samples were used to 
ensure the appearance of precipitation, which is an indication of saturation. The solution 
was equilibrated for 1 minute at 25 °C in the dark, and centrifuged for 1 minute at 
16,000 × g (25 °C, darkness). 10 l of the supernatant was mixed with 440 l of the 
SEC buffer containing 1.2 M (NH4)2SO4 for quantifying the protein concentration by 
absorption spectrophotometry at 280 nm. 
2.2.5 Bioinformatics 
2.2.5.1 Protein characterisation 
Basic biochemical properties of proteins such as molecular weight, pI, and 280 were 
estimated by submitting the sequence to the Protein calculator server 
(http://www.scripps.edu/~cdputnam/protcalc.html). 
Domains were identified and annotated from amino acid sequences of proteins using the 
SMART server (http://smart.embl-heidelberg.de/, Letunic et al., 2012). 
2.2.5.2 Sequence alignment 
Homologous sequences were aligned with ClustalW 2.0.9 (Larkin et al., 2007). Aligned 
sequences were viewed with CLC sequence viewer (CLC bio). The colour scheme of 
amino acid residues is as shown in Fig. 2.2. 
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Figure 2.2 Colour scheme of the amino acids in CLC sequence viewer. The residues are coloured 
according to their chemical properties. 
 
2.2.5.3 Surface entropy reduction server 
Clusters of residues best suited for introducing mutations according to “surface entropy 
reduction” (SER) strategy were chosen using a combination of manual and automated 
assessments based on criteria described in Goldschmidt et al. (2007). The criteria were 
as follows. 
 The cluster consists of amino acids with high conformational entropy that are likely 
to occur on the proteins surface and unlikely to participate in protein-protein 
interaction. Default mutable amino acids are lysine, glutamate, and glutamine. 
 Such a cluster must occur in a loop region. SER mutations have been most 
successful when introduced in loops as they are likely to be solvent exposed. SER 
mutations were reported to be less effective when introduced on the surface 
exposed face of a helix. 
 The target mutable residues must not be mutated if they are conserved, because 
conservation implies functional significance of the residue. 
Surface exposure of the suggested mutable clusters was checked based on the 
preliminary protein structure where possible. Where the structural information was 
absent, a homology model (Section 2.2.5.3) was used instead.  
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2.2.5.4 Homology modelling  
Modeller was used to create homology models using template structure and target 
protein sequence according to the procedure given in the tutorial at 
http://salilab.org/modeller/.  
2.2.6 Crystallisation of proteins 
2.2.6.1 Crystallisation screening 
Crystallisation screening was carried out with a Mosquito robot (TTP labtech). For the 
screening of crystallisation conditions for a new protein, JCSG+, PACT premier, PGA, 
and Morpheus kits (Molecular Dimensions) were often used for sparse matrix and 
systematic screening. Reservoir volumes were 80 l and 45l for 2-drop and 3-drop 96-
well plates, respectively. Drop sizes were 400 nl, containing the protein solution and the 
reservoir solution at a volume ratio of 1:1. The plates were incubated in the darkness 
either at 14, 19, or 25C. Plates were inspected daily under a microscope with a green 
filter during the first week of setup, and then every 2 weeks for up to 3 months. Drops 
were scored according to a scheme described in Benvenuti & Mangani, (2007). 
2.2.6.2 Optimisation of crystallisation conditions 
The optimisation of crystallisation conditions was carried out mostly with 24-well XRL 
plates with hanging drop or sitting drop set ups. Optimisation parameters included the 
chemical composition of the reservoir solution, volumes of the reservoir and the drop, 
the volume ratio of the protein solution and the reservoir solution, protein concentration 
and temperature. Additive screen 1 (Molecular Dimensions) was used to further 
optimise the chemical composition of the crystallisation condition. Streak seeding with 
cat whiskers and solution microseeding was used to grow crystals better suited for 
analysis (Bergfors, 2009, Chapter 6). 
2.2.7 Crystallographic structure determination 
2.2.7.1 Diffraction data collection 
All protein crystals were vitrified with liquid nitrogen under the presence of a suitable 
cryoprotectant. The strategy for data collection was determined either manually or 
automatically by EDNA software available at most MX beamlines at synchrotrons. 
Experimental parameters depend on a multitude of factors. The wavelength of X-rays 
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obtained from a rotating copper anode is fixed at 1.54 Å, whereas the wavelength is 
tuneable at most synchrotron beamlines. The exposure time per diffraction image 
depends on the intensity of the beam and sensitivity of the detector. Generally, the 
detector distance was adjusted in order to maximise the pixel resolution of the 
diffraction image without losing the spots at high diffraction angles. The rotation angle 
per image was set to avoid the overlap of the spots, and this depends on the quality of 
the incident X-rays and the mosaicity of the crystal. The total angular range for data 
collection depends on the space group of the crystal as well as how susceptible the 
crystal is to radiation damage. 
2.2.7.2 Data processing 
Either the CCP4 (Bailey, 1994) or the Phenix (Adams et al., 2010) software suite were 
used for most part of the data processing. Both suites contain a number of identical 
softwares, and CCP4 was used unless otherwise specified.  
2.2.7.2.1 Indexing and scaling 
Datasets were indexed with either iMosflm 1.0.5 or 1.0.6 (Leslie and Powell, 2007) or 
XDS (Kabsch, 2010). The default was iMosflm 1.0.5, but iMosflm 1.0.6 and XDS were 
used for indexing data from a Pilatus detector. Intensities were scaled with Scala (Winn 
et al., 2011) and converted to amplitudes with Truncate (French and Wilson, 1978).  
Statistics given at the indexing stage in iMosflm can give indications as to which space 
group is correct. Potential Bravais lattices are listed in order of increasing penalty. 
Penalty is a value correlated with  that indicates the degree of mismatch between the 
positions of the observed reflections and the calculated reflection of the idealised lattice. 
 (x,y) and  () values are the root mean square difference between the observed and 
calculated reflections in mm and  °, respectively (Battye et al., 2011). 
Reliability factors were calculated with the following equations (Evans, 2006).  
             ∑∑          
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where I is the intensity, and nh is the number of observations of reflection h. Ihl is the lth 
observation of reflection h, and < Ih > is the mean intensity of all reflections which are 
related by crystallographic symmetry. Reliability factors indicate accuracy of the 
measured intensities. Rmerge(sym), the most widespread statistics, is calculated by dividing 
the sum of differences between each intensity measurement Ihl and the mean intensity 
< Ih > by what is essentially the sum of all intensities. In recent years, the statistical 
incorrectness of Rmerge(sym) has been pointed out, because the Rmerge(sym) rises as the 
multiplicity increases. More improved statistics have been introduced in recent years 
(Blow, 2002). Rmeas(r.i.m) is a more robust Rsym which indicates the reliability of 
individual measurement independent of multiplicity (Diederichs and Karplus, 1997). 
Each reflection’s contribution is adjusted by a factor of nh/(nh-1), where nh is the 
multiplicity. The factor of 1/(nh-1) found in Rp.i.m, which was originally discussed in 
Weiss & Hilgenfeld (1997), yields information about the average precision of the data. 
Truncate program also subjects datasets to “L-test” to test for the presence of twinning 
(Padilla and Yeates, 2003). This test utilises the L-values calculated from local pairs of 
reflection intensities, and is insensitive to phenomena such as anisotropic diffraction 
and pseudo-symmetry. The L-value is calculated with the following equation. 
                  
Where I1 and I2 are intensities of a local pair of reflections. 
Quality of a diffraction dataset can also be judged from the intensity statistics in the 
output from the scaling operation. The ratio <I>/<(I)> where <I> is the estimated 
mean intensity and <(I)> is the mean standard deviation of the measurements.  
<I>/<(I)> can be plotted as a function of resolution (Blow, 2002). 
2.2.7.2.2 Molecular replacement 
Matthews software (Kantardjieff and Rupp, 2003) was used to calculate the Matthews 
coefficient and solvent content from the unit cell parameter and the molecular mass of 
the protein in the unit cell. Phases were determined by molecular replacement using the 
known homologous structures with Phaser (McCoy et al., 2007). Some search models 
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were treated with Chainsaw (Stein, 2008) where non-conserved residues were pruned to 
the C atom of the side chain. 
2.2.7.2.3 Model building and refinement 
The initial model used for refinement was either the search models used for the 
molecular replacement or a model generated automatically by AutoBuild module of 
Phenix (Adams et al., 2010). The former method was always used unless otherwise 
specified. Structures were modelled and refined by iterative rounds of manual and 
automatic refinement using Coot (Emsley et al., 2010) and Refmac5 (Murshudov et al., 
2011).  
Refinement weighting of Refmac5 determines the strength of geometric constraints 
imposed onto the structure during refinement routines. Smaller weighting value imposes 
tighter constraint and vice versa. Refinement weighting was mostly set at default and 
determined automatically by the program, but a small value such as 0.1 was chosen 
where tighter geometric constrain was preferred. 
2.2.7.2.4 Generation of library for biliverdin 
The library file necessary for determining the ideal geometry of a ligand that is not 
included in the default collection of Coot and Refmac5 were generated with the 
following procedure. The coordinate of the BV molecule was extracted from the high 
resolution structure of DrBphP (2O9C), and was submitted to the PRODRG server 
(http://davapc1.bioch.dundee.ac.uk/prodrg/, Schüttelkopf and van Aalten, 2004). The 
bond lengths, angles, and types were manually modified according to a high resolution 
crystal structure of biliverdin dimethyl ester (Cambridge structural database accession: 
bilver) where applicable. The resulting library file was used during refinement with 
Coot and Refmact5.  
2.2.8 Structural analyses 
2.2.8.1 Visualisation of molecular models 
Protein structural coordinates in PDB format were viewed with PyMOL (DeLano, 
2002). 
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2.2.8.2 Visualisation of protein-ligand and protein-protein interaction 
Ligplot 4.5.3 was used to plot protein-ligand and protein-protein interactions (Wallace 
et al., 1995). 
2.2.8.3 Structural superposition 
Global protein structure superpositions were achieved by “SSM superpose” function of 
Coot or super command of PyMOL. When the range of residues needed to be specified 
for local structural superposition, “LSQ superpose” function of Coot was used. 
2.2.8.4 Evaluation of surface electrostatic properties 
Protein structure coordinate files were subjected to analysis of Poisson-Boltzmann 
electrostatics calculations with PDB2PQR (Dolinsky et al., 2007), and subsequently the 
electrostatic surface potential diagrams were generated with Adaptive Poisson-
Boltzmann Solver (APBS) plugin for PyMOL (Baker et al., 2001). 
APBS electrostatic surface potential diagrams were coloured by electrostatic potential (-
5 kT/e, red to +5 kT/e, blue) with the “Colour by potential on sol. acc. surf.” option 
enabled. 
2.2.8.5 Secondary structure assignment to protein structures 
Secondary structures in a protein structure were objectively assigned with DSSP 
(Joosten et al., 2011, Kabsch and Sander, 1983). Each residue was assigned to be either 
-helix, isolated -bridge, -strand, 3/10-helix, 5-helix, hydrogen bonded turn, bend, or 
no secondary structure. The proportion of the secondary structure relative to either the 
modelled residues or the total residues in the construct was calculated.  
2.2.8.6 Calculation of the angle between two helices 
Intersecting angle between two -helices was calculated with QHELIX (Lee et al., 
2007). Chou algorithm was selected unless otherwise specified. Ten terminal residues 
were selected in order to calculate the angle between the termini of a continuous helix, 
as selection of limited segments (e.g. five residues) led to aberrant results with large 
disagreement between Chou and Kahn algorithms. 
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2.2.8.7 Protein structure surface area calculation  
Solvent accessible area and contact area of protein structures were calculated by 
Areaimol (Saff and Kuijlaars, 1997). The dimer interface area was calculated from the 
difference in solvent accessible surface area per chain in a monomeric and dimeric form 
of a molecule. 
2.2.8.8 Calculation of the angle between planes 
The averaging plane was calculated form selection of atoms by Olex2 (Dolomanov et al., 
2009) with the mpln command. The angle between two planes was calculated by the sel 
command. The coordinate file format had been converted form .pdb to .xyz by 
Discovery studio 3.1 (Accelrys). 
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Chapter 3: Structural characterisation of Agp1 in the Pr-form 
3.1 Overview 
Protein structures at atomic detail combined with available biochemical and biophysical 
data can provide deep insights into a protein’s functional mechanism. As a first step of 
gaining structural understanding about the functional mechanisms of phytochromes, 
crystallisation of Agp1 in the Pr-form was attempted.  
3.2 M20: Chromophore binding domain (PAS-GAF) 
To solve the structure of Agp1 in the Pr-form, a relatively short protein product termed 
M20 was used first (Noack et al., 2007). This construct encompasses the chromophore 
binding domain (CBD) which includes the PAS and GAF domains, and is the minimum 
domains necessary for lyase function that is responsible for covalent attachment of the 
bilin chromophore. In classical bacteriophytochromes, chromophore attachment to the 
CBD results in formation of the Pr-form (Noack et al., 2007, Wagner et al., 2005). 
There are phylogenetically distinct phytochromes, however, that only need a GAF 
domain to form a functional holoprotein that undergoes photoconversion from the Pr 
ground state into the Pfr-form (Cornilescu et al., 2008). 
M20 was initially considered as a suitable target for structural elucidation of Agp1 for 
the following reasons. Firstly, the rate of successful crystallisation as defined by a 
statistical study from a structural genomic study is higher for the protein with the size of 
M20 (313 residues) than M15 (504 residues) (Slabinski et al., 2007). Secondly, though 
M20 and equivalent constructs of other phytochromes are capable of forming a covalent 
bond with the bilin followed by an emergence of increased absorption in the Q-band, 
they are not able to form the Pfr-form neither by photoconversion nor by dark-reversion 
in case of bathy-phytochrome (Noack et al., 2007, Wagner et al., 2005, Yang et al., 
2008, Yang et al., 2007). The inability to form the Pfr-form was regarded as an 
advantageous trait for crystallisation trials as it increases the chance of protein being 
more conformationally homogeneous, a favourable characteristic for crystallisation 
(Benvenuti and Mangani, 2007). Despite the inability for M20 holoprotein to undergo 
full photoconversion, M20 holoprotein was always handled under the safelight, because 
some spectral changes are evident when M20 holoprotein was exposed to the light 
which may be associated with conformational change (Noack et al., 2007). The choice 
of such a shorter construct for crystallographic structure determination may be justified 
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by the fact that the currently available phytochrome structure with the highest resolution 
is of the PAS-GAF domains of DrBphP (Auldridge et al., 2012). Finally, the structural 
information of a shorter construct may help to solve the structure of a longer construct, 
as it may be used as a search model in molecular replacement during phase 
determination. 
3.2.1 Expression and purification of M20-BV protein 
The gene of the M20 protein was expressed as described in Section 2.2.3. Typically 4 
litres of LB-ampicillin media were used per batch to express and purify protein. The 
purity of M20 apoprotein following affinity chromatography was checked with SDS-
PAGE (Fig. 3.1).  
Purified apoprotein was assembled in vitro with BV for two hours in the darkness. IEX 
was applied to separate holoprotein from apoprotein as it became evident during an 
analytical IEX that BV incorporation is less efficient with M20 apoprotein than with 
M15, which is likely due to the lack of the PHY domain. The fractions containing the 
holoprotein were pooled, concentrated, and applied to SEC to isolate a conformationally 
homogeneous population of the protein, as well as to exchange the buffer to SEC buffer 
(20 mM Tris-HCl pH 7.8 at 20C, 1 mM EDTA with or without 50 mM NaCl). Purified 
protein was concentrated to typically 20 – 30 mg/ml, and either used immediately or 
flash-frozen with liquid nitrogen in 0.1-1.0 ml aliquots and stored at -80 °C in darkness. 
Purified M20-BV had a typical SAR value (Section 1.3.3) of 1.2–1.7 (Fig. 3.3), which 
on average is higher than that of M15-BV (1.23, Scheerer et al., 2006). This is still 
lower than the expected range of SAR values which can be estimated based on the 
simple assumption that while Qmax of M15-BV and M20-BV are the same, M20-BV 
will have a lower 280 due to smaller number of amino acids with high absorption 
coefficient. Based on that assumption, the SAR value of M20-BV should accord to the 
equation given below. 
                                              
The experimentally determined SAR value for M20-BV is lower than the calculated 
SAR, which may be attributed to either persisting apoprotein contamination and/or due 
to the lack of the PHY domain. The assembly of phytochromes with the bilin 
chromophore is characterised by an increase in absorption in the Q-band, and it has 
been observed in phytochrome structures that the configuration of the bilins are 
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conserved, including its characteristic tilt of the D-ring with respect to the co-planar B- 
and C-rings (Wagner et al., 2005). Such a spatial constraint to the BV in the holoprotein 
which is not found in the free bilin in solution may be correlated with a high extinction 
coefficient and max in the Q-band in holophytochromes. The absence of the PHY 
domain in M20 could lead to structural differences of the bilin from that in the M15 
structure which are responsible for the different absorbances in the Q-band. Increase in 
the absorption in Q-band in context of bilin configuration and chromophore-protein 
interaction is not well documented in the literature owing to its complexity. A relevant 
observation in this context could be that there is an increased absorption in the Q-band 
of Agp2 holoprotein with 5Ea15Ea-BV chromophore, which was assumed to be the 
result of improved protein folding following NAP column separation (Inomata et al., 
2009). Also, it was found in a study with Agp2 that the PCM fragment is unable to form 
holoprotein with normal spectral properties, and the absorption spectrum of the CBD 
fragment is affected even further (Karniol et al., 2005). A high tilt of the D-ring of the 
bilin in CBD structures of DrBphPs were attributed to the lack of the PHY domain 
(Essen et al., 2008). These findings demonstrate that not only each domain contributes 
to bilin incorporation, but the degree of contribution differs among phytochromes, 
despite similar domain structures. 
The assembly mixture was subjected to purification with IEX, which successfully 
separated the holoprotein from the apoprotein (Fig. 3.2). Typically between 20–40% of 
the total eluate was apoprotein despite BV being supplied in molar excess during 
assembly. Such inefficient uptake of BV was not observed in case of M15 (Section 
6.2.1), and the inefficiency of M20 is attributed to the lack of the PHY domain, even 
though to date not much is known about its role in bilin incorporation.  
 
Figure 3.1 SDS-PAGE showing affinity purified M20 apoprotein. Lane M, 5 l of Applichem 
molecular weight marker; Lane 1, M15 apoprotein for comparison; Lane 2, M20 apoprotein. 20 g 
of sample was loaded per well in lanes 1 and 2. 
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Figure 3.2 Purification of M20-BV protein. A) IEX elution profile of M20-BV following the 
assembly. UV-vis absorption spectra of the peak I B) and II C) from IEX. The first peak contains 
M20-BV holoprotein while the second peak consists predominantly of apoprotein. D) A SEC elution 
profile of M20-BV with a Sephacryl 200 column. The blue, brown, and green lines indicate the 
absorption (mAU at 280 nm), conductivity (mS/cm), and buffer volume ratio A/B (%), respectively. 
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Figure 3.3 UV-vis absorption spectrum of purified M20-BV holoprotein. The SAR value 
(A702/A280) is 1.69.  
 
3.2.2 Crystallisation screening with purified M20-BV protein 
The M20-BV holoprotein was subjected to crystallisation trials using the following 
screening kits - JCSG+, PACT premier and PGA (Molecular Dimensions), Hampton 
screen 1 and 2 (Hampton), and JBScreen Classic 1 to 10, JBScreen 1 to 4, JBScreen 
Kinase 1 to 4 and JBScreen PEG/Salt 1 to 4 (Jena Biosciences). Despite this being the 
most intensive screening in the present study, no lead condition was identified from it. 
M20-BV crystals have been found however, in a preliminary trial in which the 
solubility of M20-BV holoprotein was studied as a function of precipitant concentration 
of several types (Fig. 3.4). These crystals were found by chance about 550 days after the 
plate was set up, long after the period for routine checks had ended. The plate had been 
exposed to fluctuating temperature and light conditions during the last several months 
of incubation. The emergence of crystals after a long period is explained by slow 
evaporation due to imperfect sealing of the crystallisation set-up. In that case the lack of 
a lead condition in the screening may be rationalised that insufficient protein and/or 
precipitant concentration were being addressed. This is consistent with a high solubility 
of M20-BV protein, such that the protein could be concentrated up to 60 mg/ml. 
Hexagonal crystals were found in a condition of 5% PEG4000 following about 550 days 
of incubation (Fig. 3.4.B) were cryoprotected with 20% (v/v) glycerol in the reservoir 
solution prior to vitrification in liquid nitrogen. 
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Figure 3.4 Crystals of M20-BV grown under various types of PEG solutions. A) 5% PEG1000, B) 
5% PEG 4000, C) 5% PEG8000.  
  
A B 
C 
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3.2.3 Analysis of M20-BV crystals 
Diffraction images were collected for some of the well-formed M20-BV crystals at 
beamline ID23-1 (ESRF, Grenoble, France). The crystals were judged to consist of 
M20-BV protein rather than salt, from their green colour and the diffraction patterns, 
but none of the collected diffraction images was of sufficient quality for the 
determination of M20-BV structure (Fig. 3.5). Indexing was not possible as the number 
of reflexions per image was less than optimal for iMosflm which is 200 – 1000 spots 
per image. 
Low diffraction quality may be attributed to any of the factors such as inherently low 
diffraction quality of M20-BV crystals, conformational heterogeneity by exposure to the 
light, and chemical heterogeneity as a result of protein degradation during the prolonged 
incubation period. 
 
  
Figure 3.5 A diffraction image of a M20-BV crystal. The quality is poor and the diffraction only 
occurs maximally to a resolution of about 15.5 Å.  
  
A B 
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3.3 M20s: truncated M20 construct 
After the initial attempts to solve the structure of M20-BV have failed due to the 
inability to obtain crystals with suitable diffraction quality, the gene construct was 
modified in hope that the produced protein may crystallise more readily. The 
modification corresponding to the truncation of the first nine amino acid residues at the 
N-terminus was considered for the two separate lines of reasoning. 
Previously a variation of Agp1 M15-BV without the first N-terminal nine amino acids 
has led to the formation of crystals with better diffraction quality (P. Scheerer, personal 
communication). Therefore the omission of this region was proposed to result in the 
successful crystallisation of M20 protein. 
Secondly, as described in Section 1.3.7.1, whether the first nine amino acids at the N-
terminus is part of the endogenously expressed protein in A. tumefaciens is unclear. 
Omission of the N-terminal region has been shown to have little effect on the 
biochemical activities of Agp1 M15-BV protein in vitro (Noack et al., 2007). 
Optimum truncation of a protein could result in a protein with preferable solubility and 
crystallisation propensity. The optimum truncation point may be determined by creating 
a library of differently truncated proteins (Listwan et al., 2009). For the purpose of this 
project, however, such an extensive optimisation was not carried out on M20 protein in 
favour of solving the structure of a longer construct, M15, the structure of which will be 
more informative than M20.  
3.3.1 Generation of M20s plasmid construct 
An expression construct termed pNM19a bearing the coding sequence of M15 1-9 was 
selected as the basis for generating an expression vector for M20 1-9, therefore 
generation of the construct only involves the omission of the sequence of the PHY 
domain. M20 1-9 construct will be referred to as M20s hereafter. Also a construct 
based on pNM19a has the benefits of pET based vector system which allows 
controllable, high levels of expression under compatible host cells. Details of the 
generation of M20s plasmid construct is shown in Appendix 2. 
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3.3.2 Expression and purification of M20s-BV protein 
M20s apoprotein was expressed, purified and assembled following the identical 
protocol as for the M20 protein, resulting in holoprotein with absorption spectra 
indistinguishable from that of the M20-BV protein. The protein was concentrated to 
typically 20 – 30 mg/ml prior to screening for crystallisation conditions. 
3.3.3 Crystallisation screening with purified M20s-BV protein 
Conditions from JCSG+, PACT premier and PGA kits were screened to crystallise 
M20s-BV holoprotein. Screening was carried out following the identical protocol as for 
the M20-BV holoprotein (Section 3.2.2). Crystallisation trials were also carried out 
around the condition in which M15-BV crystallise well (200 mM CaCl2, 20% (w/v) 
PEG3350, 100 mM Tris-HCl pH 8.0 at 20 °C), but without success. Promotion of 
crystal formation was attempted by cross-seeding with Agp1 M15-BV crystals into pre-
equilibrated drops of M20s-BV using cat whiskers. No lead crystallisation condition has 
been identified in any of the trials, however.  
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3.4 M15 and M15s: Photosensory core module (PAS-GAF-PHY) 
On the contrary to the initial anticipation, neither M20-BV nor M20s-BV protein 
crystallised readily to allow for the structural determination. Hence the focus was turned 
to M15 construct and its variation, which encompass the entire photosensory core 
module (PCM) including the PAS, GAF, and PHY domains. Due to the presence of the 
PHY domain, the PCM of phytochromes are capable of undergoing photoconversion 
from the Pr-from into the Pfr-form (Noack et al., 2007). Structural information of 
phytochrome PCM will therefore give deeper insights for the functionalities of 
phytochromes, such as the mechanism of photoconversion and signal transduction, 
compared to that of CBD. 
To this end, three versions of the wild type (WT) M15 were attempted for crystallisation. 
The differences in the coding sequence and the strains of E. coli cells used for protein 
expression are listed in Table 3.1. Crystallisation of M15 protein lacking the first nine 
N-terminal residues was also attempted as it was observed to produce better crystals (P. 
Scheerer, personal communication). This shorter construct without the nine N-terminal 
residues is referred to as M15s hereafter, while proteins expressed from both pAg1-M15 
and pNM9a are generally referred to as M15, unless otherwise specified. 
Throughout the present study, only proteins with the chromophore-binding cysteine at 
the 20
th
 position were used for crystallisation purposes to ensure the formation of 
covalent bond between the protein and the bilin moiety. For some biochemical studies, 
however, a mutant that cannot form a covalent bond with a BV was used. The protein 
produced from a construct termed pNM9c had the cysteine residue at 20
th
 position 
replaced with an alanine.  
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Construct Base plasmid 
and source 
Sequence description E. coli strain used for 
protein expression 
pAg1-M15 pQE12   
(Qiagen) 
Agp1 1 – 504 and hexahistidine tag XL1-Blue 
pNM9a pET21b 
(Novagen) 
Agp1 1-504, LE (XhoI site), and 
hexahistidine tag 
BL21(DE3) 
pNM9c pET21b  
(Novagen) 
Agp1 1-504 with C20A mutation, LE 
(XhoI site), and hexahistidine tag 
BL21(DE3) 
pNM19a pET21b 
(Novagen) 
Agp1 10-504, LE (XhoI site), and 
hexahistidine tag 
BL21(DE3) 
Table 3.1 List of M15 constructs at the start of the project. Proteins with the WT sequence were 
used for crystallization trials. 
3.4.1 Expression and purification of M15 / M15s-BV protein 
M15 and M15s apoproteins were overproduced as described in Section 2.2.3.6.2, and 
the purification protocol was identical regardless of the expressed protein variation or 
the strains of cells used, including the C20A mutant of M15. Typically 4 litres of LB-
ampicillin media were used per batch to express and purify the protein. Purity of M15(s) 
apoprotein purified by affinity chromatography was checked with SDS-PAGE (Fig. 3.6).  
Purified apoprotein was assembled in vitro with BV. Assembled M15(s)-BV 
holoprotein was purified by SEC with +/- 50 mM NaCl, 20 mM Tris-HCl pH 7.8 at 
20C, and 1 mM EDTA using either Sephacryl 200 16/60 or Superdex 200 10/300 
column (GE Healthcare) (Fig. 3.7). Holoprotein containing fractions with high SAR 
values were pooled and concentrated to 20-30 mg/ml. Absorption spectra of the purified 
protein was measured in order to determine the protein concentration and to inspect the 
SAR value to infer the relative purity of the holoprotein (Fig. 3.8). Purified protein was 
either used immediately or flash-frozen with liquid nitrogen in 0.1-1.0 ml aliquots and 
stored at -80 °C in darkness. 
Additional purification step to purify the holoprotein from the apoprotein was deemed 
unnecessary for M15(s)-BV, as judged from analytical IEX in Section 6.2.1. As far as 
M15 fragment is concerned, the difference in elution volumes in IEX between 
apoprotein and the BV adduct is comparatively higher than the difference between the 
apoprotein and the 15Ea adduct. IEX was routinely used to purify the 15Ea adduct from 
the apoprotein, therefore IEX is in theory capable of isolating the BV adduct from the 
apoprotein. Yet no apoprotein peak was ever identified when M15-BV holoprotein was 
subjected to IEX, and this was attributed to more efficient BV assembly by M15 than 
M20, possibly by the virtue of the PHY domain. 
Chapter 3: Structural characterisation of Agp1 in the Pr-form 
97 
 
 
 
Figure 3.6 SDS-PAGE gel showing the expression and purification of M15 apoprotein. Lane 1, 
insoluble fraction after cell lysis; Lane 2, clear lysate after cell lysis; Lane 3, flow-through from the 
affinity column following sample application; Lane 4, flow-through from the affinity column during 
washing stage, the first half; Lane 5, flow-through from the affinity column during washing stage, 
the second half, Lane 6, purified apoprotein. 
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A     SEC with M15-BV
 
  
 
 
Figure 3.7 Purification of M15-BV holoprotein. A) SEC elution profile of M15-BV holoprotein. 
Blue and brown lines indicate the absorption (mAU at 280 nm) and conductivity (mS/cm), 
respectively. UV-vis absorption spectra of peak-containing fractions from SEC. B) Fraction B9, C) 
Fraction B5, D) Fraction B1. Fraction B9 was assumed to be improperly folded protein associated 
with BV. Similar elution profile was observed between Sephacryl 200 and Superdex 200. Of the 
peaks with normal spectrophotometric properties, the minor (fraction B5) and the major peak 
(fraction B1) were found to correspond to the dimer and the monomer, respectively (Appendix 5). 
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Figure 3.8 UV-vis absorption spectra of purified M15-BV holoprotein. The SAR value is 1.24. 
Typical SAR value of purified M15-BV samples was in a range of 1.0-1.25. Asoret (393)/A280 is 0.44. 
 
3.4.2 Crystallisation screening with purified M15/M15s-BV protein 
Purified M15-BV protein was subjected to crystallisation trials with the following 
crystallisation screens; JCSG+, PACT premier, PGA, MemStart, and MemSys 
(Molecular Dimensions), and JBScreen Classic 1 to 10, JBScreen 1 to 4, JBScreen 
Kinase 1 to 4 and JBScreen PEG/Salt 1 to 4 (Jena Biosciences). 
Several lead crystallisation conditions were identified, out of which condition B6 of 
JBScreen PEG/Salt 1 was chosen to carry out an optimisation, on the basis of 
favourable crystal morphology of singly growing needles. Optimisation resulted in 
crystallisation condition (16% w/v PEG3350, 200 mM CaCl2, 100 mM Tris-HCl pH 8.0, 
2.5% (v/v) glycerol) in which rod shaped crystals appeared reproducibly, typically 
within 2 weeks of incubation at 19-25C (Fig. 3.9). The crystallisation condition 
reported in Scheerer et al., 2006 (23% w/v PEG3350, 100 mM Tris-HCl pH 8.0, 50 mM 
NaCl) was also attempted, but it resulted in a crystal form with less volume per length 
which was deemed less suitable for crystallographic analysis. The two conditions are 
similar and the only substantial difference is the valence of the cation. It was observed 
during the optimisation process that conditions with divalent cations such as Mg
2+
 and 
Ca
2+
 often resulted in crystals with more favourable morphology than those with 
monovalent cations such as Na
+
 and K
+
. The type of anion in Ca
2+
 salts did not 
influence the crystallisation as far as CaCl2, Ca(NO3)2, and Ca(C2H3OO)2 were tested. 
Crystals with typical dimensions of  0.15 mm ×0.15 mm × 0.80 mm were 
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cryoprotected in two steps with the reservoir solutions containing glycerol at 10% (v/v) 
increments (20% v/v final) prior to the vitrification in liquid nitrogen.  
 
  
Figure 3.9 Crystals of WT M15-BV growing under the optimised condition. 
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3.4.3 Analysis of M15(s)-BV crystals  
M15(s) -BV crystals were tested for diffraction at the ESRF synchrotron at the 
following beamlines; ID14-1, ID14-4, and ID23-1. Collected diffraction datasets were 
analysed for their quality based on statistics such as maximum resolution, signal-to-
noise ratio of intensities as expressed by the mean of I/ (Section 2.2.7.2.1), presence of 
twinning, and accuracy of intensities as judged by Rmerge. The best dataset termed 11-2 
was collected at beamline ID14-4 at the ESRF synchrotron and it exhibits anisotropic 
diffraction that extends maximally to 2.77 Å resolution. This was a slight improvement 
compared to the crystals described in the previous report (Scheerer et al., 2006). The 
improvement may be attributed to improvement in protein preparation, crystallisation 
condition, and/or cryoprotection. 
Datasets were indexed and integrated with iMosflm, and the intensities were scaled with 
Scala. The space group suggested by Pointless, I422, was in agreement with the 
previous report (Scheerer et al., 2006), and the unit cell parameters were essentially the 
same. The phases were determined by molecular replacement. The search models were 
either the preliminary structure of the Agp1 M15-BV which had been modelled from a 
previously collected dataset (Scheerer et al., 2006), or the combination of the high 
resolution structure of DrBphP CBD (2O9C) and the PHY domain of Cph1 (2VEA). 
The PHY domain of Cph1 in the Pr-form was judged to be a better search model than 
the structure of PaBphP in the Pfr-form, based on a comparison with the preliminary 
structure of M15-BV. The structures of DrBphP and Cph1 were processed with 
Chainsaw (Stein, 2008) by pruning the side chain atoms to -carbon for the non-
identical residues. 
The refinement proved to be difficult. The difficulties during the refinement of the 
protein moiety were characterised by the Rfree value remaining high at about 40%, and 
weakly defined electron density map in many locations including the bilin binding 
pocket (Fig. 3.10). A “pathological crystal form” (Dauter et al., 2005) was suspected, 
and hypotheses were made to identify the source of difficulty in the refinement. Firstly, 
a case of pseudosymmetry could have led to overestimation of the symmetry in the 
crystal. Secondly, the problem may be due to a twinning of the crystal. Finally, the 
problem may be due to the presence of conformational heterogeneity in the dimer. 
Rather than two chemically identical monomers being related by crystallographic 
symmetry, monomers may be in a different conformation, and the heterogeneity may 
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occur either at the protein moiety like in the case of WT PaBphP structure (3C2W, 
Yang et al., 2008) with four independent dimers in the asymmetric unit or in the vicinity 
of the bilin binding pocket as reported by the presence of two Cph1 isoforms in its 
ground state (Song et al., 2011). 
The problem of pseudosymmetry may be addressed by processing data in space groups 
with lower symmetry. To this end, the dataset 11-2 was indexed and scaled with several 
other candidate space groups suggested by iMosflm (Table 3.3) and the results are 
shown in Table 3.4. The lowest overall Rmerge value was observed with P1, but this may 
be the result of      〈  〉 of a reflection being added more times in higher symmetry 
space groups, therefore Rmerge cannot be used as a reliable criterion to compare the 
results of scaling between different space groups (Blow, 2002), and for such purpose, 
multiplicity-weighted reliability factors such as Rmeas or Rp.i.m. should be used (Evans, 
2006). Space group P1 exhibited the lowest overall Rmeas value of 0.060, whereas I422 
exhibited the most favourable overall Rp.i.m. and mean I/ of 0.027 and 17.3, 
respectively. Collectively, identification of the correct space group from the scaling 
statistics was judged to be difficult, and there is no clear evidence that I422 is the wrong 
space group. 
The presence of twinning in the dataset 11-2 was detected using the L-test (Fig. 3.11). 
This adds to the complication of identifying the correct space group, as no twinning is 
possible in I422, as well as reducing the reliability of the final data following the de-
twinning operation. Further attempts of structural refinement of WT M15-BV are 
described later in Section 3.9, where the refined structure of “SER26-BV”, a mutated 
M15-BV was used as the search model. It is noted that the estimated B-value of the 
dataset is unusually high (94.5 Å
2
). Since structural heterogeneity has been reported in 
the PaBphP crystal structure (Yang et al., 2008) and the average B-value and the 
estimated B-factor are also very high (127 Å
2
 and 70 Å
2
, respectively), it is possible that 
the degree of disorder of the molecules in this crystal form is high, thus posing 
difficulty over the satisfactory refinement. 
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Figure 3.10 Weakly defined electron density of M15-BV. The structure and electron density 
following molecular replacement with a preliminary model of M15-BV, following refinement 
with Refmac5. A) Coordinates of protein moiety (green stick) and the 2Fo – Fc map (grey mesh) 
at the bilin binding pocket. The electron density is contoured at 1.0 . B) Same as view as A, but 
with the BV molecule of the superimposed structure of DrBphP (cyan stick, 2O9C).  R/Rfree 
values at this stage of refinement are 0.4004/0.4600. 
 
Protein (Dataset) M15-BV (11-2) 
Beamline / wavelength [Å) ID14-4 / 0.9375 
Space group I422 
Unit cell dimensions a = b = 174.20 Å, c = 79.28 Å 
 =  =  = 90 ° 
Resolution range (outer shell) [Å] 72.16 – 2.77 (2.92 – 2.77) 
No. of observations 144322 
No. of unique reflections 15690 
Multiplicity 9.2 
Completeness overall (outer shell) [%] 99.4 (99.8) 
<I/(I)> overall (outer shell) 17.3 (4.0) 
Rmerge overall (outer shell) 0.076 (0.586) 
Rmeas overall (outer shell) 0.080 (0.620) 
Rpim overall (outer shell) 0.027 (0.200) 
Mosaicity ( ° ) 0.49 
Estimated B-value (Wilson plot) [Å
2
] 94.5 
Table 3.2 Data-collection and processing statistics of M15-BV dataset 11-2. Values are from data 
processing in the space group I422. 
A B 
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Number Space 
group 
Penalty a b c    
(x,y) 

() 
1 P1 0 79.4 129.4 129.6 84.5 72.2 72.2 0.12 0.58 
2 C2 1 191.8 174.1 79.4 90.0 114.4 90.0 0.12 0.58 
3 C2 1 246.5 79.4 1742.0 90.0 134.9 90.0 0.14 0.56 
4 I222 2 79.4 174.1 174.7 90.0 90.0 90.0 0.12 0.58 
5 C2 2 79.4 246.3 129.6 90.0 107.8 90.0 0.17 0.56 
6 C2 2 79.4 246.9 129.4 90.0 107.8 90.0 0.12 0.58 
7 F222 4 79.4 246.3 246.7 90.0 90.0 90.0 0.18 0.54 
8 I4 5 174.4 174.4 79.4 90.0 90.0 90.0 0.14 0.58 
Table 3.3 Results from indexing of dataset 11-2, collected from a M15-BV crystal. Potentially 
correct space groups and their unit cell parameters are output by analysing a dataset with iMosflm. 
 
 
 Overall Inner Outer 
#1 P1    
Rmerge 0.042 0.024 0.440 
Rmeas 0.060 0.035 0.623 
Rpim 0.042 0.024 0.440 
Mean ((I)/sd(I)) 9.9 25.3 1.7 
    
#4 I222    
Rmerge 0.066 0.039 0.546 
Rmeas 0.074 0.042 0.632 
Rpim 0.033 0.020 0.275 
Mean ((I)/sd(I)) 13.6 25.7 2.9 
    
#6 C2    
Rmerge 0.063 0.033 0.527 
Rmeas 0.076 0.042 0.632 
Rpim 0.042 0.024 0.345 
Mean ((I)/sd(I)) 9.7 21.0 2.0 
    
#8-1 I4    
Rmerge 0.066 0.039 0.546 
Rmeas 0.074 0.042 0.632 
Rpim 0.033 0.020 0.275 
Mean ((I)/sd(I)) 13.6 25.7 2.9 
    
#8-2 I422    
Rmerge 0.076 0.045 0.586 
Rmeas 0.080 0.049 0.620 
Rpim 0.027 0.019 0.200 
Mean ((I)/sd(I)) 17.3 30.6 4.0 
Table 3.4 Scaling statistics of dataset 11-2 in several space groups. Most 
favourable values for the overall resolution are emphasized in block. 
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Figure 3.11 L-test for twinning of the dataset 11-2 of M15-BV crystal. Twin fraction was lower than 
for other datasets of M15-BV crystals. 
 
  
Figure 3.12 A diffraction image of a WT M15-BV crystal. A) Overview and B) Close-up view of a 
section enclosed by a square. 
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3.5 Surface entropy reduction strategy 
3.5.1 Background 
In the previous sections, attempts to solve the structure of Agp1 in various truncated 
forms have been described. Those efforts have resulted in partially improving the 
preliminary structure of Agp1, which has been derived from a diffraction dataset 
described in a previous publication and improved data obtained thereafter (Scheerer et 
al., 2006). As far as the maximum resolution of diffraction datasets is concerned, 2.77 Å 
has been the best. Since in the various attempts to crsytallise WT M15-BV only a single 
crystal form was obtained for which serious problems with structure refinement were 
observed consistently as described in the previous section, it was deemed necessary to 
adopt a new strategy to obtain crystals of a different form and a better diffraction quality 
to enable structure determination. 
3.5.2 Current situation surrounding the field of protein crystallography 
Since the advent of protein crystallography, solving the structures of proteins of interest 
continues to be an important aspect of biology in the post-genomic era for detailed 
insights of the mechanistic function that can be deduced from the coordinates. Despite 
the increasing wealth of available techniques and recent development of high-
throughput methods, obtaining crystals of sufficient quality for diffraction analysis 
remains to be a big obstacle in protein crystallography today. This is partially due to the 
fact that the “low-hanging fruits”, i.e. more easily crystallised proteins, have been more 
thoroughly explored. Statistics from structural genomic studies estimate that the 
likelihood of a given protein entering the pipeline to crystallise is in the range of 30-
40%. The probability for the structure to be solved from those crystals is further limited, 
and ultimately only 10-20% of the proteins entering the pipeline will be successfully 
structurally determined, thus leaving the majority of the difficult proteins behind (p313, 
Bergfors, 2009). This is consistent with the fact that the only way to sustain the output 
from modern structural genomic projects, facilitated by high-throughput technologies, is 
to input more candidate proteins into the pipeline (Ericsson et al., 2006). It will 
therefore become increasingly important in the future to directly address this issue that 
the majority of proteins are not readily crystallisable. 
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3.5.3 Strategies for increasing the propensity of a protein to crystallise 
Many different approaches have been developed for crystallising the protein of interest. 
The success of protein crystallisation indeed depends on finding the optimal 
crystallisation condition, but more importantly, the protein itself is the fundamental 
variable that determines the outcome of the screening (Czepas et al., 2004, Longenecker 
et al., 2001). Strategies used in modern protein crystallography to modify the target 
protein include truncation of the construct (Listwan et al., 2009), limited proteolysis 
(Dong et al., 2007), mutation (Derewenda, 2004b), addition of large tags (Smyth et al., 
2003), co-crystallisation with cofactors (Benvenuti and Mangani, 2007), and surface 
methylation (Walter et al., 2006). To some extent, some of the strategies have already 
been incorporated in the present study. All attempts to crystallise Agp1 described herein 
were performed with holoproteins of truncated constructs. The current lack of any 
crystal structure of apo-phytochrome may be a testament for the necessity of the ligand 
to stabilise the structure to make the protein amenable to crystallisation. In the present 
study, apoproteins of mutant M15 proteins were screened but did not give a lead 
condition (Section 6.1).With regards to the type of chromophore as an optimisation 
parameter, Agp1 crystals with 15Za have been shown to exhibit better diffraction 
quality than the holoprotein with the natural chromophore, BV (Scheerer et al., 2010, 
Scheerer et al., 2006). The effect is probably due to higher conformational homogeneity 
of the holoprotein with 15Za than the holoprotein with BV, because 15Za in the 
holoprotein does not undergo the light induced isomerisation, and the holoprotein 
constitutively assumes a Pr-like state. But the fact that other phytochrome structures 
with their natural chromophores were refined satisfactorily is a testament that a natural 
phytochrome holoproteins are capable of forming crystals of sufficient quality, despite 
being potentially photosensitive. BV was deemed sufficient, and an alternative 
optimisation strategy was sought.  
3.5.4 Background to mutating the protein for crystallisation 
It has been known from earlier days of protein crystallography that some proteins are 
more amenable to crystallisation whereas others are less so. This phenomenon is 
exemplified by the differences in crystallisation propensities between the protein 
homologues from different species, and this has been used to an advantage by early day 
crystallographers in the form of homolog-screening (Derewenda, 2004a). It is a viable 
option to change the source organism when the protein proves difficult to crystallise 
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(p79, Blundell and Johnson, 1976). Though working with a protein from another species 
may yield positive results, it is a time-consuming approach, however. The purification 
protocol needs to be re-established, and the biochemically active range of the protein 
may be different. It may therefore be more efficient to modify the existing target protein 
to improve the crystallisation propensity without altering the structure and the function 
of the protein. Homologue screening may not be feasible if the protein of interest is a 
high-value target of human origin with medical relevance. The vast majority of the 
protein structures solved and deposited in the databases derives from heterologously 
expressed material, and this approach enables the resulting protein to be modified easily 
by introducing the change to the expression construct (Derewenda, 2004b). 
An early example of successful crystallisation by protein engineering is the case of the 
human ferritin H-chain. A Lys86Glu mutation was introduced to the human homologue 
to emulate a Ca
2+
 mediated crystal contact which was found in the crystal of rat 
homologue of the protein (Lawson et al., 1991). 
Surface methylation of amino groups was successfully employed to solve the structure 
of chicken myosin subfragment-1 (Rayment et al., 1993) and since then it has become a 
widely accepted rescue strategy for proteins reluctant to being crystallised (Walter et al., 
2006).  
In the present study, site-directed mutagenesis was chosen over protein methylation for 
the following reasons. (i) Even if the methylation reaction is perfectly reproducible and 
reaches completion, i.e. all the amino groups of lysines and the N-terminal methionine 
residue are methylated, only two variations of the protein are possible as products 
together with the non-methylated protein. The mutation approach on the other hand will 
offer the freedom of location, number, and the type of mutation to be introduced, 
leading to more variations for testing. (ii) Methylation process is unlikely to proceeds to 
completion in reality. This will lead to inhomogeneity of the sample, which is 
unfavourable for crystallisation of macromolecules (Benvenuti and Mangani, 2007). 
(iii) Once the mutated plasmids are produced, the production and purification protocol 
of mutant proteins are expected to be the same as the established protocol. Producing 
mutant protein will thus be more cost and time effective. 
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3.5.5 Mutation strategy employed thus far for crystallisation of other 
phytochromes 
There are three cases where mutating the protein resulted in better diffracting 
phytochrome crystals (Auldridge et al., 2012, Mailliet et al., 2011, Wagner et al., 2007). 
Wagner and co-workers succeeded in improving the maximum diffraction of the 
crystals of DrBphP from 2.5 Å resolution (1ZTU) to 1.45 Å resolution (2O9C) (Wagner 
et al., 2007). The presence of chemically impossible overlap between symmetry related 
Tyr307 was identified in the 1ZTU structure and was assumed to cause a local disorder 
detrimental to crystallisation (Fig. 3.13). A Tyr307Ser mutant was designed to reduce 
the conflict and the mutation was justified on the basis of the distance of the mutated 
residue from the bilin pocket. Mutation of the equivalent residue of Agp1 was first 
considered as a potential strategy, and in principle this is plausible considering the 
similarity between currently available phytochrome structures and the high degree of 
sequence identity between Agp1 and DrBphP for the PAS-GAF domains (37.6 %). 
Upon inspection of the electron density map of the preliminary M15-BV structure at 
Phe297, the equivalent of DrBphP Tyr307, the conformation of the phenyl side chains 
were not identical to that of DrBphP Tyr307, but in fact the side chains of two 
symmetry related molecules were pointing away from each other. This observation must 
be taken with care as the calculated electron density of the preliminary structure of M15 
is not entirely reliable especially for the side chains. When the side chain conformations 
for other phytochrome crystal structures in biologically relevant parallel homodimers 
were studied, the closest distances between the pairs of atoms of the residues were at 
distances not considered to cause a steric clash as in the case of 1ZTU. Hence it was 
hypothesised that the steric clashes caused by residues corresponding to Tyr307 in 
DrBphP phytochrome is not a universal characteristic for all phytochromes, therefore 
the applicability of this strategy to Agp1 is questionable. 
Approaches described by Mailliet et al., 2010 and Auldridge et al., 2012 to mutate the 
residue(s) necessary for photoconversion in Cph1 and DrBphP, respectively, have led to 
better diffracting crystals. Mutations to render phytochromes photo-inactive may 
increase the conformational homogeneity of the sample, but since the ultimate aim of 
the study is to carry out structural comparison of Agp1 in the Pr- and the Pfr-forms, the 
mutation to alter the conformation of the functionally important residues was deferred. 
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Papiz and co-workers successfully crystallised the CBD of RpBphP2 (Bellini and Papiz, 
2012a). The WT RpBphP2 CBD was not amenable to being crystallised. 
Crystallogenesis of RpBphP2 was achieved by introducing the residues involved in 
crystal contacts in the RpBphP3 structure (Yang et al., 2007). Mutation resulted in 
successful crystallisation of RpBphP2, albeit with a different crystal form from that of 
RpBphP3. At the time of planning mutagenesis of Agp1, two PCM structures were 
available (Cph1, Essen et al., 2008; PaBphP, Yang et al., 2008), but applicability of the 
approach of Papiz and co-workers may not be as plausible for Agp1 as for RpBphP2. 
Sequence identities between Agp1, Cph1, and PaBphP (roughly 33%, Table 1.4) is not 
as high as between RpBphP2 and RpBphP3 (52%). Furthermore, structural differences 
are greater among phytochrome PCM (PAS, GAF, and PHY domains) structures than 
CBD (PAS and GAF domains) structures. There are considerable differences in the 
positions of the PHY domain relative to the PAS-GAF domains in Cph1, PaBphP, and 
preliminary Agp1 structures (Fig. 3.29), therefore introducing residues participating in 
crystal contacts in other phytochromes to Agp1 may not result in a successful 
crystallogenesis. 
Since the aim of this study is to gain functional insights from phytochrome structures, 
attention must be paid to avoid altering the protein function where possible, therefore a 
more generally applicable approach that does not inadvertently affect the protein’s 
function was sought instead for designing Agp1 mutants.   
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Figure 3.13 Dimer interfaces of DrBphP at Tyr307 and equivalent in other phytochromes. The 
closest distances between pairs of residues are shown by dotted lines. A) DrBphP (1ZTU), Tyr307, 
0.9 Å. This is close proximity between two symmetry related monomers is a physically impossible 
clash, and the region is disordered in the crystal. B) DrBphP Y307S (2O9C), Ser307, 5.5 Å. C) Agp1 
preliminary structure, Phe297, 9.4 Å. D) PaBphP (3C2W), Ile294, 6.0 Å. E) RpBphP3 (2OOL), 
Leu316, 7.5 Å.  The electron density of Agp1 is contoured at 1. 
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3.5.6 Other strategies for Agp1 mutagenesis 
It has been shown in the past that it is possible to engineer existing crystal contact sites 
to improve the crystallisation propensity of proteins. In a systematic study in which all 
twenty-one mutations at thirteen different crystal packing residues yielded isomorphous 
crystals under the same condition as the WT, two mutants exhibited exceptionally 
improved resolution (Mizutani et al., 2008), but the authors conclude that rational 
prediction for effective crystal engineering is difficult. Another example is a case of 
increased crystal volumes as a result of mutations which reduced the side chain entropy, 
and changing the mode of a crystal contact from a solvent mediated one to direct side 
chain contacts has also been reported (Meher et al., 2009).  
Rational engineering of existing crystal contact sites requires the structural information. 
At the time of planning the mutagenesis strategy, the Agp1 M15-BV preliminary 
structure was assigned with the amino acid sequence for the PAS and GAF domains 
while the PHY domain was modelled as a poly-alanine chain (Scheerer et al., 2010). 
The allocation of correct amino acids in the PHY domain may be deduced by homology 
modelling, but for the task of predicting the effect of crystal contact engineering, the 
reliability of the preliminary structure and homology models were deemed insufficient. 
In turn a blind approach was adopted instead, using minimal prior knowledge specific to 
Agp1 or other phytochromes. Such approach may result in obtaining novel crystal forms, 
and to this end two strategies for mutagenesis were considered.  
A strategy to mutate lysine into arginine or glutamine was originally proposed by 
Dasgupta and co-workers (Dasgupta et al., 1997). In a survey of the contact sites at 
oligomer interfaces and crystal interfaces from 58 and 223 proteins, respectively, it was 
suggested that substitution of lysine, the least favoured residue at crystal interfaces, with 
arginine or glutamine, the two most favoured residues, may promote the formation of 
crystal contact sites, therefore resulting in crystallisation of a protein. 
The “Surface entropy reduction” strategy, originally devised by Derewenda and co-
workers, aims to improve the crystallisation propensity of proteins by decreasing the 
conformational entropy during crystallisation (Derewenda and Vekilov, 2006). The 
crystallisation process involves transfer of protein molecules from the solution to the 
crystal at constant temperature and the process is governed by Gibb’s free energy. The 
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Gibbs-Helmholtz equation at a constant temperature is expressed in the equation below, 
and Gibb’s free energy consists of two components, enthalpy and entropy. 
                            
Where G°cryst is Gibb’s free energy, H°cryst is enthalpy, S°cryst is entropy and  indicates 
the difference in any of these for the system before and after the crystallisation. The 
crystallisation process is thermodynamically favoured when the change in Gibb’s free 
energy is negative as a result of contribution from both enthalpy and entropy. Given that 
only moderately negative changes in Gibb’s free energy, usually in the range of -10 to -
100 kJ mol
-1
, are associated with protein crystallisation (Vekilov, 2003), and changes in 
enthalpy are often either moderate (-70 kJ mol
-1
 for lysozyme (Schall et al., 1996)) or 
negligible (~0 kJ mol
-1
 for ferritin, apoferritin, and lumazine synthase (Gliko et al., 2005, 
Petsev et al., 2001, Yau et al., 2000)), the crystallisation process must be predominantly 
entropy driven. The entropy component in the above equation consists of entropic 
contributions from both protein and water molecules forming a layer of structured water 
surrounding the protein, therefore the equation may be further extended to the form 
shown below. 
                                                 
Some amino acids contribute to an increase in the Gibb’s free energy during the 
crystallisation process. This is because when the residues with many conformations 
(high entropy) in solution are stabilised as a result of the crystallisation, the drop in 
conformational entropy (TSprotein, a negative value) increases the Gibb’s free energy due 
to the negative operation on the entropy in the equation given above. Replacing residues 
which decrease the conformational entropy during the crystallisation (“low entropy 
residues”) with alanine with no conformational entropy will in theory make the 
crystallisation process more thermodynamically favourable (Table 3.5).  
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  Residue TScoil (kcal / mol) 
 
Ala 0.000 
 
Gly 0.000 
 
Pro 0.000 
 
Val -0.541 
 
Phe -0.544 
 
Asn -1.708 
 
Glu -1.763 
 
Lys -1.973 
 
Gln -2.107 
 Arg -2.120 
Table 3.5 The conformational entropy of selected amino acids multiplied with temperature (300 
K). Five amino acids with the lowest and highest conformational entropy-dependent change in 
energy upon crystallisation in coil regions (TScoil) are shown. Adapted from Avbelj and Fele, 
(1998). 
Lysine and Glutamate are the primary mutable residues in this strategy. Lysine occupies 
12 – 15% of protein surfaces, yet only 5.4% of oligomer interfaces. This indicates that 
the presence of lysine is disfavoured at protein-protein interaction sites. Like lysine, the 
presence of glutamate is deferred at interfaces between proteins. Glutamate occupies 
10.3% of protein surfaces, yet it constitutes only 4.1% of oligomer interfaces. It must 
also be noted that glutamate is present predominantly on the surface of the protein and 
that only 12% of Glu residues within the polypeptide are buried. Mutating glutamine 
with alanine will provide entropic benefits without decreasing the protein solubility 
significantly, as the change in charge is smaller than GluAla or LysAla mutations. 
Glutamine is less suited as a SER target residue, however, as a higher proportion of 
glutamine residues are present in the protein interior (17%) compared to glutamate 
(12%), and glutamine constitutes a smaller proportion in proteins (3.7%) which makes 
glutamine a less suitable target for a blind approach (Derewenda and Vekilov, 2006). 
Arginine is not regarded as a target mutable residue, because oligomer interfaces 
actually favour arginine so that the strategy by Dasgupta recommends mutating lysine 
into arginine and glutamine. To the best of the author’s knowledge, no case of 
successful SER approach targeting asparagine has been reported, despite its fifth lowest 
conformational entropy in coil (Table 3.5). 
Therefore the primary targets of mutable residues are lysine and glutamate because of 
their high probability to occur at the surface of the protein but not at oligomer interfaces, 
and mutating them into alanine will make crystallisation more thermodynamically 
favourable. A successful case of SER approach to target aspartate residues has also been 
reported (Cierpicki et al., 2006), but aspartate is not the primary target due to its 
frequent presence at protein-protein interaction sites. 
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Numerous successful cases have been reported for both strategies by Dasgupta et al. and 
by Derewenda et al. To the best of the author’s knowledge, there is only one study in 
which two strategies were directly compared for their impact on crystallisation (Czepas 
et al., 2004). Therein it was concluded that Dasgupta’s approach improved the 
crystallisation propensity of the protein, but the effect was not as dramatic as SER 
approach. 
In the present study, the SER approach was adopted as a method of improving the 
quality of Agp1 crystals. SER mutations were only carried out on Lys and/or Glu 
residues occurring consecutively without a gap, because the beneficial effect to 
crystallisation is known to be more pronounced than when the mutations were 
introduced to a single residue (Cooper et al., 2007).  
  
Chapter 3: Structural characterisation of Agp1 in the Pr-form 
116 
 
3.6 Single cluster surface entropy reduction mutants 
3.6.1 Generation of single cluster surface entropy reduction mutants 
3.6.1.1 Target site determination 
Initial candidates of mutants according to the SER strategy were designed simply by 
identifying two or more consecutive lysine and/or glutamate residues, and the maximum 
gap allowed was a single residue. Based on this simply criterion, nine initial candidates 
were identified (Fig. 3.14). Hereafter the SER candidate clusters will be referred to by 
the order in the sequence from the N-terminus, i.e. SER2 refers to E86A/E87A. SER1 
(E7A/K8A) was immediately removed from the list of candidates, as plasmid pNM19a 
which lacks the coding sequence corresponding to the first nine N-terminal residues 
(Section 3.4) was the base to generate the mutated constructs. Three final candidates 
were selected from the initial candidates according to the following additional criteria. 
Firstly, the mutation must only be introduced in the loop region on the surface of the 
protein. The SER approach is more successful when the mutation is introduced to loops 
rather than -helices (Goldschmidt et al., 2007). Residues that do not occur on the 
protein surface will not influence the entropy upon crystallisation, except for an 
unforeseen conformational change that is associated with the mutation of buried residue, 
which is hard to predict. The secondary structure of the regions containing the candidate 
residues was checked by inspecting the preliminary structure of Agp1. For regions 
where the structural information was missing and/or the primary structure was not 
assigned (poly-alanine model region), a homology model of Agp1 based on the crystal 
structures of Cph1 (2VEA) and DrBphP (2O9C) was used. Only SER2 (E86A/E87A), 
SER3 (E96A/K97A/K98A), and SER6 (E336A/K337A) were found likely to occur in 
loop regions, and the degree of surface exposure of these residues in the candidate sites 
was confirmed with Areaimol (Saff and Kuijlaars, 1997).  
Secondly, the residues to be mutated must not be conserved amongst other 
phytochromes to minimise the potential functional effect the mutation may introduce. 
To this end, a sequence alignment of Agp1 with other phytochromes was utilised.  
Finally, the candidate residues were checked for any report of functional alteration upon 
mutation of the corresponding residues in other phytochromes. To this end, as many 
mutational studies on phytochromes as possible were compiled, and based on the 
sequence alignment, the residues corresponding to the candidate SER residues were 
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checked for previously reported mutational studies. The candidate mutation sites and 
the corresponding residues in other phytochromes are shown in Table 3.6. To the best of 
the author’s knowledge, no mutation has been carried out on the residues corresponding 
to the SER targets to date. However, the lack of evidence for the functional importance 
of the target residues is not the evidence that mutating those residues will not affect the 
protein function. 
Alongside the manual selection of the mutable residues, the sequence of Agp1-M15s 
was submitted to the SERp server (http://services.mbi.ucla.edu/SER/) for automated 
identification of mutable residues (Goldschmidt et al., 2007). Thereby three mutable 
clusters were identified, and these clusters were identical to SER3, SER6, and SER2, in 
order of decreasing priority. The identification of the same clusters as mutable residues 
by both manual selection and the automated search is not surprising considering that the 
criteria used in the processes were essentially the same. Consequently, three candidate 
clusters, SER2 (E86A/E87A), SER3 (E96A/K97A/K98A), and SER6 (E336A/K337A) 
were selected for carrying out SER mutations to Agp1 (Fig. 3.15). 
3.6.1.2 Generation of the plasmid constructs 
Three single cluster SER mutations were introduced to the pNM19a plasmid according 
to the QuikChange protocol (Section 2.2.2.9) and the procedure is described in 
Appendix 3.  
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MQRERLEKVMSSHTPKLDSCGAEPIHIPGAIQEHGALLVLSAREFSVVQASDNLANYIGVDLPIGAVATE 
ANLPFISVLSAWYSGEESNFRYAWAEKKLDVSAHRSGTLVILEVEKAGVGESAEKLMGELTSLAKYLNSA 
PSLEDALFRTAQLVSSISGHDRTLIYDFGLDWSGHVVAEAGSGALPSYLGLRFPAGDIPPQARQLYTINR 
LRMIPDVDYKPVPIRPEVNAETGAVLDMSFSQLRSVSPVHLEYMRNMGTAASMSVSIVVNGALWGLIACH 
HATPHSVSLAVREACDFAAQLLSMRIAMEQSSQDASRRVELGHIQARLLKGMAAAEKWVDGLLGGEGERE 
DLLKQVGADGAALVLGDDYELVGNTPSREQVEELILWLGEREIADVFATDNLAGNYPTAAAYASVASGII 
AMRVSELHGSWLIWFRPEVIKTVRWGGDPHKTVQESGRIHPRKSFEIWKEQLRNTSFPWSEPELAAAREL 
RGAIIGIVLRKTEE 
Figure 3.14 Clusters of mutable residues identified within Agp1-M15 sequence. Two or more 
consecutive Lys or Glu residues with maximum gap of one residue are highlighted. Initial candidate 
SER mutation clusters were, SER1, E7A/K8A; SER2, E86A/E87A; SER3, E96A/K97A/K98A; 
SER4, E113A/E115A/K116A; SER5, E124A/K125A; SER6, E336A/K337K; SER7, E382A/E383A; 
SER8, K469A/E470A; SER9, K501A/E503A/E504A. 
 
 
Table 3.6 SER-target residues in Agp1 and corresponding residues in other phytochromes. No 
mutation, whether naturally occurring or introduced artificially, to the residues corresponding to the 
SER targets in Agp1 has not been reported in any phytochromes. 
  
Amino acid Res idue number Amino acid Res idue number Amino acid Res idue number Amino acid Res idue number
E 86 W 82 I 91 I 105
E 87 S 83 A 92 R 106
E 96 E 92 D 100 E 115
K 97 H 93 A 101 R 116
K 98 G 102 A 117
E 336 D 333 H 341 Q 355
K 337 D 334 D 342 G 356
Amino acid Res idue number Amino acid Res idue number Amino acid Res idue number Amino acid Res idue number
A 96 S 92 I 156 V 190
L 97 K 93 L 157 W 191
P 106 D 102 P 166 P 200
A 107 F 103 F 167 F 201
A 108 V 104 Y 168 Y 202
L 346 A 346
S 347 D 347
Cph1DrBphP
N/AN/A
N/A N/A
A. thaliana PhyBA. thaliana PhyA
Agp1 PaBphP RpBphP2 RpBphP3
N/A
A 
 
B 
 
C 
 
Figure 3.15 Location of the SER target clusters. A preliminary structure of M15 is displayed as a 
dimer in C representation, with one monomer coloured green and the other coloured cyan. The 
target clusters are displayed as violet spheres. Location of the A) SER2 (E86A/E87A), B) SER3 
(E96A/K97A/K98A), and C) SER6 (E336A/K337A) clusters relative to the global protein structure. 
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3.6.2 Expression and purification of single cluster SER-BV protein 
Apoproteins of SER2, SER3, and SER6 mutants were overexpressed with 1.5 L of RB-
Amp media. Apart from the significantly reduced yield of apoprotein for SER3 and 
SER6, no difference in the characteristics of the protein was observed during affinity 
purifications, so that the mutant apoproteins were successfully purified following the 
previous protocol (Section 3.4.1). Samples during the expression and affinity 
purification of the mutants were visualised by SDS-PAGE gels (Fig. 3.16). Presence of 
SER2 protein in the flow-through during sample application and washing stage may 
indicate inefficient binding of the protein to the Ni
2+
 charged resin, but this was 
attributed to extremely high level of soluble protein which saturated the binding 
capacity of the column, and this is consistent with relatively high level of SER2 yield 
compared to other SER mutants.  
For each SER mutant the yield after affinity purification was different from that of the 
WT protein (data not shown), suggesting that the solubility of M15 proteins changed 
following SER mutations. The effect of SER mutations on the solubility of the proteins 
is discussed in more detail in Section 5.2. 
Affinity purified SER mutant apoproteins were subjected to the same protocol as the 
WT M15s protein with regards to the assembly with BV and the following purification 
with SEC (Section 3.4.1). Purified holoprotein was concentrated to 25 mg/ml for 
screening.  
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Figure 3.16 SDS-PAGE gels (10%) showing the expression and affinity purification of single 
cluster SER mutants. A) SER2. B) SER3. C) SER6. In all cases, the purification stages in the 
individual lanes are as follows. Lane 1, cell pellet before induction; Lane 2, cell pellet after 
induction; Lane 3, insoluble fraction after lysis; Lane 4, soluble fraction after lysis; Lane 5, column 
flowthrough when the cleared soluble fraction was applied onto the affinity column; Lane 6, first 
half of the flowthrough from the affinity column during the wash, Lane 7, second half of the 
flowthrough from the affinity column during wash; Lane 8, purified protein eluted from the affinity 
column; M, SN marker. Lane 8 of the first gel appear faint due to low quantity of protein being 
loaded into the well. 
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3.6.3 Crystallisation screening with purified single cluster SER-BV protein 
Following the successful production and purification of the SER2, SER3, and SER6 
mutants, they were characterised by multitudes of biochemical approaches prior to 
crystallisation trials (Section 5.3).  
De novo screening was carried out on BV adducts of the SER mutants (SER-BV) in 
order to maximise the chance of obtaining new crystal forms. Screening was carried out 
with JCSG+, PACT-premier, and PGA kits (Molecular Dimensions) along with the WT 
M15s-BV protein as control. The protocol used was identical to that for the WT M15s-
BV protein (Section 3.4.2). 
Crystallisation trials with the SER-BVs initially resulted in re-discovering the 
crystallisation conditions already identified for the WT protein. An exception is SER3-
BV, which was later found to crystallise in a novel crystal form. Since this novel form, 
however, was first obtained with another SER mutant, SER36-BV, crystallisation of 
SER3-BV will not be discussed in detail here. 
3.6.4 Analysis of single cluster SER-BV crystals 
Many crystallisation conditions have been identified for the BV adducts of SER2, SER3, 
and SER6, but most of the conditions consisted of PEG of intermediate molecular 
weights (3350-8000) with salts containing mono/di-valent cation in a mildly alkaline 
range of pH 7.5 – 8.5, which are essentially variations of the crystallisation condition 
for the WT M15-BV holoprotein (Section 3.4.2). Crystals of the single cluster SER 
mutants with a morphology indistinguishable from the WT holoprotein crystals 
appeared under the optimised condition for the WT holoprotein. SER2-BV crystals 
exhibited comparatively favourable morphology featuring high volume per length, and 
the crystals were subjected to diffraction analysis at the ESRF synchrotron.  
A dataset termed 5-3 with relatively good diffraction quality was collected from a 
SER2-BV crystal at ID14-1 at the ESRF synchrotron (Fig. 3.17). The dataset termed 5-3 
was indexed, scaled, and processed with the same protocol as used for the dataset from 
the WT holoprotein crystals (Section 3.4.3). The scaling statistics and L-test for 
twinning are as shown in Table 3.7 and Fig. 3.18, respectively, and they indicate the 
quality to be not as good as that of dataset 11-2 of WT M15-BV crystal (Section 3.4.3). 
Given that SER2-BV crystals exhibit a similar morphology to the WT crystals, it is not 
surprising that the unit cell parameters and the apparent space group are essentially the 
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same. Structural refinement was attempted following the phase determination with 
molecular replacement using the space group I422, but a case of “pathological” crystal 
was evident as the structural refinement proved to be difficult similarly to the case of 
WT (Data not shown). Given the persistence of crystallographic difficulties in SER2-
BV crystals, no further attempts were made to solve the structure with single cluster 
mutant of the protein. 
Screening of single cluster SER mutant proteins led to identifying similar crystallisation 
conditions to that of the known conditions for the WT M15s. Furthermore, it has been 
shown that the crystal form of SER2 crystal to be the same as the WT crystal, and the 
same is assumed to apply to other SER mutant crystals judging by the crystal 
morphology and the condition in which crystals grow. 
It has been confirmed from crystallisation condition, crystal morphology, and more 
directly by data processing that SER2-BV holoprotein crystal is in the same 
“pathological” form to that of the WT holoprotein, thereby resisting satisfactory 
structural refinement. It is also likely for SER3-BV and SER6-BV adducts to be in the 
same crystal form, and for this reason, more extensive changes were judged to be 
necessary for inducing crystallisation in a novel form. 
 
 
Figure 3.17 A diffraction image of SER2-BV holoprotein crystal.  
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Protein (Dataset) SER2-BV (5-3) 
Beamline/wavelength [Å) ID14-1 / 0.9334 
Space group I422 
Unit cell dimensions a = b = 171.06 Å, c = 78.52 Å,  =  =  = 90 ° 
Resolution range (outer shell) [Å] 54.79 – 2.76 (2.91 – 2.76) 
No. of observations 64254 
No. of unique reflections 13305 
Multiplicity 4.8 
Completeness overall (outer shell) [%] 88.3 (80.9) 
<I/(I)> overall (outer shell) 7.9 (2.2) 
Rmerge overall (outer shell) 0.107 (0. 677) 
Rmeas overall (outer shell) 0.120 (0.769) 
Rpim overall (outer shell) 0.052 (0.352) 
Mosaicity ( ° ) 1.91 
Estimated B-value (Wilson plot) [Å
2
] 58.4 
Table 3.7 Crystal data of dataset 5-3 of a SER2-BV crystal. 
 
 
Figure 3.18 L-test for twinning of dataset 5-3 of SER2-BV crystal. Twin fraction of the dataset 5-3 
from a SER2-BV crystal is higher than the dataset 11-2 from a WT crystal (Fig. 3.11). 
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3.7 Double cluster surface entropy reduction mutants 
Screening single cluster SER mutants resulted in identification of similar crystallisation 
condition to the WT Agp1 M15-BV protein. The crystal form of the WT was preserved 
in all single cluster SER mutant crystals as inferred by morphologies, as well as by 
analysing the diffraction images from SER2-BV crystals, thus the crystals of the single 
cluster SER mutants are expected to be in the “pathological” crystal form, except for 
SER3-BV crystal which was later found to crystallise in an (NH4)2SO4-based condition 
with a novel form (Section 5.4). Introduction of single clutter SER mutation did not 
result in drastic alteration of crystallisation propensity of the protein, and furthermore it 
was not possible to improve the quality of the crystals by crystallographic techniques, 
such as re-crystallisation (Wagner et al., 2005), streak/micro seeding, or by altering the 
crystallisation configuration to sitting-drop. Hence in an effort to obtain crystals of BV 
adducts of Agp1 PCM in alternative form, simultaneous introduction of two SER 
mutations was attempted, as it was hypothesised that additional SER mutation may 
induce new crystal form by further shifting the thermodynamically stable intermolecular 
interaction in crystallo.  
3.7.1 Generation of double cluster surface entropy reduction mutants 
Two double cluster SER mutants, SER26 and SER36 were arbitrarily chosen for 
production. To carry out mutagenesis, pNM19a plasmid bearing SER6 mutation was 
chosen as the template. SER6 plasmid was subjected to mutagenesis with SER2 F and 
SER2 R primers to produce SER26, and with SER3 F and SER3 R to produce SER36 
mutant according the QuikChange protocol in Section 2.2.2.9. Plasmids were purified 
from successfully transformed colonies, and successful mutagenesis was verified as 
described in Appendix 4. 
3.7.2 Expression and purification of double cluster SER-BV protein 
Double cluster SER mutants were produced and affinity purified following the identical 
protocol to that of the WT and single cluster SER mutant proteins (Fig. 3.19, Section 
3.4.1 and 3.6.2). Introduction of SER2 or 3 mutations decreased the solubility of the 
SER6 protein like when SER2 and 3 single cluster mutations were introduced to the WT 
protein (Section 5.2). Apoproteins were assembled with BV following the same 
protocol as for the WT M15s, and subjected to SEC with Superdex 200 column (Section 
2.2.3.7.6).  
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Figure 3.19 SDS-PAGE gels showing the expression and affinity purification of SER26 and SER36 
mutants. Various purification stages indicated by the numbers were separated by SDS-PAGE (10%). 
Lane 1, Cell pellet before induction; Lane 2, Cell pellet after induction; Lane 3, Insoluble fraction 
after lysis; Lane 4, Soluble fraction after lysis; Lane 5, Column flowthrough during applying the 
cleared soluble fraction onto the affinity column; Lane 6, Column flowthrough from washing , Lane 
8, Purified protein eluted from the affinity column. 
 
3.7.3 Crystallisation screening with purified double cluster SER-BV proteins 
Purified SER26-BV and SER36-BV proteins were used in de novo crystallisation 
screening with JCSG+, PACT-premier, PGA, and Morpheus kits (Molecular 
Dimensions) according to the standard protocol (Section 2.2.6.1). Lead conditions were 
identified for both SER26-BV and SER36-BV and optimisation was carried out based 
on those conditions. The optimised conditions are shown in Table 3.8. 
Following the identification of a new crystal form with SER36-BV protein in an 
(NH4)2SO4-based condition, SER3-BV was also found to crystallise in a similar novel 
form under the same crystallisation condition (JCSG+ 2.4). No diffraction images of 
SER3-BV crystals could be collected at a synchrotron, however, due to the time 
constraints. 
Crystals suitable for diffraction analysis were obtained in a condition containing 2 l 
each of protein solution at 25 mg/ml and the reservoir solution, and imperfect tetragonal 
bipyramidal crystals of SER26-BV and SER36-BV crystals with less defined 
morphology appeared within 2 weeks of setup (Fig. 3.20). Reproducibility of the crystal 
was high for SER36-BV, but only moderate for SER26-BV crystal. 
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Introduction of SER mutation clusters resulted in novel crystal forms, where SER26 
crystallised in a novel form, and SER3 and SER36 crystallised in another novel form, as 
judged from the new crystallisation conditions and new crystal morphologies. 
 
 
Protein Reservoir solution composition Temperature (°C) 
SER26-BV 0.03 M diethyleneglycol, 0.03 M triethyleneglycol,  
0.03 M tetraethyleneglycol, 0.03 M pentaethyleneglycol, 
20% Glycerol, 10% PEG8000, 
0.05 M MES, 0.05 M Imidazole pH 6.5 
25 
SER3-BV 
SER36-BV 
1.1-1.2 M (NH4)2SO4 
50-200 mM Li2SO4 
0.1 M Tris-HCl pH 8.5 
14 
Table 3.8 Optimised crystallisation conditions of SER26-BV and SER36-BV protein. 
 
 
    
Figure 3.20 Mutated M15 crystal in novel forms. A) SER26-BV crystal with imperfect tetragonal 
bipyramidal form. SER3-BV B) and SER36-BV C) crystals with relatively undefined morphology. 
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3.8 Structural determination of SER26-BV 
3.8.1 Analysis of double cluster SER-BV crystals 
Crystals of SER26-BV and SER36-BV were analysed at ID14-1 and ID14-4 at the 
ESRF synchrotron (Fig. 3.21). Diffraction images obtained from SER36-BV crystals 
were of poor quality and no dataset was collected, but diffraction images from SER26-
BV were of superior quality and isotropic than that of the WT M15-BV crystal, and the 
crystal data are summarised in Table 3.9.  
  
  
Figure 3.21 Diffraction images from crystals of mutated M15 proteins. A) A diffraction image of 
SER26-BV, exhibiting improved maximum diffracting resolution, and B) the up-close view of the 
delimited region. C) A diffraction image of SER36-BV, and D) the up-close view of the delimited 
region. 
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Protein (Dataset) SER26-BV (4-1) 
Beamline / wavelength [Å] ID14-4 / 1.0718 
Space group P43212 
Unit cell dimensions [Å, °] a = b = 69.35, c =236.85  
 =  =  = 90 
Resolution range (outer shell) [Å] 49.04 – 1.82 (1.92 – 1.82) 
No. of observations 714810 
No. of unique reflections 52618 
Multiplicity 13.6 
Completeness overall (outer shell) [%] 99.8 (100.0) 
<I/(I)> overall (outer shell) 20.2 (4.2) 
Rmerge overall (outer shell) 0.080 (0.602) 
Rmeas overall (outer shell) 0.083 (0.626) 
Rpim overall (outer shell) 0.023 (0.173) 
Mosaicity ( ° ) 0.19 
Estimated B-value (Wilson plot) [Å
2
] 31.9 
R/Rfree (%) 21.90/25.87 
Number of water molecules per ASU 239 
R.m.s. deviations from ideal geometry  
 Bond lengths [Å] 0.026 
 Bond angles [°] 2.126 
 Chiral volumes [Å
3
] 0.151 
Table 3.9 Summary of data-collection and refinement statistics. 
 
 
Figure 3.22 L-test for twinning on SER26-BV crystal. The observed values are closer to the values 
of “Expected untwinned” than WT M15-BV (Fig. 3.11) and SER2-BV (Fig. 3.18). 
N
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3.8.2 Data processing and refinement 
Phases were determined by molecular replacement with Phaser (McCoy et al., 2007) 
using the high resolution structure of DrBphP (2O9C) and the PHY domain (331-514) 
of Cph1 (2VEA). The structure was refined by cycles of automated and manual 
refinement with Refmac5 (Murshudov et al., 2011) and Coot (Emsley et al., 2010). The 
library file necessary for defining the ideal geometry of the covalently bound biliverdin 
was derived as described in Section 2.2.7.2.4. Three possible geometries of the methyl 
side chain was tested (Section 3.10.4), and the covalent bond distance between sulphur-
gamma atom and C3
2
 atom of BV was defined to be 1.790 Å as in DrBphP structure 
(2O9C, Wagner et al., 2007). 
Refinement of SER26-BV structure resulted in a model consecutively defined for 
residues Glu 18 to Glu 504 of the Agp1 primary structure. Disordered loop regions were 
omitted, which were Met 10 – Leu 17, Leu 505, Glu 506, and His 507- His 512. 
Residues Leu 505 – Glu 506 and His 507 – His 512 correspond to translated XhoI 
restriction site and the C-terminal hexahistidine tag, respectively. 
Refinement statistics are detailed in Table 3.9. The structure was refined to R/Rfree 
values of 0.2190/0.2587. The number of water molecules per asymmetric unit is 239, 
which is small considering the relatively high resolution of the dataset and the 
molecular weight per asymmetric unit. This is due to a conservative estimation at the 
current stage of refinement, and more water molecules will be identified in the final 
refinement cycles. 
In addition to the BV molecule in the bilin pocket of the GAF domain, another ligand 
was found in a cavity between the GAF and the PHY domains. The density of the ligand 
is neighboured by Asp167, Phe168, Gly169, Leu170, Trp274, and Gln310. The identity 
of the ligand was judged to be a Tris molecule from the protein buffer based on the 
molecular weight and the presence of a tetrahedral atom inferred from the electron 
density (Fig. 3.23). The judgement was supported by the “Ligand identification” 
module in Phenix which listed Tris as the most likely ligand out of all the reagents 
present in the crystallisation drop. 
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Figure 3.23 Positive difference map of a putative ligand. Density of a ligand with a tetrahedral atom 
in the vicinity of Asp167, Phe168, Gly169, Leu170, Trp274, and Gln310 is displayed in cyan mesh. 
Picture is presented in cross-eye stereo. The Fo – Fc map is contoured at 3. 
 
3.8.3 Assessment of the extent of radiation damage 
Radiation damages at the covalent link between the BV and the conserved Cys residue 
have been reported in bacteriophytochrome CBD structures (Wagner et al., 2005, Yang 
et al., 2007). Presence of similar radiation damage in Agp1 was investigated with 
dataset 4-1. From the original entire dataset that covers 180 ° over 900 images, the first 
and the last 400 images were independently merged, scaled, and subjected to molecular 
replacement with the structure of SER26-BV, followed by a round of refinement by 
Refmac5. 400 images cover 80 ° that contain 99.9% of the unique data with average 
multiplicity of 2.3. The resulting electron densities from two datasets are shown in Fig. 
3.24. Since no clear difference is observed between the two in the region encompassing 
the covalent bond, no substantial radiation damage is believed to have occurred during 
the data collection, and justifies merging the entire images in favour of high multiplicity. 
  
Figure 3.24 Electron density maps from two sections of the dataset processed independently. 
Electron density calculated from the first 400 images A) and the last 400 images B) are 
indistinguishable when viewed at the same map contour level at 1. The covalent bonds between the 
BV moiety and Cys 20 have been omitted from the figures. 
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3.9 An attempt to solve the structure of WT Agp1 with the high 
resolution mutant structure 
Successful structural determination of SER26-BV opened an opportunity to use the 
reliable mutant structure for the molecular replacement for very accurate phase 
determination. Thereby it will be possible to completely remove one of the problems 
which may have been preventing the refinement of the WT structure. 
3.9.1 Molecular replacement and refinement 
The merged and scaled diffraction dataset 11-2 from a WT M15-BV crystal was 
subjected to phase determination by molecular replacement using the refined structure 
of SER26-BV but without the BV. A large scale conformational change was found to be 
associated with the change in the crystal from (Section 3.10.2), therefore the search 
models were supplied as two separate ensembles, the PAS-GAF (18 – 312) and the 
PHY (326 – 503), similarly to how the phase determination of SER26-BV was carried 
out with two search models derived from the DrBphP and Cph1 structures (Section 
3.8.2). The BV was removed from the search model, however, in order to avoid the 
model bias during the refinement. Molecular replacement was carried out with Phaser 
either in CCP4 or Phenix, but in either cases phases were determined unambiguously 
regardless of the space groups chosen from the list of plausible candidates that were 
originally considered (Table 3.3) wherein molecules were found to form parallel dimers, 
though the number of asymmetric units vary according to the degree of symmetry of the 
chosen space group. Structures in space groups of P1 and I422 were refined by cycles of 
automatic and manual refinement with Refmac5 and Coot. In case of refinement in P1, 
where eight molecules exist per asymmetric unit, medium non-crystallographic 
symmetry constraints were applied for all molecules in Refmac5. Refinement in P1 did 
not reveal any alternative conformation, which suggests that a space group with higher 
symmetry is correct. The best refinement was achieved in I422 with R-factor/Rfree 
values of 0.2773/0.3586, respectively. In comparison to the previous attempts (Section 
3.4.3), some improvements can be found. The electron density map covering nearly all 
the rings of the BV is in accordance with the correct configuration found in the refined 
mutant structure, albeit some side chains and the thioether linkage with Cys20 is 
invisible, perhaps due to insufficient refinement, or the radiation damage in case of the 
latter (Fig. 3.25A). The electron density map at the Tongue of the PHY domain which 
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could not be modelled in the WT preliminary structure due to diffuse density is again, 
diffuse (Fig. 3.25B). 
 
 
 
Figure 3.25 The structure of M15-BV and the electron density following refinements with more 
reliable phase information. The electron density map is contoured at 1.5. A) The model and the 
electron density of the WT M15-BV are shown in green stick and grey mesh, respectively. The 
electron density covering nearly all the rings of the BV molecule is in agreement with the correct 
BV orientation, as inferred by the BV model of the refined SER26-BV structure (cyan). B) Only 
diffuse electron density is found at the Tongue of the PHY domain (magenta), similarly to the 
previous attempt to refine the structure of the WT M15-BV.  
A 
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The Tongue of the PHY domain 
GAF domain 
PHY domain 
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Cys 20 
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3.9.2 Identity of the source of crystallographic difficulties 
Even though the quality of the phase information was probably improved by using a 
more reliable search mode in molecular replacement, the source of crystallographic 
difficulties in the crystal of the WT M15(s)-BV may still be accounted for by either 
twinning and/or pseudosymmetry. Relatively low resolution makes the subtle 
conformational difference between two molecules with apparent crystallographic 
symmetry very hard to detect, and despite some improvements to the electron density 
by the more reliable phase information, the WT structure could not be refined 
satisfactorily within the duration of the present study. 
It is noteworthy that structural heterogeneity of phytochromes in one form has been 
repeatedly documented in the past. Conformational differences were found between 
monomers in four dimers in the asymmetric unit in the WT structure of PaBphP (3C2W, 
Yang et al., 2008). A study on Cph1 with NMR spectroscopy, and references therein 
indicate the heterogeneity of the phytochromes in the Pr-form. Two ground state 
isoforms were termed Pr-I and Pr-II for Cph1, where these two refer to Cph1 in the Pr-
form but differing by their hydrogen-bonding networks and the charge distribution in 
the tetrapyrrole cavity (Song et al., 2011). Perhaps the unsuccessful refinement of the 
WT Agp1 structure may be attributed to the natural heterogeneity of phytochromes.   
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3.10 Structural analysis of Agp1 and comparison to other 
phytochromes 
To the best of the author’s knowledge, Agp1 is the first classical bacteriophytochrome 
to be structurally determined as the entire PCM fragment at high resolution, and this 
adds to the existing collection of phytochrome structures and enables to correlate the 
structural features to the underlying determining variables (Table 3.10).  
Phytochrome Spectrophotochromic 
property 
Class Attached 
chromophore 
Dark stable 
form 
Agp1 Classical Bacterial BV Pr 
Cph1 Classical Cyanobacterial PCB Pr 
PaBphP Bathy Bacterial BV Pfr 
RpBphP3 Unusual** Bacterial BV Pr 
DrBphP Classical Bacterial BV Pr 
SyB-Cph1 Classical † Cyanobacterial, 
PAS-less 
PCB Pr 
RpBphP1 Bathy Bacterial BV Pfr 
Table 3.10 The list of phytochromes whose structures were used in comparative study. **RpBphP3 
undergoes photoconversion from the Pr- to Pnr-form (near-red light absorbing state). † The extent to 
which SyB-Cph1 represents canonical phytochromes is still under discussion (Hughes, 2010). 
Structural comparisons were carried out mostly between Agp1 and other phytochromes 
in their WT form in the ground state, because the differences between the WT and the 
mutant(s) are discussed in the corresponding publications. A high resolution structure of 
DrBphP bearing a Y307S mutation (PDB code: 2O9C) was exceptionally preferred over 
the WT structure (PDB code: 1ZTU), however, because of the much higher resolution 
of the mutant protein structure. With regards to molecular interactions between the BV 
and amino acid sidechains, Agp1 resemble other phytochromes in the Pr-form. 
Comparison between Agp1 and the two available Cph1 structures reveals higher 
similarities between Agp1 and the WT structure (Pr-II isoform, 2VEA) rather than the 
Y263F mutant structure (Pr-I isoform, 3ZQ5) (Mailliet et al., 2011). 
All structural analyses on Agp1 that are described in the following sections are based on 
SER26-BV structure unless otherwise stated, because the structure of the WT M15-BV 
could not be refined satisfactorily (Section 3.9). 
3.10.1 Domain composition 
The structure of Agp1 PCM holoprotein contains PAS, GAF, and PHY domains like the 
PCM fragments of other phytochromes (Essen et al., 2008, Yang et al., 2008). All three 
domains in a phytochrome PCM possess a well-established common topology (Essen et 
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al., 2008, Yang et al., 2008), and the same applies to Agp1 (Fig. 3.26). Each domain, as 
identified by the SMART server using the WT Agp1 sequence, has an invariable core 
with five strands forming an anti-parallel -sheet and an -helix(ces) between the 
second and the third -strands. Additionally, the GAF and the PHY domain possess an 
-helix(ces) between the second and the third, and the third and the fourth -strands. 
Formation of a trefoil knot, a unique characteristic of phytochromes, is also found in 
Agp1. The N-terminal region (Asp18-His35) penetrates the loop region between 8 and 
8 (Fig. 3.26) of the GAF domain (Pro215 – Ser247), and then interfaces the PAS and 
the GAF domains. The GAF and the PHY domains are connected by a long helix 
between 9 of the GAF domain and 10 of PHY domain. The region called the 
“Tongue” or “Arm” of the PHY domain between 15 and 15 of the PHY domain 
(Agp1 Pro 437 – Ser 481) contributes to the inter-domain interface between the GAF 
and PHY domains (Essen et al., 2008, Yang et al., 2008). The “Tongue” of Agp1 
consists of two pairs of anti-parallel -strands, and the distal pair from the PHY domain 
interacts with a crevice formed by 1, 6, and 8 and thus shielding the BV from 
solvent access (Fig. 3.27). 
Only partial modelling of the 1 helix was possible due to undefined electron densities 
of the residues preceding Asp 18, even though the expressed protein includes Met 10 to 
Leu 17 of the M15s construct. The 1 helix is speculated to extend in a similar fashion 
to Cph1 (2VEA and 3ZQ5) if unhindered (Section 3.10.5). This local disorder is 
interpreted to be the result of crystal contact between two molecules that do not 
belonging to one anti-parallel dimer. This crystal contact between two SER26-BV 
molecules termed arbitrarily as A and B consists of the tip of the Tongue of A and 12 in 
the PHY domain of B, and then 18 in the Tongue of A and 11 in the PHY domain of 
B. There is also an intra-molecular interaction between the tip of the Tongue and the N-
terminal helix, much like in Cph1 (Essen et al., 2008, Mailliet et al., 2011). If 
unmodelled residues of SER26 (Met 10 to Leu 17) of the A molecule were allowed to 
continue with the same conformation as in Cph1 (PDB codes: 2VEA and 3ZQ5), then 
this will cause a steric clash with the B molecule (Fig. 3.28). In hindsight, choosing 
M15s (Agp1 10-504, LE, and hexahistidine) lacking the first nine residues for carrying 
out SER mutations may have contributed to crystallisation of SER26-BV in this novel 
form, as additional N-terminal residues could have prohibited crystallisation. 
Alternatively, this observation could lead to the structure guided optimisation of the 
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construct by further removing those N-terminal residues without defined electron 
densities, and that may further improve the diffraction quality and/or the reproducibility 
of SER26-BV crystal (Section 3.7.3).  
 
 
 
Figure 3.26 Topology of Agp1-M15. A) Ribbon diagram of an anti-parallel dimer pair of SER26-
BV molecules. PAS (20-117), GAF (142-320), and PHY (326-504) domains identified by SMART 
server with WT Agp1 M15 sequence are coloured red, blue, and green, respectively. B) Topology 
diagram of the Agp1 structure. -helices and -strands are represented by cylinders and arrows, 
respectively. -helices and -strands are separately numbered in order from the N-terminus to the C-
terminus. Figure adapted and modified from Yang et al., 2008. 
 
  
A B 
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Figure 3.27 The BV molecule is shielded from the solvent in the Agp1 holoprotein structure. Four 
structures are views from four angles that are 90 ° apart along the y-axis. Structures are shown in 
space-filling model with the protein in grey and the BV in yellow. The BV is hardly visible from all 
directions, and this is an indication of effective solvent shield. 
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Figure 3.28 A crystal contact between two SER26-BV molecules. PAS domains of two Cph1 
structures were truncated to Val5, the equivalent of the first residue of SER26 construct (Met10), 
and superposed onto the SER26-BV structure. A) An overview of the crystal contact site. B) Close-
up view of the enclosed region in the overview. The PHY domain of the SER26 A molecule is 
omitted for clarity. Structural superposition between SER26-BV A molecule and PAS domains of 
Cph1 (2VEA and 3ZQ5, Val5 – Ala125 was achieved with global superposition with SER26-BV as 
the reference.  
  
A 
B 
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3.10.2 Inter-domain orientation and the mode of dimerisation 
SER26-BV crystallised as anti-parallel dimer rather than a parallel dimer as in WT 
M15-BV. Other phytochrome PCMs have crystallised as anti-parallel dimer, but 
furthermore SER26-BV and the crystal structure of the WT Cph1 (PDB code: 2VEA) 
coincidentally share the same space group with one molecule per asymmetric unit, 
therefore the unit cell parameters are similar as a result (Table 3.11). Smaller unit cell 
volume by SER26-BV (SER26-BV, 113911.72 Å
3
; 2VEA, 1491643.90 Å
3
) is a 
consequence of its more compact conformation arising from a tight bend at the linker 
helix between the GAF and the PHY domains. The angle between the first and the last 
ten residues of the linker helix between the GAF and the PHY domains in M15-BV 
(WT), SER26-BV, and Cph1 (2VEA) are 13.89 °, 49.12 °, and 29.66 °, respectively 
(Fig. 3.29). A tight bend by SER26-BV at the linker helix between the 9 of the GAF 
and the 10 of PHY domain has the highest angle, and this further confirms the 
flexibility in this region as discussed in previous publications (Essen et al., 2008, 
Mailliet et al., 2011, Yang et al., 2008, Yang et al., 2009). There is a weak correlation 
between the form of phytochromes and the angle at the linker helix. Phytochromes in 
the Pfr-form tend to adopt more straight conformation and vice versa. The 3ZQ5 
structure of Cph1 in the Pr-form with a straight linker helix does not fit to this rule, 
however, but crystal structures are subject to packing induced conformational change. 
More structural data of phytochromes are required to enable identification of 
conformational outliers. Alternatively, electron microscopy and/or SAXS may provide 
structural information that better represents the global conformation in vivo. 
SER26-BV crystallised as anti-parallel dimer with a larger buried surface area at the 
dimer interface (1960.7 Å
2
) compared to the parallel dimers in the WT M15-BV crystal 
(1374.5 Å
2
). The dimerisation of the WT M15-BV is mediated by helical bundles 
involving N-terminal and C-terminal regions of the linker helix between the GAF and 
PHY domains. The helical bundles at the N-terminus of the linker helix involve 4 and 
9 of each monomer whereas the helical bundles at the C-terminus of the linker helix 
involve 10 and 15 of each monomer. The dimer interface of SER26-BV mainly 
consists of 10 of the PHY domain of a molecule interacting with the 9 and 4 of the 
symmetry related dimer mate. The anti-parallel dimer of SER26-BV resembles that of 
the two crystal structures of Cph1 (2VEA and 3ZQ5). On a closer inspection, there is a 
subtle difference in anti-parallel structures of Cph1 and SER26-BV. In Cph1 the dimers 
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appear to be more elongated because the monomers are somewhat more offset from the 
twofold symmetry axis (Fig. 3.30). 
All the crystal structures of phytochromes solved to date form dimers, but the mode of 
dimerisation is not uniform (Table 3.11). As described in Section 1.2.4, all SKs must 
form a parallel dimer to carry out its kinase activity, thus the anti-parallel dimerisation 
is believed to be an artefact of crystallisation and does not reflect the quaternary 
structure in vivo. 
The factors that determine the mode of dimerisation in phytochrome PCM structures 
were proposed to be either of the following – the crystallisation condition or the lineage 
of the phytochrome. Prior to crystallisation of SER26-BV, anti-parallel dimerisation 
was only observed in crystals of Cph1 (cyanobacterial phytochrome) obtained under 
crystallisation conditions of high ionic strength. Both assumptions were invalidated by 
the observation that crystallisation of SER26-BV (bacterial phytochrome) as an anti-
parallel dimer occurs in at low ionic strength (Fig. 3.30). 
Recently the structure of RpBphP2 CBD was determined (Bellini and Papiz, 2012a). 
Since the WT RpBphP2 proved recalcitrant to being crystallised, an extensive effort 
was made for its crystallogenesis by replacing the residues corresponding to those 
participating in crystal contacts in the crystal structure of RpBphP3 (Yang et al., 2007). 
Therein, the possibility that an Arg residue (RpBphP3 Arg 150) plays a key role in 
mediating parallel dimer in phytochromes was proposed. This is in accordance with the 
crystallisation propensities of Agp1 M20 and M15 holoproteins which is discussed in 
Section 3.11.1 (See also Section 6.3). 
The factor which determines that mode of dimerisation was attributed to the presence of 
epitopes that can mediate crystal contacts. In Section 5.5, a study is presented where 
correlations between the presences of such epitopes and possible crystal forms are 
shown. Our crystallographic studies on Agp1 M15 proteins have shown that it is 
possible for a phytochrome PCM to crystallise as both parallel and anti-parallel dimer, 
therefore it is plausible that the subtle structural differences at the protein surface, rather 
than other physico-chemical factors, determine whether one or another mode of dimer 
formation occurs in a crystal.  
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A 
Agp1-M15 (WT) 
Pr-form, 13.89 ° 
C 
Cph1 (2VEA) 
Pr-form, 29.66 ° 
E 
PaBphP (3C2W) 
Pfr-form, 6.75 ° 
 
 
 
B 
Agp1-SER26-M15 
Pr-form, 49.12 ° 
D 
Cph1 (3ZQ5) 
Pr-form, 16.33 ° 
F 
PaBphP (3G6O) 
Pfr/Pr-mixed, 17.22 ° 
 
 
 
Figure 3.29 Global conformations of phytochrome PCM structures. Structures were superposed 
globally and are presented in the same orientation. The first and the last ten amino acid residues used 
to calculate the bend of the inter-domain helix are coloured cyan. The proteins (PDB codes) and the 
residue ranges are as follows. A) Agp1 WT preliminary structure, 289-298 & 325-334. B) Agp1 
SER26-BV, 289-298 & 325-334. C) WT Cph1 (2VEA), 298-307 & 336-345. D) Cph1 Y263F 
(3ZQ5), 298-307 & 336-345. E) WT PaBphP (3C2W), 286-295 & 318-327. F) PaBphP Q188L 
(3G6O), 285-294 & 321-330. The 3IBR structure of PaBphP Q188L was omitted as the global 
conformation is essentially identical to that of the 3G6O structure. 
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Year  Phytochrome Fragment PDB code Mode of 
dimerisation 
2005 DrBphP CBD 1ZTU Parallel 
2007 RpBphP3 CBD 2OOL Parallel 
2007 DrBphP Y307S CBD 2O9C Parallel 
2008 Cph1 PCM 2VEA Anti-parallel 
2008 PaBphP PCM 3C2W Parallel 
2009 PaBphP Q188L PCM 3G6O, 3IBR Parallel 
2011 Cph1 Y263H PCM 3ZQ5 Anti-parallel 
2012 DrBphP D207H CBD 3S7N, 3S7O, 
3S7P 
Parallel 
2012 DrBphP D207H/Y263F CBD 3S7Q Parallel 
 Agp1 PCM N/A Parallel 
 Agp1 E86A/E87A/E336A/K337A PCM N/A Anti-parallel 
Table 3.11 List of crystal structures of phytochromes and the mode of dimerisation in chronological 
order. All CBD fragment crystals described so far form parallel dimers, but both parallel and anti-
parallel dimers are found for PCM fragments. 
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Parallel Anti-parallel 
  
PaBphP (3C2W) 
0.45 M (NH4)2SO4, 
0.1 M Tris-HCl, pH 7.7 
Cph1 (2VEA) 
2 M Na Acetate, 
0.1 M Mg Acetate, pH6.7  
  
PaBphP Q188L (3G6O, 3IBR) 
0.5% PEG4000, 
0.01 M Na Acetate, pH 4.6 
Cph1 Y263H (3ZQ5) 
2.5 M Na Acetate, 
0.1 M MES pH 6.5  
 
 
Agp1 M15-BV  
200 mM CaCl2, 
16% PEG3350, 0.1 M Tris-HCl, 
2.5% Glycerol, 
pH 8.5 
Agp1 SER26 (E86A/E87A/E336A/K337A) 
0.03 M diethyleneglycol, 
0.03 M triethyleneglycol, 
0.03 M tetraethyleneglycol, 
0.03 M pentaethyleneglycol, 
20% Glycerol, 10% PEG8000  
0.05 M MES, 0.05 M Imidazole, pH 6.5 
Figure 3.30 Mode of dimerisation and crystallisation conditions of phytochrome PCM crystal 
structures. Parallel dimer exhibited by A) PaBphP (3C2W), B) PaBphP Q188L (3G6O, 3IBR), C) 
Agp1. Anti-parallel dimer exhibited by D) Cph1 (2VEA), E) Cph1 Y263H (3ZQ5), F) Agp1 
E86A/E87A/E336A/K337A. Ribbon diagrams are coloured according to the domains as defined by 
SMART server. Agp1 (PAS, 20-117; GAF, 142-320; PHY, 326-504), PaBphP (PAS, 12-113; GAF, 
139-313; PHY, 314-498), Cph1 (PAS, 15-125; GAF, 152-330; PHY, 331-513). Red, PAS; Blue, 
GAF; Green, PHY. 
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3.10.3 Electrostatic surface potentials of phytochrome PCMs 
The electrostatic surface potential of Agp1 was calculated with the PDB2PQR server 
followed by APBS (Section 2.2.8.4) along with the PCMs of other phytochromes in 
their ground state (Fig. 3.31). Distributions of positive and negative charges as well as 
non-polar regions at the dimer interface indicate that the modes of dimerisation for 
PCM of Agp1, Cph1, and PaBphP are mixtures of ionic and hydrophobic interaction, 
and cannot easily be attributed to a single type of interaction. 
 
 
 
  
Figure 3.31 Electrostatic surface potentials of PCMs of three phytochromes in their ground states. 
A) Structures of three phytochromes were superposed globally and presented in ribbon diagram and 
orientated for viewing the dimer interface. Agp1, Magenta; Cph1 (2VEA), Green; PaBphP (3C2W), 
Cyan. APBS electrostatic surface potential diagrams of B) Agp1, C) Cph1, and D) PaBphP, coloured 
by electrostatic potential (-5 kT/e, red to +5 kT/e, blue). 
 
  
Agp1: Magenta; 
Cph1 (2VEA): Green; 
PaBphP (3C2W), Cyan 
Agp1 
PaBphP 
3C2W 
Cph1 
2VEA 
A 
B 
C D 
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3.10.4 Determination of the mode of biliverdin binding 
As described in Section 1.3.2, a correlation exists between the types of the bound bilin 
and the location of a conserved cysteine where the covalent bond occurs, i.e. plant and 
cyanobacterial phytochromes bind to PB and PCB, respectively, via a cysteine in the 
GAF domain, whereas bacterial and fungal phytochromes bind to BV with a 
chromophore-bonding cysteine in the N-terminal of the PAS domain. PB/PCB and 
BV feature ethylidene and vinyl side chains at C3 of the A-ring, respectively, in their 
free form (Fig. 1.7). The geometry of the C2 atom of the bilin chromophore could 
change following the assembly of the holoprotein, therefore the orientation of the 
methyl side chain at the C2 atom could give information regarding the mode of binding 
between the bilin and the phytochrome. 
In the first phytochrome structure (1ZTU), the A-ring of the BV was modelled with an 
endocyclic double bond, therefore the methyl side chain at the C2 atom was assumed to 
maintain the co-planar geometry to the A-ring (Fig. 3.32A) (Wagner et al., 2005). 
Hereafter the term “co-planar form” will refer to the geometry of the A-ring methyl side 
chain of the bilin following the originally proposed mode of BV attachment. 
The A-ring of PB (and PCB) adopts a non-planar geometry with an exocyclic double 
bond and the C2 atom assumes S chirality upon formation of the covalent bond with 
plant (or cyanobacterial) phytochrome (Fig. 3.32B), except for the PCB of SyB-Cph1 
which has the R chirality at the C2 atom (Cornilescu et al., 2008). 
A new BV attachment mechanism was proposed for bacteriophytochromes when a 
detailed analysis was carried out with the high resolution structure of DrBphP (Wagner 
et al., 2007). The C2
1
 methyl carbon of the BV rotates towards Met 259 in the high 
resolution structure, hence the C2 carbon was deduced to assume a tetrahedral 
configuration. Consistently the BV A-ring was modelled with exocyclic double bond 
and non-planar geometry and the BV was proposed to convert to 2(R),3(E)-PB 
following the assembly process, which has the opposite chirality at the C2 carbon of the 
bilin of plant/cyanobacterial phytochromes (Fig. 3.32C). 
It must be noted, however, that the DrBphP structure was solved in a truncated form of 
CBD, therefore leaving a possibility for an inadvertent artefact to be present. Since the 
diffraction dataset for Agp1 SER26-BV in the present study extends to 1.82 Å 
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resolution, the highest resolution reported for crystals of a phytochrome PCM to date. 
Geometric analysis of the A-ring was attempted. 
Geometric analysis was performed by carrying out independent refinements where the 
geometry of the BV is constrained according to the three forms. The libraries that define 
the geometric constraints during refinements were generated by extracting the 
coordinates of the BV molecule from the high resolution DrBphP structure, and the 
coordinates were modified with Discovery Studio 3.1 (Accelrys). Three models were 
generated with the methyl side chain at the C2 atom of the A-ring in two chiralities (S 
and R) or co-planar with the A-ring, therefore the geometries were the same as those in 
holoproteins depicted in Fig. 3.32 B, C, and A, respectively. Three library files with 
different configuration at the C2 carbon were obtained as described (Section 2.2.7.2.4, 
Section 3.8.2). The library files were used during refinement with Refmac5 (Murshudov 
et al., 2011), where the weight matrix was either defined automatically by Refmac5 or 
as an arbitrarily small value of 0.1 (Section 2.2.7.2.3). In all three geometric modes, 
automatically defined weighting terms were 0.5. The output coordinates, the electron 
density map (2Fo - Fc), and the difference maps (Fo - Fc) were inspected. 
Firstly, a possibility for the tetrahedral C2 atom to be in S-form like 
plant/cyanobacterial phytochrome (S-form) was immediately ruled out. When the 
refinement was carried out with the C2 atom in S-form with automatically defined 
weighting, the methyl side chain was placed in a rather planar orientation (Fig. 3.33B), 
which was suspected to be the result of counteracting effects of geometrical constraints 
defined by the library and the C2
1
 atom being moved to fit into the electron density map. 
The hypothesis was confirmed when the refinement was repeated with weighting value 
of 0.1, where the orientation of the methyl side chain was predominantly determined by 
the library. A positive density for the methyl side chain appeared to indicate that either 
the co-planar configuration or R-forms to be correct (Fig. 3.33C). 
It is more difficult to judge from 1.82 Å resolution data whether the stereochemistry of 
the C2 atom is in the non-chiral or R-form, however. When the refinement was carried 
out with automatically determined weighting, the C2
1
 atom resulted in a good fit into 
the electron density map regardless of the stereochemistry of the C2 atom. Though data 
collected to 1.82 Å is not sufficient by its own to draw a decisive conclusion, the 
electron density map of Fig. 3.33 is slightly skewed towards R-from of C2 atom. 
Additionally, the double bond between the C3 and C3
1
 atom of the A-ring is co-planer 
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to the A-ring (Fig. 3.32C) in the refined Agp1 structure, and this suggests the presence 
of exocyclic double bond. Therefore the geometry of the bilin molecule was modelled 
identically to the BV in DrBphP structure which features an exocyclic double bond with 
C2 atom in the R-form. 
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Bilin in the free form Bilin in holo-phytochrome 
 
 
 
Figure 3.32 Formation of the covalent bond between the cysteine and the bilin chromophores. 
Structure of the A-ring of the bilin in the free form (Left) and following the lygation (Right). A) 
Originally proposed mode for bacteriophytochrome in which a thioether bond forms between C3
2
 
atom of the BV and the S-gamma atom of the conserved Cys residue in the N-terminal of the PAS 
domain, and the A-ring maintains the endocyclic double bond. B) The mode for plant and 
cyanobacterial phytochromes, in which tetrahedral C2 atom of the PCB adopts the S-form. C) A 
binding mode for bacteriophytochrome based on the high resolution structure of DrBphP (Wagner et 
al., 2007). BV converts to 2(R), 3(E)-PB, with its tetrahedral C2 atom in R-form and a non-planar 
A-ring with exocyclic double bond. Figures adapted from Wagner et al., 2005 (A) and Wagner et al., 
2007 (B, C). 
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bacteriophytochrome 
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Figure 3.33 Determination of the stereochemistry of the C2 atom of the bilin moiety in Agp1 
structure. A) The arrow indicates the point of view for the subsequent diagrams. B) C) Results 
following a refinement with C2 atom of the bilin in S-form with weighting of automatic and 0.1, 
respectively. D) E) Results following a refinement with C2 atom of the bilin in the co-planar form 
with refinement weight values of automatic and 0.1, respectively. F) G) Results following a 
refinement with C2 atom of the bilin in R-form with refinement weight values of automatic and 0.1, 
respectively. Automatically determined weighting terms were 0.5 in all three geometric modes. 
  
Exocyclic double bond, C2 = S-form 
Refinement weight = Auto 
Endocyclic double bond, co-planar form 
Refinement weight = Auto 
Exocyclic double bond, C2 = R-form 
Refinement weight = Auto 
Exocyclic double bond, C2 = S-form 
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Endocyclic double bond, co-planar form 
Refinement weight = 0.1 
Exocyclic double bond, C2 = R-form 
Refinement weight = 0.1 
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3.10.5 The N-terminal region 
Two -helices in the vicinity of the bilin pocket were found to be collinear in the WT 
Cph1. Cph1 1 and 7 are located at the N-terminal region and the GAF domain, 
respectively (Essen et al., 2008). Within the same study, bacteriophytochromes 
structures available at that time (DrBphP, Wagner et al., 2005, Wagner et al., 2007; 
RpBphP3, Yang et al., 2007) were described as lacking the -helix in the N-terminal 
region which was interpreted as due to either the lack of PHY domain or the presence of 
the chromophore-binding Cys residue in the N-terminal region. Structures of N-termini 
of the WT and Q188L mutant of PaBphP were interpreted as unstructured coil, which 
was described as a contrast to a three-turn helix of the Cph1 structure by Yang et al. 
(2009). 
Analysing phytochrome structures with DSSP, however, presents more complete picture. 
An -helix was found in the N-terminus of Agp1 from Ser 19 to Ala 22 (Fig. 3.34). 
Furthermore, 3/10 helix was found at the N-terminus of DrBphP (2O9C), RpBphP3 
(2OOL), and PaBphP (3C2W), but not in structures of Q188L mutant of PaBphP (3IBR 
and 3G6O). 
An -helix in the N-terminal region of Agp1 refutes one of the hypotheses presented by 
Essen et al. (2008), because Agp1 is a bacteriophytochromes with the chromophore-
binding Cys residue in the N-terminus. Conversely, the other hypothesis of attributing 
the lack of the N-terminal -helix to the lack of the PHY domain is not refuted. 
Phytochrome CBD can form the Pr-form as defined spectrophotometrically, but it is still 
plausible to hypothesise that the PHY domain to influence the formation of the N-
terminal region on the basis of close proximity of the Tongue of the PHY domain and 
the N-terminal region as seen in phytochrome PCM structures.  
The helix of Agp1 is shorter than that of Cph1 structures, and the reason for the lack of 
electron density in the N-terminal region was speculated in Section 3.10.1 (Fig. 3.28). It 
also remains to be seen for other bacteriophytochromes if the N-terminal -helix is 
present and if so, it will be as long as that of Cph1 if unperturbed by a crystal contact. 
Whether the 3/10 helix at the N-terminus of PaBphP is its bona fide feature or not is 
difficult to discern, because the helix was not found in Q188L mutant structures in 
mixed state. It is possible that the conformation of this region was assuming 3/10 helix 
by chance. Currently PaBphP is the only phytochrome with the structure of the Pfr-form, 
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therefore the sample size is too small to allow confident description of the structure of 
the Pfr-form in general.  
Since the structural determination of PCM of Cph1 (Essen et al., 2008) and PaBphP 
(Yang et al., 2008), there has been a hypothesis that the differences in secondary 
structure between them to reflect the differences between the Pr- and Pfr-forms. CD-
spectroscopy was employed to investigate this hypothesis and the result is described in 
Section 6.6.2. 
The structure of Agp1 and detailed analyses on other structures enable more accurate 
deduction of the underlying variables which are manifested as the structure, but more 
structures especially of the Pfr-form will enhance our understanding. 
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Figure 3.34 Conformations at the N-terminal region preceding the PAS domain. elices in the N-
terminal region as defined by DSSP are coloured. A) Agp1 SER26-BV, B) Cph1 (2VEA), C) 
DrBphP (2O9C), D) RpBphP3 (2OOL), E) PaBphP (3C2W). 3/10 helix in PaBphP was not rendered 
as a helix by default in PyMOL, therefore the secondary structure assignment was manually 
changed. Structures of mutants were checked for their secondary structures at the N-terminal 
region, and were found to be essentially the same as the wild type for Cph1 (WT: 2VEA and 
mutant: 3ZQ5) and DrBphP (WT: 1ZTU and mutants: 2O9C, 3S7N, 3S7O, 3S7P, and 3S7Q). 
Structures of PaBphP (WT: 3C2W and mutants: 3IBR, and 3G6O) were similar, but 3/10-helix 
was only found in the WT structure by DSSP. 
  
A Agp1, Pr-form B Cph1, Pr-from 
C DrBphP, Pr-form D RpBphP3, Pr-form 
E PaBphP, Pfr-form 
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3.10.6 The PHY domain 
The PHY domain of phytochromes are characterised by the presence of the Tongue, an 
extension that interacts with the GAF domain. The Tongue of Agp1 consists of two anti-
parallel -sheets similar to that of Cph1, except that the tip is shorter for Agp1. This 
contrasts with that of PaBphP, featuring a coil and an -helix (Fig. 3.35). This 
conformational difference between the Pr and the Pfr-form is believed not to be an 
artefact of crystal packing, because the secondary structures at the Tongue are 
conserved between the WT and the mutant structures despite the differences in the 
crystal form (Table 3.12). The preliminary structure of the WT Agp1 also has the 
Tongue with a -sheet structure as far as the electron density of limited quality can be 
interpreted, despite crystallisation in a different crystal form than SER26-BV. 
Similarities between Agp1 and Cph1 are also found within the core of the PHY domain. 
The loop prior to 13 in Agp1 and the equivalent structure in Cph1 share a similar 
conformation, which is distinct from that of PaBaphP. In classical phytochromes the 
loop conformation is partially due to the presence of a conserved Pro (Pro 376 in Agp1, 
Pro 383 in Cph1), which is absent in PaBphP (Fig. 3.36). This Pro interacts 
hydrophobically with Tyr 412, Val 415, and Phe 435 (corresponding residues in Cph1 
are Phe 419, Val 422, and Phe 440).  
Two short helices immediately following the GAF-PHY linker helix are found in Agp1 
and Cph1, and in Agp1 the angle between 11 (Trp 338 – Gly 344) and 12 (Glu 346 – 
Val 356) is 111.8. Only one helix corresponding to the former one is found in PaBphP, 
the rest of the region being occupied by a loop. 
It is difficult to comment on the effect of these conformational differences between Pr 
and Pfr-forms in terms of signal transduction in the absence of a full-length structure of 
a phytochrome. 
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Figure 3.35 Conformation at the “Tongue” of the PHY domain of three phytochromes. Residues 
corresponding to 326 to 504 of Agp1 are coloured. A) Agp1 SER26-BV, B) Cph1 (2VEA), C) 
PaBphP (3C2W). Phytochromes in the Pr-form possess -strands in the region, whereas the 
corresponding region of PaBphP in the Pfr-form comprises coil and an -helix. 
 
 
 
 
 
Phytochrome Variation PDB code Space group 
PaBphP WT 3C2W C2221 
PaBphP Q188L mutant 3BIR and 3G6O P65 
Cph1 WT 2VEA P43212 
Cph1 Y263F mutant 3ZQ5 C121 
Table 3.12 List of phytochrome PCM crystal structures and their space groups. Space group of the 
WT and the mutant crystals are different, but secondary structures are well conserved. 
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Figure 3.36 Structural differences between classical and bathy phytochromes. Alignment of the core 
of the PHY domain was achieved with LSQ superpose in Coot with the following range of residues. 
Agp1 (Asp 359 – Arg 436), Cph1 (Gly 367 – Arg 441), and PaBphP (Asp 353 – Arg 428). A) A 
conserved Pro residues in classical phytochromes contributes to conformation of the loop between 
12 and 13, which is different between classical (Agp1 and Cph1) and bathy (PaBphP) 
phytochromes. B) Sequence alignment indicates some unique amino acid contents by PaBphP 
unshared with Agp2, another bathy-phytochrome (indicated by arrows). Instances of non-conserved 
residues unique to PaBphP accord with a hypothesis of bathy-phytochromes to have multiple origins 
(Rottwinkel et al., 2010). C) Conformational differences at the helix(ces) that immediately follow(s) 
the GAF-PHY linker helix. Green: Agp1, Cyan: Cph1, Magenta: PaBaphP. 
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3.10.7 The Bilin chromophore 
The BV molecule of Agp1 has the same stereochemistry as that of DrBphP, which is 
5Zs10Zs15Za. Overall, Agp1 exhibits chromophore-protein interactions conserved in 
other phytochromes in the Pr-form, such as DrBphP, RpBphP3 and Cph1. With regards 
to the two Cph1 structures, Agp1 is more similar to 2VEA (proposed isoform II) than 
3ZQ5 (Y263F mutant, proposed isoform I) in terms of side chain orientation in the bilin 
pocket. Structural features where the RpBphP3 structure deviates from the norm were 
regarded to reflect its unique photochromic property to give rise to the Pnr-form upon 
irradiation at Qmax. 
The D-ring of the BV in Agp1 is tilted with respect to the co-planar B and C-rings, 
much like in other phytochrome structures in the Pr-form., but more similar to 
bacteriophytochromes (RpBphP3: 2OOL and DrBphP: 2O9C) than cyanobacterial 
phytochrome (Cph1: 2VEA). In Agp1, the angle between the D-ring and the C-ring is 
50.5 °, which is more similar to bacteriophytochromes (DrBphP, 1ZTU – 44.4 °, 2O9C 
- 50.8 °; RpBphP3: 2OOL - 39.8 °) than a cyanobacterial phytochrome (Cph1: 2VEA – 
26.3 °, 3ZQ5 – 37.2 °). The conformation of the BV in Agp1 is a result of conserved 
hydrophobic pocket consisting of Y166, V176, F193, P194, Y253, and F465 in the 
vicinity of the D-ring. 
Agp1 is unique among phytochromes in the Pr-form in that the relative position of the 
conserved His 280 is on the -facial side of the D-ring, rather like PaBphP in the Pfr-
form. The importance of this His in the formation of the Pfr-form has been 
demonstrated in both classical and bathy phytochromes (Zienicke et al., 2010, Wagner 
et al., 2008, Yang et al., 2009). Also Agp1 stands out from all other structurally 
determined phytochromes in terms of the tilt of the imidazole ring of His 280 relative to 
the D-ring, because the direction is opposite (Fig. 3.38). Nevertheless a hydrogen bond 
between the NE2 atom of the conserved histidine and the oxygen atom of the D-ring of 
the bilin is conserved between Agp1, DrBphP, and Cph1 (Fig. 3.39 and Fig. 3.41). 
This unusual side chain conformation is brought about by polar as well as hydrophobic 
environments surrounding the His 280 that are unique to Agp1, and there are several 
deviations in the corresponding segments of amino acid sequences in Agp1 from the 
other classical phytochromes (Fig. 3.37 and 3.39). 
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Firstly, in Agp1 a non-conserved Leu 164 occupies the space of the typical Met residue 
(DrBphP: Met 174, Cph1: Met 174). This qualitatively similar but shorter side chain 
makes hydrophobic interaction to the D-ring just like Met residues in other 
phytochromes (Fig. 3.39), but may allow the BV or surrounding residues to adopt 
slightly different conformation by the virtue of its smaller dimension. The presence of a 
positively charged lysine in this position in RpBphP3 and SyB-Cph1 may reflect their 
unique photochromic activity. Secondly, a position occupied by hydrophobic residues in 
other phytochromes is occupied by polar Thr 259, and this creates a water mediated 
hydrogen bond between Thr 259 and His 280, which is absent in other phytochromes. 
Thirdly, the hydrophobicity at the position of Met 254 is conserved, but the side chain 
conformation is different as it points away from His 280. Additionally, the 
conformation of His 280 may be influenced by Arg 162. The conformation of the latter 
is only conserved among Agp1, RpBphP3, and one of two alternative conformations in 
the Cph1 2VEA structure, but different from DrBphP (2OOL), Cph1 (the other of two 
alternative conformations in 2VEA and 3ZQ5). The conformation of Arg 162 in Agp1 
may be determined by two amino acids in its vicinity, Leu 185 and Pro 186, neither of 
which are spatially well conserved. The conformation of RpBphP3 His 299, the 
equivalent of His 280 in Agp1, is similar to other phytochromes despite the presence of 
Arg 181 being in a conformation similar to that of Agp1. This may be attributed to the 
presence of a non-conserved Lys 183 to prevent the tilt of imidazole ring of His 299. 
It was proposed in Essen et al., 2008 that greater tilts observed at the D-ring of BV in 
CBD fragments of bacteriophytochromes may be an artefact caused by the lack of the 
PHY domain. However, the structure of the entire PCM of Agp1 suggests as one 
possible scenario that the high D-ring tilt is the norm for bacteriophytochromes. 
Alternatively, it is possible that the high D-ring tilt in Agp1 even in the presence of the 
PHY domain is unique to Agp1, caused by an unusual conformation of His 280. More 
structural evidence is required to fully prove the structural isomorphism between CBD 
and PCM. For example, knowledge of the entire PCM structure of DrBphP would help 
to clarify this issue. 
As of now it is difficult to rationalise how both conserved and non-conserved 
interactions involving His 280 may affect the spectrophotochromic properties of Agp1. 
Hydrogen bond between the His residue and the oxygen atom of the D-ring is conserved, 
but under an assumption of structural isomorphism of CBD and PCM, there is no clear 
correlation between the Qmax of the Pr-form and the tilt angle of the D-ring in 
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bacteriophytochromes (Agp1 702 nm, 50.5 °; RpBphP3 705 nm, 2OOL - 39.8 °; 
DrBphP 700 nm, 1ZTU - 44.4 °, 2O9C - 50.8 °). SAR values (AQmax/A280) have not 
been reported for RpBphP3 and DrBphP, therefore no comparison could be made to 
Agp1 in this regard. 
 
Figure 3.37 Sequence alignment of amino acid residues that interact with His 280 in Agp1. Some 
deviations are found in amino acid sequence in Agp1.  
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3.10.8 Solvent shield surrounding the bilin moiety 
Covalent bond between Cys 20 and BV in Agp1 appears similar to that of DrBphP, 
whose mode of binding has been used as the model (Wagner 2007). In Cph1, Leu 15 
corresponds to the chromophore-binding Cys in the N-terminus of 
bacteriophytochromes, whereas mostly hydrophobic residues occupy the corresponding 
position of the chromophore-binding Cys in the GAF domain of Cph1 in 
bacteriophytochromes (Agp1 Val 249, DrBphP Met 259, PaBphP Ile 246, RpBphP3 Thr 
268). In Agp1, Ile 459 – Pro 461 of the Tongue (Cph1: Leu 469 – Pro 471, Essen et al., 
2008) forms a hydrophobic shield around the thioether linkage, but Tyr 458 of Cph1, 
another component of the solvent shield, is not well conserved in bacteriophytochromes. 
Agp1 Thr 452 occupies the equivalent location of Cph1 Tyr 458 with the side chain 
protruding in a similar direction. In Agp1, Thr 452 is in proximity of the thioether 
linkage between the BV and Cys 20, but the distance between Thr 452 and the thioether 
linkage is clearly more than if the position of Thr 452 is occupied by a larger Tyr 
residue. Cph1 Tyr 458 is close to the A-ring of the PCB that its van der Waals force is 
recognised by the default setting of the Ligplot (Fig. 3.41), but the thioether linkage in 
Cph1 protrudes away from Tyr 458, unlike in Agp1. Presumably the acquisition of a 
residue with a bulky side chain to act as a solvent shield in this position is an 
evolutionarily adaptation associated with the positional change of the chromophore-
binding Cys from the N-terminus to the GAF domain.  
Interestingly, in DrBphP structure, the space corresponding to the solvent shield (Agp1 
Ile 459 – Pro 461) is partially occupied the N-terminal region (Fig. 3.40). The structure 
of DrBphP lacks the PHY domain, therefore its structure may be an artefact. Sequence 
alignment however, supports the notion for the N-terminal region to act as the solvent 
shield in DrBphP. Residues equivalent for the solvent shield of the Tongue are present 
in DrBphP (Leu 463 – Pro 465), but there is a deletion of the sequence unique to 
DrBphP in the vicinity, therefore the tip of the Tongue of DrBphP will not shield the 
BV to the same degree as in Agp1 or Cph1, making it very likely that the same N-
terminal conformation as observed in the DrBphP structure is also adopted in the full-
length structure since it is required for the solvent shield by compensating for the 
shorter Tongue of the PHY domain in DrBphP.  
The residues equivalent to the above-mentioned solvent shield from the Tongue is 
present in PaBphP (Leu 454 – Pro 456), but they are not spatially conserved in the WT 
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structure. The lack of the solvent shield from the Tongue is partially compensated by 
Leu 9 in PaBphP. This is likely to be the result of PaBphP assuming the Pfr-form, 
however. 
Cph1 does not have a Pro residue immediately prior to Cys 259 in the GAF domain. 
The Pro residue is conserved among all structurally determined bacteriophytochromes 
and SyB-Cph1. This Pro can be interpreted to be the ancestral trait functioning to 
provide rigidity to the N-terminal end of the 8 of Agp1 and the corresponding region 
in other phytochromes, but may have become functionally redundant for Cph1 because 
formation of covalent bond at the GAF domain limits the conformational freedom. 
Therefore the lack of the Pro residue in Cph1 may be the result of stochastic silent 
mutation undirected by evolutionarily pressure. 
   
 
Figure 3.40 Solvent shields around the thioether linkage. Cartoon and stick model of A) Agp1, B) 
DrBphP, and C) Cph1. D) Sequence alignment of a part of the Tongue. The numbers in parentheses 
indicate the difference in the number of residues of this region relative to Cph1. Cph1 Tyr 458, a 
bulky solvent shield is only found in Cph1. This is regarded to be an evolutionarily development 
associated with the change in the chromophore-binding Cys residue from the N-terminus to the GAF 
domain. The N-terminal region of DrBphP partially occupies the space corresponding to the solvent 
shield of the PHY domain of other phytochromes. This is likely to compensate for a relatively 
shorter tip of the Tongue, and the N-terminal conformation is likely to be the same in the full-length 
structure. 
A B C 
D 
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3.10.9 Propionate side chains 
Some molecular interactions in the vicinity of propionate side chains of C- and D-rings 
were found to differ between Cph1 and DrBphP, and this is thought to reflect the 
differences between bacterial and cyanobacterial phytochrome (Essen et al., 2008), 
which may give rise to different types of photochemistry between them (Rockwell et al., 
2009).Consistent with this idea, in terms of molecular interactions, Agp1 resembles 
DrBphP more closely than Cph1. 
Tyr 206, Arg 244, and Ser 247 interact with the B-ring propionate of BV in Agp1. The 
salt bridge between the B-ring propionate and Arg 244 is conserved in all canonical 
phytochromes in the Pr-form. The interaction between the Tyr and the Ser with the B-
ring propionate is conserved among bacteriophytochromes in the Pr-form (DrBphP and 
RpBphP3). In Cph1, the equivalent interaction between the B-ring propionate and the 
N-atom of Ser 247 in Agp1 is realised by the N-atom of Tyr 257 in Cph1, but the 
equivalent polar interaction between the OH-group of Tyr 206 in Agp1 is not possible 
in Cph1 due to the absence of the hydroxyl group in Phe 216. An Ile residue which 
forms a hydrophobic walling around the A- and the B-ring of the bilin in other 
phytochromes is also present and is conformationally conserved in Agp1. The shortest 
distance between two moieties are longer in Agp1, however, and the hydrophobic 
interaction by the Ile residue is not recognised by Ligplot with the default parameters 
(Agp1: Ile 25 CG2 – BV CMB 4.1Å, DrBphP (2O9C): Ile 29 – BV CMD 3.9Å, Cph1 
(2VEA): Ile 20 – PCB CBD 3.6Å) (Fig. 3.41). 
The propionate side chain of the C-ring of the BV in Agp1 interacts with His 250, Ser 
262, and Ser 264, all of which are invariably conserved among structurally defined 
bacteriophytochromes. The interaction between Ser 264 and the C-ring propionate is 
conserved among bacterial phytochromes in the Pr-form. The importance of this residue 
for maintaining the Pr-form has been demonstrated by the Ser261Ala mutant in PaBphP 
which shows no detectable formation of the Pr-form upon illumination (Yang et al., 
2009). As similar interaction is present in Cph1 involving Thr 274, but its larger side 
chain relative to Ser induces the carboxyl group of the C-ring propionate to be rotated 
by about 90 relative to that in bacteriophytochromes. The conformation of the C-ring 
propionate side chain of PCB in Cph1 does not allow the formation of a hydrogen bond 
equivalent to that between His 250 and the C-ring propionate in Agp1. 
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A hydrogen bond is present between C-ring propionate and Ser 275 in PaBphP, but the 
position of the latter is occupied by Ala in classical phytochromes (Agp1, DrBphP, and 
Cph1) preventing such an interaction (Yang et al., 2009). 
Exceptionally, the conformation of Ser 262 of Agp1 is more similar to the equivalent 
Ser 272 in Cph1 rather than DrBphP, but the interaction between the Ser residue and the 
C-ring propionate is similar between Agp1 and DrBphP as regards the direct hydrogen 
bond between the two moieties, whereas the interaction between the C-ring propionate 
and Ser 272 in Cph1 is mediated by a water molecule (Fig. 3.42). 
These subtle differences in phytochromes between species could be the result of the 
selective pressure imposed on the host organisms which resulted in fine-tuning of the 
photochemical activities. Thus, the differences in conformation and the subsequently 
the hydrogen bonding network may underpin the differences in photochemical 
properties between bacterial and cyanobacterial phytochromes. One such difference is 
the ability of Cph1, a cyanobacterial phytochrome, to maintain the photoconverted Pfr-
form without the dark-reversion, which is unlike bacterial phytochromes. 
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Figure 3.41 Molecular interactions of the bilin moieties in phytochrome structures. Water molecules 
are omitted. Diagram produced by Ligplot (Wallace et al., 1995). A) Agp1 SER26-BV, B) DrBphP 
(2O9C), C) RpBphP3 (2OOL), D) Cph1 (2VEA). Orientation of the bilin moiety and the relative 
positions of the equivalent residues have been adjusted to Agp1 as the reference. Positions of the 
conserved residues that are not found in Agp1 have also been adjusted to be consistent with one 
another in terms of relative position to the bilin moiety on the diagram. 
C 
(RpBphP3, 
2OOL) 
D 
(Cph1, 
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Figure 3.42 Comparison of side chain conformations between Agp1, Cph1 and DrBphP. Agp1 Ser 
264 is conserved with DrBphP, but conformational conservation is exhibited at Agp1 Ser262 is with 
Cph1. Met 254 imposes less van der Waals force than Leu, which ultimately contribute to C-ring 
being shifted towards it compared to the others. 
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3.10.10 Structural differences between the Pr and Pfr-forms at the molecular level 
Structural comparison between the PCM fragments of Agp1 and Cph1 reveals 
similarities between them. This is significant, because the observation is despite a 
relatively long phylogenetic distance between Agp1, a bacteriophytochrome and Cph1, 
a cyanobacterial phytochrome (Lamparter, 2004). Therefore the similar conformation 
between them is deemed the true representative of the Pr-form as originally suggested 
by Essen and co-workers (Essen et al., 2008). 
The same argument could be made for the structures of the bathy-phytochromes, 
PaBphP and RpBphP1, the latter of which was determined recently (Bellini and Papiz, 
2012b, Yang et al., 2008). The similarities between PaBphP and RpBphP1 include the 
global conformation and the secondary structure of the Tongue of the PHY domain. Yet 
the similarities are despite the lack of conservation of the residues that stabilise the Pfr-
from, for example the equivalent interactions to those involving Arg 453 and Gln 188 
are not present in RpBphP1 structure (Bellini and Papiz, 2012b). The similarities 
exhibited by two independent phylogenetically distant phytochromes may indicate that 
these structures represent the Pfr-form for all phytochromes.  
Many structural differences are evident form comparing the structures of the 
phytochromes in the Pr- and the Pfr-forms, and the differences between the two forms 
may be attributed to differences at the primary structure level. Interestingly, however, 
there are also examples of strongly conserved residues participating in a key interaction 
in one form but not in the other form. 
The interaction that stems out of the conserved “PAxDIP” motif differs between 
Agp1/Cph1 in the Pr-form and PaBphP in the Pfr-form. In classical phytochromes in the 
Pr-form, the Asp (Agp1 Asp 197) within the PAxDIP motif forms a hydrogen bond with 
a Tyr (Agp1 Tyr 253) and a salt bridge with an Arg (Agp1 Arg 462), the latter of which 
is a part of conserved PRxSF motif (Essen et al., 2008). The Arg in turn forms a 
hydrogen bond with the oxygen atom of the second Gly of the conserved W
G
/AG motif 
(Agp1 Gly 446), but an additional interaction between Arg 472 and Ala 457 in Cph1 is 
absent in Agp1, due to the conformational difference at the Tongue in which the latter 
residue is located. Interestingly, none of these interactions occurs in PaBphP, despite 
conservation of the PAxDIP motif, PRxSF motif, the equivalent of Agp1 Tyr 253 
(PaBphP Tyr 250) and the W
G
/AG motif. The PaBphP Asp 194 in the PAxDIP motif 
interacts with Arg 453 and Ser 459, both of which are widely conserved (Yang et al., 
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2008). The equivalent interactions involving the homologous Arg 458 and Ser 464 in 
Agp1 are absent. There are countless instances where strongly conserved residues are in 
different conformations. Interdomain polar interactions between the GAF and the PHY 
domains are shown overlaid onto a sequence alignment in Fig. 3.43, and it demonstrates 
the fact that some identical amino acids exhibit context dependent conformation. 
A high degree of conservation of the “WG/AG” motif (Agp1 445-447) in the Tongue and 
its role in establishing an unusual conformation in Cph1 has been reported (Essen 2008). 
In Agp1, the hydrogen bonds involving the W
G
/AG motif is conserved with Cph1. 
Inspection of the main chain torsion angles of the equivalent residues in Agp1, Cph1 
(2VEA), PaBphP (3C2W) and RpBphP1 (4EHO) suggests that phytochromes in the Pr-
form (Agp1 and Cph1) may not require a Gly residues for rigidly maintaining the 
conformations found in the crystal structures (Fig. 3.44). Yet interestingly the W
G
/AG 
motif is widely conserved among phytochromes, indicating the presence of selective 
pressure to maintain these residues. The torsion angles of this region in PaBphP (Pfr-
form), however, indicate that a glycine is required for its conformation found in the 
crystal structure. Perhaps this observation supports a hypothesis for phytochromes to 
undergo dynamic conformational change during photoconversion from the Pr to the Pfr-
form that is described later. Examples where the presence of a glycine facilitates large 
conformational change by acting as a “hinge” have been reported, for example DNA-
binding HapR protein (Dongre et al., 2011). An analysis with RpBphP1 shows that the 
dihedral angles of the W
G
/AG motif are within the allowed region of the Ramachandran 
plot for the general amino acids. A wide range of dihedral angles (Table 3.13), together 
with disorder found in some chains of the crystal structures of PaBphP and RpBphP1 in 
the W
G
/AG motif, is consistent with an idea of a dynamic motion involving the W
G
/AG 
motif. 
In classical phytochromes the conserved Trp residue (Agp1 Trp 445, Cph1 Trp 450) of 
the W
G
/AG motif is situated close to the bilin pocket, and undergoes a hydrophobic 
interaction with the first proline of the “PAxDIP” motif (Agp1 Pro 194, Cph1 Pro 204), 
as well as forming a polar interaction with a Glu residue (Agp1 Glu 470, Cph1 Glu 480) 
via their side chains. An interesting case of spatial compensation is found in PaBphP, 
where the space equivalent to Agp1 Trp 445 relative to the GAF domain is occupied by 
Trp 463 (Agp1 Trp 468), and this is despite the equivalent of Agp1 Trp 445 is present in 
PaBphP in the form of Trp 437. The equivalent of Agp1 Glu 470 is also present in 
PaBphP as Glu 465, but neither is the equivalent interaction between Agp1 Trp 445 – 
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Glu 470 present in PaBphP nor does Glu 465 form any polar interaction with its side 
chain. 
It is noteworthy that some residues in regions with completely different conformations 
are widely conserved in phytochromes. If a residue makes an interaction via a main 
chain atom, the selective pressure to conserve its side chain will not be as strong as a 
case where an interaction occurs via its side chain. For example, a case of conserved 
interaction via main chain atoms despite dissimilar amino acid content is shown in 
Section 6.5.2. Observations that several identical amino acid residues are found to 
assume different conformations in the Pr- and Pfr-forms suggest the importance in 
maintaining those residues, especially if such a residue participate in an interaction in 
one form, but the corresponding interaction is absent in the other form. The reason 
behind a high degree of amino acid conservation in context dependent conformation 
may be because the PHY domain undergoes conformational change between that found 
in Pr (Agp1 and Cph1) and Pfr (PaBphP and RpBphP1) forms, thereby the switching of 
conformation poses selective pressure even on a seemingly unimportant residue in one 
form that makes a key interaction in the opposite form.   
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Figure 3.44 Torsion angles of the W
G
/AG motif in Agp1, Cph1 (2VEA), PaBphP (3C2W) and 
RpBphP1 (4EHO). The “A” chain was used where multiple chains are available. A) The Phi and Psi 
angles are overlaid onto the Ramachandran plots for general amino acids (non-glycine and non-
proline residues) and glycines. The torsion angles of the W
G
/AG motif of Agp1 and Cph1 are either 
within or very close to the allowed regions for the general amino acids, which may suggest that 
glycines may not be required to maintain the conformations found in the crystal structures. The 
torsion angles of Gly 439 of PaBphP lie far from the allowed regions for general amino acids. 
Ramachandran plot diagrams adapted form Lovell et al. (2003). B) Tabulated torsion angles of the 
W
G
/AG motif in three phytochromes. Values are in angles (°). 
 
A 
B 
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Table 3.13 Torsion angles of the WG/AG motif all the chains of the crystal structures of PaBphP 
(3C2W) and RpBphP1 (4EHO). Dihedral angles of the corresponding residues range wide, and the 
W
G
/AG motif was disordered in some chains. Altogether, an inherent flexibility of the region appears 
to be conserved in phytochromes in the Pfr-form. Values are in angles (°). 
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3.11 Discussion and future works 
3.11.1 M20 holoprotein 
A shorter fragment of Agp1, M20 either with or without the first nine N-terminal 
residues, failed to produce suitable crystals for structural determination reproducibly, 
despite proteins produced from these constructs were subjected to the most intensive 
screening in the present study. Apart from the possible failure to find a suitable 
crystallisation condition, the failure to crystallise M20(s)-BV may be attributed to its 
physical properties such as detailed below. 
The amino acid composition of the surface of M20 may be thermodynamically 
unfavourable for crystallisation, either because of the lack of suitable crystal epitopes or 
a higher proportion of amino acid residues with high conformational entropy than in 
M15. This hypothesis was tested by calculating the proportion of solvent accessible 
lysine and glutamate, the primary target residues for the SER strategy, on the surface of 
the monomeric models of SER26, M15 (WT), and M20 (WT). Structural models of the 
latter two were generated based on the SER26-BV structure using PyMOL, and 
analysed using Areaimol. The proportions of solvent accessible Lys and Glu residues on 
the surface of SER26, M15, and M20 obtained by this method are 12.8%, 17.6%, and 
15.0%, respectively. M20 has a lower proportion of the SER target residues on the 
surface than readily-crystallisable M15 protein, therefore the recalcitrance of M20 to 
crystallise cannot be solely accounted for by the surface entropy. 
An alternative hypothesis for rationalising the difficulty to crystallise M20 involves the 
oligomerisation propensity of M20. The oligomerisation of proteins can be positively 
correlated with the success of crystallisation trials according to a statistical study from a 
structural genomic project (Price II et al., 2008). The M20 protein consisting only of the 
CBD is less likely to form a dimer compared to M15 protein consisting of the PCM, 
because the former has less dimer interface area due to the lack of the PHY domain 
(Section 6.2.1). 
A recent structural study on RpBphP2 CBD further supports the notion of dimerisation 
to be important for successful crystallogenesis. The study indicated a single arginine to 
play a key role for the formation of a dimer by the virtue of its long side chain (Bellini 
and Papiz, 2012a).  
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The fact that the M20 dimer exists as a lower proportion of the total sample is attributed 
to two factors. Firstly, M20 has lower dimer interface area compared to M15, and 
secondly a Thr (position 131) occupies the position corresponding to Arg 150 in 
RpBphP3. Crystallisation of PaBphP as a parallel dimer, despite the presence of Gln 
residue in the corresponding position, was attributed to the presence of the PHY domain 
which provides an additional dimer interface (Bellini and Papiz, 2012a), and the same 
may be assumed for the crystallisation of WT Agp1 M15(s) as a parallel dimer. 
3.11.2 M15 holoprotein 
Despite the accurate phase information supplied by molecular replacement with SER26-
BV coordinates, the structure of M15-BV could not be refined satisfactorily. The 
possibility of pseudosymmetry was addressed by processing the data with lower 
symmetry space groups, while using the twin refinement option of Refmac5 where 
applicable did not result in any appreciative improvement. Moreover, Phenix.refine, an 
alternative refinement program was interchangeably used with Refmac, but the exact 
source(s) of the problem could not be identified, and the final R/Rfree values were 
0.2773/0.3586 with undefined electron density in some areas, including the BV moiety.  
3.11 3 SER26-BV 
Application of the SER approach effectively addressed the “pathological” case by 
changing the crystal form, and led to the determination of Agp1 structure, albeit as a 
biologically irrelevant anti-parallel dimer. The detailed effect of SER mutations are 
discussed in Section 5.5. 
3.11.4 Structural comparison of Pr and Pfr-forms of phytochromes 
Structural observations were carried out in an attempt to relate structural features to the 
underlying variables, and in particular to draw out key differences between Pr and Pfr-
forms. It must be made clear prior to any conclusions, however, that the structure of 
PaBphP in the Pfr-form (ground state for bathy phytochrome) may not represent the Pfr-
form of classical phytochromes (photoconverted state). An additional question may be 
posed over whether the PaBphP structure is representative for the entire bathy-
phytochrome family, based on a phylogenetic study of bathy-phytochromes from 
bacteria from Rhizobiales order (Rottwinkel et al., 2010). The Rottwinkel study presents 
a hypothesis for several bathy-phytochromes (PaBaphP, type 1; Rhizobiales bathy 
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phytochromes, type 2) to have separate origins. In that case, the bathochromic ground 
state in these bathy-phytochromes must be the result of convergent evolution. 
Sequence comparisons between Agp1, Cph1, and PaBphP reveal differences in the 
primary structure between classical and bathy-phytochromes at the GAF and the PHY 
domains, e.g. Q188 and Ser 275, which are unique to PaBphP (Yang et al., 2009), or 
Agp1 Pro 376 that is unique to classical phytochromes. They have become presumably 
adapted for stabilising the bilins in different conformations. On the other hand, many 
conserved amino acid residues adopt different conformations in classical and bathy 
phytochromes. This kind of context-dependent conformation begs a question: what is 
the identity of the determinant factor for the protein conformation, particularly at the 
Tongue of the PHY domain? Based on the crystal structures of the PaBphP Q188L 
mutant in mixed Pfr/Pr-forms, a gross conformational difference found between 
phytochromes in the Pr-form (Cph1, DrBphP) and the Pfr-form (PaBphP) was deemed 
unlikely to reflect the molecular trajectories of the photoconversion (Yang et al., 2009). 
It is possible, however, that Q188L mutation in PaBphP affected not only the rate of 
dark reversion (Pr to Pfr), but also some point, in the chain of events that is simply 
referred to as “photoconversion”, is perturbed. Therefore the structure of PaBphP 
Q188L mutant in the spectrophotometric Pr-form may not exhibit the natural 
conformation of the Pr-form. For example, A. thaliana PhyB mutants with normal 
spectrophotometric property but deficient in signal transduction have been reported 
(Nagatani, 2010). To date, no evidence has been presented to verify the biochemical 
properties of the PaBphP Q188L mutant in the spectrophotometric Pr-form to represent 
that of the WT, for example by electron microscopy (global conformation in solution) 
or kinase assay (signal transduction). 
As an alternative picture of photoconversion, a dynamic conformational change, where 
conformations of the conserved amino acids switch from those observed in the Pr-form 
(Agp1 and Cph1) and the Pfr-form (PaBphP), is possible. According to this model, the 
PaBphP structure truly represents the Pfr conformation of the classical phytochromes. 
The residues that make key interactions either in classical phytochromes in the Pr-form 
or bathy-phytochromes in the Pfr-form are highly conserved in all phytochromes, 
despite their conformations being different. Also, the presence of a highly conserved 
W
G
/AG motif may suggest mobility of the Tongue. This raises another question of 
whether the PHY domain of a classical phytochrome can adopt the conformation similar 
to that of bathy-phytochromes, and vice versa. It will not be entirely impossible, though 
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thermodynamically unfavourable compared to the native ground stable form, therefore 
even if an alternative conformation should arise (the Pfr-form for the classical, and the 
Pr-form for the bathy phytochromes), the conformation will soon revert back to the 
thermodynamically stable form. 
With regards to what determines the stable conformation, I propose that not only the 
limited numbers of non-conserved residues unique to each type (classical and bathy), 
but also numerous other residues at the GAF-PHY interface by both domains, to 
synergistically determine the most thermodynamically favourable interaction. Such an 
idea is consistent with the observations that mutational studies explored thus far, to 
modify the spectrophotochromic property of phytochromes from one type to the other 
(e.g. bathy to classical or unusual to classical and vice versa), have never resulted in full 
conversion, in spite of attempts involving either single mutations (Yang et al., 2008, 
Yang et al., 2009), quadruple mutations in one domain (Yang et al., 2007) or even a 
whole domain swap (Zienicke et al., 2011). Mutation(s) in a single domain or single 
domain swap will shift the equilibrium of the favoured conformation of the 
phytochrome, but would be insufficient for the full conversion. The thought that 
dynamic conformational change might be associated with photoconversion is consistent 
with global conformational differences between the Pr- and the Pfr-forms, as 
demonstrated by analyses such as SEC (Esteban et al., 2005, Inomata et al., 2005, 
Lamparter et al., 2001) and limited proteolysis (Noack et al., 2007).  
The photochemical properties of phytochrome fragments published thus far leads to the 
consensus that the CBD is sufficient for bilin lyase activity as well as formation of the 
Pr-form, but insufficient for fully photoactive holoprotein (Noack et al., 2007, Wagner 
et al., 2005, Yang et al., 2008, Yang et al., 2007). There are exceptions to this, however. 
SyB-Cph1 can form the Pfr-form only with the GAF domain, while Agp2 only loosely 
accords to consensus (Cornilescu et al., 2008, Karniol et al., 2005). Unique aspects of 
SyB-Cph1, a member of the “PAS-less phytochrome” group with a non-canonical 
domain architecture may be the result of divergent evolution, so that the roles allotted to 
each domain have changed. The formation of the Pfr-form requires the PHY domain in 
both classical and bathy-phytochromes with the canonical domain organisation, and 
indeed the CBD of PaBphP was reported to be in the Pr-form (Yang et al., 2008). The 
majority of the mutants of PaBphP eventually revert to the Pfr-form in darkness, except 
for a D194A mutant which constitutively adopt the Pr-form and unable to undergo 
photoconversion (Yang et al., 2008). The latter case is exceptional because a mutation 
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of the conserved Asp has been shown to affect the formation of the Pfr-form in other 
phytochromes (Hahn et al., 2006, Wagner et al., 2008, Yang et al., 2007). Overall, the 
ground stable form of a phytochrome and the associated stereochemistry of the bilin are 
ultimately determined by the protein conformation, which itself is determined by the 
synergistic interaction between the GAF and PHY domains.
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Chapter 4: Structural characterisation of Agp1 in the Pfr-form 
4.1 Overview 
Information regarding the molecular trajectories during a phytochrome photoconversion 
event will provide insights into the mechanism of photoconversion and the signal 
transduction. SyB-Cph1 and PaBphP in their photoconverted state have been structurally 
characterised (Ulijasz et al., 2010, Yang et al., 2009). However, the structures of SyB-
Cph1 and PaBphP in their photoconverted states are not ideal for deducing the 
mechanism of signal transduction and global conformational change, respectively 
(Section 1.3.4). It is therefore desirable to structurally characterise the PCM of a single 
phytochrome in both Pr and Pfr-forms independently. Any structural differences 
between two structures are accounted for solely by the difference in their states. To this 
end, a crystallographic study was undertaken to probe the structure of Agp1 in the Pfr-
form. 
Crystallisation of Agp1 in the Pfr-form is difficult, however. Bacterial phytochromes in 
the Pfr-form are relatively unstable because they undergo dark-reversion from the 
photoconverted state into the ground state (Section 1.3.3). Full-length Agp1-BV 
undergoes dark reversion with initial rate of 3.4×10
-4
 s
-1
 which means that in the Pfr-
form completely disappears on an hour time scale (Lamparter et al., 2002). The dark 
reversion renders the Pfr-form of Agp1 a difficult target for crystallisation, because the 
time scale of the dark reversion is faster than the typical time scale required for 
crystallisation which is in the order of days to weeks. Cph1, a classical cyanobacterial 
phytochrome, is known to remain stable in its photoconverted state (Pfr-form). Such a 
property makes it an attractive target for crystallisation (Hughes, 2010), but no 
successful crystallisation of Cph1 in the Pfr-form has been reported to date.  
A strategy is required to stabilise Agp1 in the Pfr-form in order to crystallise it. To this 
end a locked chromophore termed 15Ea was employed to obtain Agp1 in a stable Pfr-
like form. 15Ea is a synthetic bilin with an additional carbon chain between the C and D 
rings to maintain the same configuration as that of BV in the Pfr-form (Section 1.3.3). 
The 15Ea adduct of Agp1 exhibits a similar absorption spectrum and kinase activity as 
the natural Pfr-form, and it is stable under illumination (Inomata et al., 2005), thus it 
was considered a good representative of the Pfr-form that is amenable to crystallisation. 
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A question is posed regarding the representativeness of the 15Ea adduct of Agp1 as the 
Pfr-form regardless of the length of the protein fragment. Recent evidences suggested 
the movement of the A-ring of the bilin moiety during the photoconversion process. A 
temperature-scan cryo-crystallographic study on PaBphP indicated the movement of the 
A-ring to follow the now undisputed C-D ring photoisomerisation (Yang et al., 2011). 
The A-ring of SyB-Cph1, a PAS-less phytochrome, was reported to be the major site of 
isomerisation during the photoconversion (Ulijasz et al., 2010). The BV in the Pr-forms 
features syn conformation at the C4-C5 single bond (Wagner et al., 2007, and Agp1 
SER26-BV in the Pr-form). In 15Ea the configuration between the A and the B rings of 
15Ea is unrestricted unlike doubly locked chromophores, therefore it is possible for the 
C4-C5 single bond between the A and the B-ring to change from the syn to the anti 
conformation if it is to occur during the formation of the Pfr-like form. A study with 
doubly locked chromophores could not unambiguously establish whether the 
conformation of the C4-C5 single bond in Agp1 is in anti or syn conformation (Inomata 
et al., 2009). 
In this section, attempts at crystallographic structural determination of Agp1 in the Pfr-
like form are described. A stable Pfr-like form was achieved by using the locked 
chromophore 15Ea, firstly with M20s followed by WT M15s and finally with SER 
mutants. 
4.2 Analysis of the assembly process 
4.2 1 Introduction 
Incorporation of BV by the Agp1 apoprotein is characterised by efficient and rapid 
autolyase activity (Section 1.3.2 and 4.2, Lamparter et al., 2002). On the contrary, 
assembly with 15Ea takes longer, requiring approximately 140 minutes for completion 
(Inomata et al., 2005). The gradual rise of the extinction coefficient of the maximum in 
the Q-band was attributed to the formation of the covalent bond between the protein 
moiety and the 15Ea. In the studies of the assembly process presented in this section six 
combinations of holoproteins resulting from three different apoproteins and two 
chromophores were used, in order to empirically determine the time required for 
assembly to be complete. This is important, because sample homogeneity is a critical 
factor that influences the outcome of crystallisation experiments (Benvenuti and 
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Mangani, 2007). It is necessary to ensure that a high proportion of phytochrome is 
covalently bound to the bilin in order to achieve high sample purity and yields. 
In the present work, the assembly process of a novel combination, between M20 and 
15Ea, was also studied. Assembly product of M20 and 15Ea was hypothesised to 
resemble an intermediate state of photoconversion from the Pr- to the Pfr-form (T. 
Lamparter, personal communication). This was because the M20-BV adduct does not 
undergo full photoconversion due to the lack of the PHY domain (Noack et al., 2007). 
The stereochemistry of 15Ea around the C-D methine bridge mimics that of BV in the 
initial stage of photoconversion (Inomata et al., 2005). Assembly of M20 and 15Ea 
could in theory give rise to a holoprotein that represents the state immediately after the 
photoisomerisation of the C15=C16 double bond between the C and D rings, but 
without the subsequent thermal relaxation required for the formation of Pfr-form. It is 
difficult to predict the intermediate state which M20-15Ea would mimic, because the 
stage at which the photoconversion of M20-BV stalls is unclear. The problem also lies 
in currently ambiguous definitions of each intermediate state (Wagner et al., 2008). 
Assembly processes of six types of holoproteins originating from combinations of three 
proteins (M15s, M15 C20A mutant, and M20s) and two bilin chromophores (BV and 
15Ea) were initiated by mixing the protein and the bilin at a molar ratio of 1:1. 
Absorption spectra were taken immediately after the assemblies were initiated, followed 
by measurements at 15 minutes, 30 minutes, 45 minutes, 1 hour, 2 hours, 3 hours, 4 
hours, 5 hours, 20.5 hours, and 21.5 hours. The absorption spectra are shown in Fig. 4.1. 
Assembly mixtures were incubated in darkness at 4 °C. 
4.2.2 Holoprotein assemblies 
Assembly processes of M15s-BV and M15 C20A-BV were rapid so that in each case no 
differences were observed in the absorption spectra immediately after and 15 minutes 
after the assembly initiation. Qualitatively similar rise of the Q-band peak were 
observed in both cases with the SAR value and max being 1.20, 703 nm for M15s-BV 
and 0.79, 701 nm for M15 C20A-BV, respectively. Though a comparatively low 
extinction coefficient associated with the lack of covalent bond is in agreement with the 
previous observations (Lamparter et al., 2003, Lamparter et al., 2002), the blue-shift by 
2 nm in max of the non-covalent adduct was previously not recognised (Inomata et al., 
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2005). This higher max and absorption of the covalent adduct is likely to be the result of 
covalent bond formation, as in the case of assembly with 15Ea which is described below. 
The slow assembly reaction of M15s-15Ea is in agreement with the previous 
observation (Inomata et al., 2005). The slow reaction was associated with a rise in the 
extinction coefficient of the peak in the Q-band and a red-shift of max, and the reaction 
lasted up to 20.5 hours. No further change in the spectrum was observed thereafter. A 
slower reaction as found in the present study may be explained by the lower temperature 
(4 °C) of the assembly condition compared to 18 °C in the previous study (Inomata 
2005).The absorption spectrum of the holoprotein exhibited max in the Q-band at 740 
nm with an SAR value of 0.58.  
The assembly of M15 C20A-15Ea was already completed by the first measurement 
immediately after the initiation. The extinction coefficient at the Q-band maximum was 
lower (SAR: 0.22) and max was blue-shifted (726 nm) compared to the covalently 
bonded adduct. This spectrum of the non-covalently bonded adduct is similar to the 
spectrum of M15s-15Ea obtained immediately after the reaction is initiated, prior to the 
absorbance increase and red-shifting of the peak in the Q-band (Inomata 2005). By 
using a mutant that lacks the necessary cysteine for covalent bond formation, I have 
confirmed that the slow reaction associated with increasing absorbance in the Q-band 
and red-shifting of max is the result of covalent bond formation. 
The assembly of M20s-BV was completed in 3 hours, and the spectrum is as described 
in Section 3.2.1. 
The assembly of M20s-15Ea resulted in an unusual spectrum. The reaction was slow 
that it required up to 20.5 hours for completion. Two peaks with absorption maxima in 
the red (644 nm) and the far-red (714 nm) region appear immediately after the assembly 
is initiated, and the peaks in the red and far-red region blue-shift and red-shift 
respectively, such that the final max are 638 nm and 727 nm. Extinction coefficients for 
each peak increase during the assembly, and the relative intensities of the peaks are 
reversed. The SAR of the peak in the red region at the start is 0.22 and finally reaches 
0.38, but SAR values of the peak in the far-red region at the start and the end of the 
reaction are 0.17 and 0.52, respectively.  
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Despite the initial anticipation that M20s-15Ea may resemble a photoconversion 
intermediate state, the absorption spectrum of M20s-15Ea is very different from the 
meta-Rc (Fig. 4.2). The absorption spectrum of cryo-trapped Agp1 in the meta-Rc state 
is characterised by a peak approximately at 700 nm and a shoulder approximately at 750 
nm (Borucki et al., 2005). Photoconversion of M20-BV results in a decrease of the 
absorbance of the peak in the Q-band, and the resulting spectrum was described as 
being similar to the spectrum of Agp1 in meta-Rc (Noack et al., 2007). The max of the 
spectrum of M20s-15Ea and meta-Rc is very different, however. The initial max of the 
peaks of M20s-15Ea are 644 nm and 714 nm. While differences in max between 
holoproteins which have bound BV or a synthetic chromophore with corresponding 
stereochemistry have been noted previously (Inomata et al., 2005), the differences in 
this case are of greater magnitude (Table 4.1). A gradual increase in the max and the 
absorption coefficient by the peak in far-red region of M20s-15Ea spectrum is 
qualitatively similar to the development of the Pfr-form during the natural 
photoconversion. 
With regards to the increasing absorption at the far-red peaks in the natural Pfr-form and 
M20-15Ea, it is difficult to draw an analogy given the current lack of understanding in 
the molecular mechanism of photoconversion and a highly artificial combination of 
truncated M20s and the synthetic 15Ea chromophore. Overall it is difficult to relate the 
observed assembly of M20s-15Ea to the natural photoconversion of Agp1, and its 
significance was not conclusively validated in the present study. 
 Natural, BV Synthetic, locked chromophores 
Pr-form Agp1 full-length BV Agp1 full-length 15Za 
702 nm 714 nm (+12 nm) 
(Inomata et al., 2005) (Inomata et al., 2005) 
Pfr-form Agp1 full-length BV Agp1 full-length 15Ea 
747 nm 739 nm (- 8 nm) 
(Inomata et al., 2005) (Inomata et al., 2005) 
Intermediate 
form 
Agp1 full-length BV M20s-15Ea 
Approximately 700 and 750 nm 644 nm (-56 nm) and 714 nm (- 36 nm) 
(Borucki et al., 2005)  
Table 4.1 Forms of Agp1 protein and Q-band max for each form, and the equivalent for the 
corresponding adduct with a synthetic chromophore. Differences in max between the holoprotein 
with the natural chromophore and the corresponding synthetic chromophore are shown in 
parentheses next to the max values of holoproteins with synthetic chromophore. The difference is 
relative to the max of natural holoproteins. In cases of 15Za and 15Ea, the difference in max from 
that of the corresponding natural holoprotein is smaller than the differences in max of meta-Rc and 
M20s-15Ea, a holoprotein hypothesised to resemble an intermediate state. 
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Figure 4.1 Absorption spectra of assembly of Agp1 in various forms with BV or 15Ea. A) M15s-
BV. B) M15s-15Ea. C) M15 C20A-BV. D) M15 C20A-15Ea. E) M20s-BV. F) M20s-15Ea. 
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Figure 4.2 Absorption spectra of Agp1 holoproteins in an intermediate (-like) form. A) The 
spectrum of M20s-15Ea immediately after the assembly is initiated. B) The spectrum of Agp1 cryo-
trapped in meta-Rc state (dotted line). Figure 6A from Borucki et al. (2005). C) The spectrum of 
photoconverted M20-BV (grey line). Figure 3 from Noack et al. (2007). 
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4.3 Large-scale production, analysis and crystallisation trials with the 
M20s-15Ea protein 
Even though the relevance of any results obtained from M20s-15Ea for the naturally 
photoconverted holoprotein is uncertain, crystallisation trials were carried out in the 
hope to obtain some structural information. Structural information of M20, a truncated 
construct, may not result in the full elucidation of the mechanism of signal transduction, 
but may show the altered protein-chromophore interaction in the vicinity of the bilin. 
The plausibility of such information may be validated by comparing it with the structure 
of PaBphP in the Pfr-form. 
4.3.1 Expression and purification of M20s-15Ea protein 
Affinity purified M20s apoprotein (Section 3.3.2) was used to produce M20s-15Ea 
holoprotein. 20 mg of apoprotein was mixed with 15Ea in DMSO at a molar ratio of 1:1 
under the presence of 10 mM DTT.  
Following 18 hours of incubation in darkness, the assembly mixture was dialysed 
against the IEX Buffer A (Section 2.2.3.7.4). A linear gradient elution from IEX Buffer 
A to IEX Buffer B was used to elute the M20s-15Ea protein from a HiTrap Q HP 
column (Section 2.2.3.7.4). Three peaks were eluted, of which one of them appears as a 
shoulder of the main peak. Fractions containing each peak were analysed by absorption 
spectroscopy (Fig. 4.3). The spectra of two minor peaks sampled at fractions C6 and 
C10 resemble spectra observed at later and early stages of the assembly of M20s-15Ea, 
respectively (Section 4.2.2). Interestingly, the spectrum of the main peak sampled from 
fraction C1 appears distinctly different from that of C6 and C10, because a peak in the 
far-red region with a max of 727 nm with a shoulder approximately at 650 nm is found, 
which is similar to the Pfr-form. Amount of protein in each peak occur in decreasing 
order of, main peak (C1, Pfr-like), first minor peak (C6, later stage of assembly), and 
second minor peak (C10, early stage of assembly), as judged from the chromatogram. 
IEX chromatography has revealed the presence of at least three products for the 
assembly of M20s protein with 15Ea which could be separated by IEX. Emergence of a 
species with a Pfr-like spectrum in the Q-band was undetected in the earlier test 
(Section 4.2.2) most likely due to the persisting presence other two species with 
different absorption spectra. In order to confirm that the species from two minor peaks 
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were not the intermediates of a slow assembly process, fractions C6 and C10 were 
incubated in darkness for 48 hours while the absorption spectra were measured at 24 
hour intervals (Fig. 4.4). Absorption spectra of fraction C6 and C10 slightly changed 
following incubation for 24 hours. The change is characterised by an increase in the 
extinction coefficient of the far-red peak, and this is in agreement with the previous 
observation (Section 4.2.2). No further change was observed in the spectra in the 
following 24 hours, and both spectra retained two absorption peaks in the Q-band, thus 
confirming that the species from two minor peaks are not assembly intermediates, but 
alternative assembly products. 
It is unclear why certain fractions of the protein results in the formation of products with 
different spectral properties. This may be explained by the inhomogeneity in the protein 
sample or 15Ea chromophore which leads to several species of holoproteins.  
Fractions containing the main peak eluted during an IEX were pooled and purified using 
an isocratic elution form a Superdex 200 column using SEC buffer with no NaCl 
(Section 2.2.3.7.6). Two peaks at elution volumes of 14.95 and 19.77 ml were obtained, 
and absorption spectra of two eluted peaks appear almost identical (Fig. 4.5). The 
broadness of the main eluted peak was attributed to the high concentration of the 
injected sample. The higher elution volume of the minor peak with a higher elution 
volume was attributed to the result of non-specific interaction rather than the difference 
in oligomeric state as judged from the calibration of the S200 column (Appendix 5). As 
a precaution only the fractions containing the main peak (fractions A12-B11) were 
pooled and concentrated for crystallisation trials, however. 
The absorption spectrum of the purified sample has a max in the Q-band at 727 nm and 
an SAR value of 0.69. Similarly to the case with M20-BV, a low SAR value is 
attributed to the lack of the PHY domain (Section 3.2.1). 
Assembly of M20s-15Ea ultimately yielded holoprotein with an absorption spectrum 
similar to that of the Pfr-form. Various forms of M20s protein were analysed by a 
native-PAGE gel which confirmed the conformational differences between the forms of 
M20s protein, in agreement with the IEX (Fig. 4.6).   
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Figure 4.3 Purification of M20s-15Ea assembly product with IEX. A) IEX elution profile of M20s-
15Ea during linear gradient elution, resulting in three peaks with distinct absorption spectra. The 
blue, brown, and green lines indicate the absorption (mAU), conductivity (mS/cm), and buffer 
volume ratio A/B (%), respectively. UV-vis absorption spectra of B) Fraction C1, C) Fraction C6, 
and D) Fraction C10. The sample from fraction C1 was diluted by 1/8 with IEX buffer A prior to the 
measurement.  
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Figure 4.4 UV-vis absorption spectra of species from two minor peaks separated by IEX. A) 
Absorption spectra of fraction C6 and B) C10 immediately after separation by IEX and after 
incubation for 24 hours, followed by additional 24 hours of incubation. 
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Figure 4.5 Purification of M20s-15Ea with SEC. A) SEC elution profile of M20s-15Ea obtained by 
isocratic elution. The blue and brown lines indicate the absorption (mAU at 280 nm) and 
conductivity (mS/cm), respectively. UV-vis absorption spectra of fractions, B) Fraction B12; C) 
Fraction B7. 
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Figure 4.6 A native-PAGE gel showing migration patterns of different forms of M20s protein. The 
last two lanes corresponding to the two peaks from SEC which were deemed identical as judged by 
absorption spectra (Fig. 4.4). Identical absorption spectra agree with the identical migration patterns 
shown here. The migration patterns of the main assembly product of M20s-15Ea in the last two lanes 
are similar to that of M20-BV, but distinctly different from that of M20 apoprotein. The migration 
patterns of the two alternative assembly products were different from each other, as well as any other 
forms of M20s. 
 
4.3.2 Crystallisation screening with purified M20s-15Ea protein in a Pfr-like state 
Purified Pfr-like M20s-15Ea holoprotein was subjected to crystallisation trials with 
JCSG+, PACT-premier, PGA, and Morpheus kits. 2-drop 96-well MRC plates with 80 
l reservoirs were used and drops comprised 200 nl of protein solution at 25 mg/ml and 
200 nl of reservoir solution. The plates were incubated at 19 °C in darkness, and were 
subjected to regular inspection, but no lead condition was identified. 
4.4 M15s-15Ea: Pfr-like form 
No lead crystallisation condition was identified for the M20s-15Ea holoprotein, but no 
further efforts were made for the following reasons. Firstly, the M20 protein lacks the 
PHY domain, therefore its structure is not ideal for gaining functional insights of the 
protein. Secondly, the absorption spectrum of M20s-15Ea is more different from that of 
M15s-15Ea compared to the native absorption spectrum of Agp1 in the Pfr-form (Fig. 
4.5). In turn more efforts were made to solve the structure of the 15Ea adduct of the 
M15s protein to solve the structure of Agp1 in the Pfr-like form that represents the 
native Pfr-form more closely and provides deeper functional insights. 
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The assembly process of M15s-15Ea takes a longer time than it does in the case of 
M15s-BV, as the process involves the quick initial binding followed by slower 
formation of the covalent bond (Section 4.2.2, Inomata et al., 2005). For this reason, 
assembly of M15s-15Ea was carried out by a long incubation in darkness similarly to 
the cases of M20(s)-BV and M20s-15Ea, because a longer assembly process increases 
the conformational homogeneity of the sample.  
Additionally M15s-15Ea was further purified by IEX to separate the holoprotein from 
the apoprotein. The differences in elution volumes of the apoprotein and the holoprotein 
is less pronounced in M15 proteins than in M20 proteins (Section 6.2), but these 
differences were sufficient for separation of the proteins and thereby to improve the 
purity of M15-15Ea. HIC was not used since no difference in elution volumes of 
apoprotein and holoproteins of M15 proteins was observed (Section 6.4.1).  
4.4.1 Expression and purification of M15s-15Ea protein 
Affinity purified M15s apoprotein (Section 3.4.1) was assembled with 15Ea by adding 
15Ea stock solution in DMSO to a molar protein/chromophore ratio of 1. The assembly 
was allowed to continue in darkness for 18 hours at 4 °C under the presence of 10 mM 
DTT. The sample was then dialysed against IEX buffer A. A linear gradient elution 
from IEX Buffer A to IEX Buffer B was used to elute the M15s-15Ea protein from a 
HiTrap Q HP column (Section 2.2.3.7.4), resulting in elution of three peaks (Fig. 4.7). 
Two minor peaks with larger elution volumes were judged to consist of holoprotein 
with different conformation from that of the protein in the main peak with a Pfr-like 
absorption spectrum. Fractions containing holoprotein with similar spectral properties to 
the previously published ones (D8 – D1) were pooled, concentrated, and purified by 
SEC (Fig. 4.8). Isocratic elution yielded a main elution peak and a minor peak with a 
larger elution volume. The latter was attributed to non-specific interaction between the 
protein and the matrix, rather than protein in different oligomeric state as judged from 
the calibration of the S200 SEC column (Appendix 5). As a precaution, only the 
fractions of the main peak were pooled, and the holoprotein was concentrated to 
typically 30 mg/ml. The SAR value of the purified M15s-15Ea holoprotein was usually 
about 0.90, which is higher than any published results, and it is an indication of more 
successful purification of holoprotein by utilising IEX. 
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Figure 4.7 Purification of the M15s-15Ea holoprotein with IEX. A) IEX elution profile of M15s-
15Ea from a linear gradient elution. The blue, brown, and green lines indicate the absorption (mAU 
at 280 nm), conductivity (mS/cm), and buffer volume ratio A/B (%), respectively. UV-vis absorption 
spectra of fractions, B) Fraction D6, SAR = 0.90; C) Fraction E3, SAR = 0.13; D) Fraction E7, SAR 
= 0.17. Even though the spectra of the two minor peaks indicate the presence of the chromophore in 
the protein, the low absorbance in the Q-band which is unlike the natural Pfr-form might reflect 
conformational heterogeneity of the protein sample.  
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Figure 4.8 SEC of M15s-15Ea holoprotein. A) Chromatogram of isocratic elution. The blue and 
brown lines indicate the absorption (mAU at 280 nm) and conductivity (mS/cm), respectively. UV-
vis absorption spectra of fractions from SEC. B) Fraction A12, SAR = 0.86; C) Fraction B11, SAR = 
0.96; D) Fraction B8, SAR = 0.91. All the protein-containing fractions exhibited essentially identical 
absorption spectra. Larger elution volume by the second peak was judged to result from non-specific 
interaction between protein and the matrix. 
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4.4.2 Crystallisation screening with purified M15s-15Ea protein 
Purified M15s-15Ea holoprotein was subjected to crystallisation trials with JCSG+, 
PACT-premier, PGA, and Morpheus kits (Molecular Dimensions). 2-drop 96-well 
MRC plates with 80 l reservoirs were used and drops comprised 200 nl of protein 
solution at 25 mg/ml and 200 nl of reservoir solution. The plates were incubated at 
19 °C in darkness, and plates were routinely inspected (Section 2.2.6.1), but no lead 
condition was identified. Furthermore, crystallisation of M15s-15Ea was attempted 
under a condition which had been successfully used for M15s-BV holoprotein (16% 
PEG3350, 200 mM CaCl2, 100 mM Tris-HCl pH 8.0 at 20 °C), but no crystallisation 
was observed. 
4.5 SER mutants-15Ea 
Screening the 15Ea adducts of WT M15s and M20s proteins did not result in 
identification of a lead crystallisation condition. The failure to obtain M15s-15Ea 
crystal under the crystallisation condition identified for M15s-BV suggests the 
conformation of the Pr-form is different from that of the Pfr-like form, so that identical 
crystal contacts cannot occur to form crystals of the same form.  
The structure of Agp1 in the Pr-form was determined as a result of SER mutation 
strategy (Chapter 3). The success was attributed to the introduction of mutations which 
resulted in the crystal form to change from the “pathological” form to the one with 
better diffraction quality. Since SER mutation patches seem to have contributed to the 
formation of novel crystal forms in the case of SER26-BV (Section 5.5), it was 
hypothesised that the SER strategy may also increase the probability of the 15Ea adduct 
to crystallise by providing a novel contact surface for crystallisation to occur.  
To this end, all the SER mutants described so far, SER2, SER3, SER6, SER26, and 
SER36, were assembled with 15Ea and subjected to crystallisation trials. 
4.5.1 Expression and purification of 15Ea adducts of SER mutants 
Apoproteins of SER mutants (SER2, SER3, SER6, SER26, and SER36) were expressed 
and affinity purified as described previously (Section 3.6.3 and 3.7.3). Affinity purified 
SER apoproteins at typical concentration of 10 mg/ml were assembled with 15Ea 
following the identical protocol as for the WT M15 (Section 4.4.1). No difference in 
assembly characteristics were observed for the different mutants adducts. 15Ea adducts 
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of the SER mutants were tested by several biochemical methods to prove that functions 
of the mutants are not inadvertently affected (Section 5.3). 
Since the assembly characteristics of SER mutants with 15Ea did not differ from that of 
the WT, IEX purification was necessary to purify the properly folded holoprotein with 
the Pfr-like absorption spectrum. All the 15Ea adducts of the SER mutants were 
subjected to IEX and SEC as described in Section 4.4.1, resulting in holoproteins with 
spectra that are indistinguishable from that of the WT M15s-15Ea (SER2-15Ea, Fig. 
4.9; SER3-15Ea, Fig. 4.10, SER6-15Ea, Fig. 4.11; SER26-15Ea, Fig. 4.12; SER36-
15Ea, Fig. 4.13). 
In all cases elution profiles were essentially identical to one another throughout the 
purification protocol. This shows that physical properties, as indicated by similar elution 
volumes in IEX and SEC, of the SER mutants have not been majorly changed (Table 
4.2).  
Elution profiles from SEC are characterised by a single peak for SER2-15Ea and SER3-
15Ea, whereas two peaks are detected for SER6-15Ea, SER26-15Ea, and SER36-15Ea. 
The second lower peak cannot be holoprotein in an alternative oligomeric state 
according to the calibration of the S200 column (Appendix 5). Instead non-specific 
interactions between the protein and the stationary phase were suspected to be the 
reason for the occurrence of these peaks. In all cases the absorption spectra of the two 
peaks have almost identical SAR values, but as a precaution only the fractions 
containing the main peak were pooled and concentrated for crystallisation trials. 
This larger elution volume of the 15Ea adduct is exclusive to those holoprotein with the 
SER6 mutation cluster, therefore hydrophobic interaction was initially assumed to occur 
at the SER6 mutation site (E336A/K337A). Yet the elution profile of WT M15s-15Ea 
and M20s-15Ea holoproteins also exhibited similar delayed second peak (Fig. 4.7 and 
Fig. 4.8, respectively), and M20s does not even have a PHY domain where SER6 
mutation site resides. The cause for this seemingly unpredictable appearance of delayed 
elution in SEC was not investigated further in this study. 
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Figure 4.9 Purification with IEX and SEC and a UV-vis absorption spectrum of the purified SER2-
15Ea holoprotein. A) The chromatogram from IEX. B) The chromatogram from SEC. The blue, 
brown, and green lines indicate the absorption (mAU at 280 nm), conductivity (mS/cm), and 
proportion buffer A/B (%), respectively. C) An absorption spectrum of the pooled SER2-15Ea 
holoprotein. 
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Figure 4.10 Purification with IEX and SEC and a UV-vis absorption spectrum of the purified SER3-
15Ea holoprotein. A) The chromatogram from IEX. B) The chromatogram from SEC. The blue, 
brown, and green lines indicate the absorption (mAU at 280 nm), conductivity (mS/cm), and buffer 
volume ratio A/B (%), respectively. C) An Absorption spectrum of the pooled SER3-15Ea 
holoprotein. 
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Figure 4.11 Purification with IEX and SEC and UV-vis absorption spectra of the purified SER6-
15Ea holoprotein. A) The chromatogram from IEX. B) The chromatogram from SEC. The blue, 
brown, and green lines indicate the absorption (mAU at 280 nm), conductivity (mS/cm), and buffer 
volume ratio A/B (%), respectively. Absorption spectra of fraction s C) A12 and D) B7 from SEC. 
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Figure 4.12 Purification with IEX and SEC and a UV-vis absorption spectrum of the purified 
SER26-15Ea holoprotein. A) The chromatogram from IEX. B) The chromatogram from SEC. The 
blue, brown, and green lines indicate the absorption (mAU at 280 nm), conductivity (mS/cm), and 
buffer volume ratio A/B (%), respectively. C) An absorption spectrum of the pooled SER26-15Ea 
holoprotein. 
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Figure 4.13 Purification with IEX and SEC and UV-vis absorption spectra of the purified SER36-
15Ea holoprotein. A) The chromatogram from IEX. B) The chromatogram from SEC. The blue, 
brown, and green lines indicate the absorption (mAU at 280 nm), conductivity (mS/cm), and buffer 
volume ratio A/B (%), respectively. Absorption spectra of fractions C) A12 and D) B13 of SEC on 
SER36-15Ea.  
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Protein IEX elution volume (ml) SEC elution volume (ml) 
M15s-15Ea  13.83 
SER2-15Ea 91.28 14.29 
SER3-15Ea  13.89 
SER6-15Ea 99.65 14.31 
SER26-15Ea 96.25 14.39 
SER36-15Ea 101.59 14.48 
Table 4.2 Similar elution volumes of the 15Ea adducts of the SER mutants in both IEX and SEC. 
Elution volumes where purification was carried out under the identical protocol were collected for 
both IEX and SEC. Entire elution volumes for IEX and SEC were 150 ml and 24 ml, respectively. 
Standard purification protocol for IEX was a linear gradient from IEX Buffer A to IEX Buffer B 
over 30 CV at 0.5 ml/min, and an isocratic elution over 1 CV at 0.5 ml/min for SEC. 
 
4.5.2 Crystallisation screening with purified SER mutants-15Ea protein 
Purified 15Ea adducts of SER mutants were subjected to crystallisation trials with 
JCSG+, PACT-premier, PGA, and Morpheus kits (Molecular Dimensions). 2-drop 96-
well MRC plates with 80 l reservoirs were used and drops comprised 200 nl of protein 
solution at 25 mg/ml and 200 nl of reservoir solution. The plates were incubated at 
19 °C in darkness, and were regularly inspected. 
Screening resulted in identification of several lead conditions for SER2-15Ea using the 
Morpheus kit. These conditions are listed in Table 4.3. The optimised crystallisation 
condition consisted of 0.07 M D-galactose, 0.1 M MES/Imidazole pH 6.5, 20% 
Glycerol and 10% PEG4000. Hexagonal rod shaped crystals typically grew to 
dimensions of ~ 0.3 mm × 0.15 mm × 0.15 mm in 2 weeks of incubation in darkness. 
For preparation purposes, crystallisation was carried out in a 24-well plate by the 
hanging drop method with 400 l of reservoir solution. All crystals grown in conditions 
from or derived from the Morpheus kit were vitrified in liquid nitrogen using 
LithoLoops without further cryoprotection, because the solutions contain 20% 
cryoprotectant. 
Often rod-shaped crystals were found to possess re-entrant faces at the longitudinal 
termini (Fig. 4.14C). This is a sign of twinning and should be noted for potential 
difficulties in processing the dataset (Hammond, 2009: 21-25). 
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Table 4.3 Lead conditions identified using the Morpheus kit in a crystallisation trial with SER2-
15Ea. 
  
 
 
Figure 4.14 Crystals of SER2-15Ea crystals. A) 0.02 M each of D-glucose, D-mannose, D-
galactose, L-fucose, 0.1 M MES/Imidazole pH 6.5, 20% Glycerol, 10% PEG4000. B) 0.1 M Sodium 
formate, 0.1 M MES/Imidazole pH 6.5, 20% Ethylene glycol, 8% PEG8000. C) 0.07 M D-galactose, 
0.1 M MES/Imidazole pH 6.5, 20% Glycerol, 10% PEG8000. 
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A B 
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4.6 Analysis of SER2-15Ea crystals 
Diffraction datasets of SER2-15Ea crystals were collected at beamlines ID14-4 and 
ID23-1 of the ESRF synchrotron, Grenoble, France. Four datasets were collected and 
the reflections were indexed and integrated either by using iMosflm or XDS, and scaled 
using Scala. 
The identification of the correct space group proved to be challenging. For most datasets 
iMosflm suggested a trigonal primitive lattice with unit cell parameters a = b = 208.23 
Å, c =207.74 Å,  =  = 90 °,  = 120 °, but examination of the indexed and merged 
MTZ file with Pointless indicates a distinctly different orthorhombic system of with a 
C-centred unit cell with unit cell parameters a = 209.60 Å, b = 363.40 Å, c =212.5 Å,  
=  =   = 90 ° as found in the space groups C222 and C2221. If a crystallographic 
symmetry is to be hypothesised for a phytochrome dimer as it has been observed for 
many phytochrome structures to date, a two-fold rotational symmetry will be included 
somewhere in the space group symbol. Interestingly, the analysis with Pointless of a 
dataset 0-4 collected in September 2011 returned P6322, which is in close agreement 
with P622 as suggested by XDS. Combining this finding with the hypotheses that two 
molecules in a phytochrome dimer in the crystal are related by crystallographic two-fold 
rotational symmetry and that the observed crystal morphology is that of hexagonal rods, 
the newly suggested P622 or variations like P6322 were assumed to be the correct space 
group. 
Data processing of datasets of SER2-15Ea crystals was not straight forward. Manually 
inspecting the positional agreement between the recorded spots and the spots predicted 
by iMosflm was difficult due to poor quality of the diffraction patterns. High mosaicity 
of the crystal leads to virtually all recorded reflections to be predicted as partial 
reflections, regardless of the choice of the candidate space group. The output statistics 
from Scala after processing in space group P622 showed that the diffraction quality of 
the SER2-15Ea crystals was poor (Fig. 4.15A). Furthermore, the presence of twinning 
was identified by L-test, which confirms the morphological indication of twinning, 
which indicates that a lower symmetry space group such as P6 or P3 is correct (Fig. 
4.15B).   
Between 4 to 6 and 18 to 22 molecules per asymmetric units were suggested for space 
groups P6322 and P3 by Matthews software, a cell content analysis program. Two 
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fragments (PAS-GAF and PHY domains) of the refined structure of SER26-BV were 
used as search models to find the solution for the dataset. No solution for the phase 
problem could be found, however, by molecular replacement. The possible reasons 
could be any of the following factors or combinations thereof; a relatively low signal to 
noise ratio of the reflections across the whole resolution range, low resolution of the 
diffraction images and conformational differences between the structures of the search 
models and the structure of SER2-15Ea in crystallo. No further substantial progress 
could be made for data analysis and optimisation of crystallisation based on SER2-15Ea 
in the time scale of the present study, and further modification to the construct was 
deemed necessary to obtain better crystals. 
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Figure 4.15 Analyses of the quality of a dataset 0-4 from a crystal of SER2-15Ea. A) Signal to noise 
ratio as a function of resolution is plotted for the dataset 0-4 (SER2-15Ea) and the dataset 4-1 
(SER26-BV). At any given resolution, the value of Mean (I)/sd(Mean(I)) of SER2-15Ea is lower 
compared to that of SER26-BV, which indicates lower diffraction quality of the SER2-15Ea crystal. 
I = intensity. B) L-test for twinning on the dataset 0-4 collected from a SER2-15Ea crystal.  
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4.7 Multiple cluster surface entropy reduction mutants 
Screening 15Ea adduct of various SER mutants resulted in crystallisation of SER2-15Ea. 
Success in obtaining crystal de novo is presumed to be a result of new crystal contact 
formation, though whether the SER2 mutation cluster directly participates in such 
contacts has not been explicitly shown. Structural determination of SER2-15Ea has not 
been successful due to poor diffraction quality of the crystals, and resulting difficulties 
in data processing. Additional efforts to improve the crystals such as modification of the 
chemical and physical condition of the crystal growth and streak/micro seeding did not 
result in marked improvement. 
It has been shown in the present study that SER mutant proteins with similar number of 
mutations have markedly different crystallisation propensities, and a similar observation 
has been reported (Derewenda, 2011). Therefore SER23 and SER236, the constructs 
with the last two remaining combinations of SER mutations were produced in the hope 
to obtaining crystals of higher quality for the 15Ea adduct. 
4.7.1 Generation of multiple cluster surface entropy reduction mutants 
The constructs of SER23 and SER236 were produced by applying SER2 mutation to the 
constructs bearing SER3 and SER36 mutations, respectively. The SER3 construct and 
the SER36 construct were subjected to QuikChange mutagenesis with SER2 F and 
SER2 R primers (Section 2.2.2.9). Candidate plasmids were purified from overnight 
cultures inoculated with single colonies of E. coli XL1-Blue cells transformed with 
mutagenesis reaction mixture. 
4.7.2 Verification of the plasmid constructs 
An expression trial was carried out in order to confirm the successful mutagenesis. Due 
to the time constraint, tests for confirming correct nucleotide sequence more directly 
were not performed. Successful mutagenesis was judged as likely, however, from 
drastically altered level of soluble expression as described in Section 4.7.3. 
4.7.2.1 Test expression 
Expression of the protein by SER23 and SER236 construct under an inducing condition 
was tested in small scale test expression (Section 2.2.3.6.1). Three candidate plasmids 
were tested for SER23 and SER236, and they were used to transform BL21(DE3) cells. 
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Cells bearing candidate plasmids each were used to inoculate 5 ml of LB-Amp media, 
and expression of the gene of the target protein was detected by SDS-PAGE (Fig. 4.16). 
Overproduction of a protein with similar molecular weight as WT M15s protein was 
found in all cases excepting the cells bearing SER23-3 and SER236-1. In all subsequent 
tests, SER23-1 and SER236-2 were used.  
 
Figure 4.16 SDS-PAGE gel showing a small scale expression trial of SER23 and SER236 proteins. 
Successful expression resulted in proteins with the expected molecular weight for candidate plasmid 
number 1 and 2 of SER23, and number 2 and 3 of SER236. Intense bands with coincidentally similar 
molecular weight to M20s protein originate from E. coli insoluble fraction, and are not degradation 
products of overproduced proteins. M, SN2 molecular weight marker. 
 
4.7.3 Expression and purification of multiple cluster SER mutant proteins 
Large scale production of SER23 and SER236 proteins were carried out using 2100 ml 
of LB-amp media following the same protocol as used for the WT M15s protein 
(Section 2.2.3.6.2). Following 18 hours of induction, 8.58 g and 7.07 g of cells were 
collected for SER23 and SER236, respectively. Both proteins were purified by affinity 
purification as described in Section 2.2.3.7.2. Preliminary quantification of the purified 
protein by absorption spectroscopy indicated the total yields are 19.575 mg and 17.304 
mg for SER23 and SER236, respectively. These values were gross overestimates as 
shown by SDS-PAGE which indicated the low proportion of target protein in the eluate 
from the affinity chromatography (Fig. 4.17). 
The high level of contamination was also confirmed during IEX. Affinity purified 
SER23 was assembled with 15Ea following the same protocol as for the WT M15s-
15Ea. What was initially assumed to be 19.575 mg of pure SER23 apoprotein was used 
for the assembly, and the sample was subjected to purification with IEX following the 
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same protocol as for other 15Ea adducts (Section 2.2.3.7.4). The elution profile was 
distinctly different from those of other 15Ea adducts with hitherto uniform pattern (Fig. 
4.18). Absorption spectra of the fractions showed the peak with elution volume of 
102.75 ml to contain SER23-15Ea holoprotein. SAR value of the pooled fractions 
containing SER23-15Ea (E2 – E6) was 0.25 which is lower than  1.00 of M15s-15Ea 
in the same stage of purification (Fig. 4.8). Lower SAR value is attributed to persisting 
contamination as shown by SDS-PAGE (Fig. 4.17). The revised estimated yield of the 
SER23 protein is 0.35 mg, according to the area of the SER23-containing peak relative 
to the total area in IEX. 
The reason for a high proportion of contamination in the affinity purified samples of 
SER23 and SER236 was attributed to their extremely low yield of soluble protein from 
the cells. Affinity purification is a binding technique where the impure starting sample 
contains proteins with varying degree of affinity to the complementary binding 
substance of the stationary phase. Given finite binding capacity of the column, yield and 
purity of the eluted target protein dynamically varies with the abundance of target 
protein in the starting material, because the target protein competes for binding sites 
with the contaminants, albeit the former usually have higher affinity to the resin. If the 
target protein is not present at high enough proportion to saturate the binding capacity 
of the column, the remaining biding site will be occupied by contaminants. Possible 
reasons for the drastically reduced yields of SER23 and SER236 is discussed in Section 
5.2. No further optimisation to increase the soluble yield of SER23 and SER236 was 
carried out. 
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Figure 4.17 SDS-PAGE gel showing purified SER23 and SER236 proteins. Lane 1,Elution from 
affinity purification of SER23; Lane 2, Elution from affinity purification of SER236; Lane 3, Pooled 
fractions (E2-E6) from IEX containing SER23-15Ea holoprotein; Lane 4, Elution from affinity 
purification of SER236 at higher concentration; M, SN2 molecular weight marker. The band thought 
to correspond to SER23 in lane 1 and SER236 in lane 4 at 54.9 kDa constitutes 9.76% and 20.60% 
of the total band intensity, respectively. Following IEX purification, the relative proportion of 
SER23-15Ea protein rose to 28.34%. Band intensity calculation performed by calculated by ImageJ 
(Abramoff et al., 2004).  
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Figure 4.18 Purification of SER23-15Ea with IEX. A) IEX elution profile of SER23-15Ea. Peaks 
belonging to contaminations are visible. The blue, brown, and green lines indicate the absorption 
(mAU), conductivity (mS/cm), and buffer volume ratio A/B (%), respectively. B) UV-vis absorption 
spectra of the eluted peaks from IEX. Peak with elution volume at 102.75 ml is characterised by 
higher SAR compared to the rest, indicating the presence of SER23-15Ea. 
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Figure 4.19 A UV-vis absorption spectrum of the pooled fractions containing SER23-15Ea 
holoprotein from IEX. Fractions from E2 to E6 that contain SER23-15Ea were pooled. SAR is 0.25, 
lower than that of WT M15-15Ea which is  1.00 and this was attributed to relatively low purity of 
SER23-15Ea holoprotein, and is confirmed in lane 4 of an SDS-PAGE gel in Fig. 4.17. 
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4.8 Discussion and future works 
Following an extensive screening of the 15Ea adduct of the WT Agp1 by our 
collaborative groups in Berlin and London, the latter of which is described in this thesis, 
did not result in identification of a crystallisation condition. Screening 15Ea adducts of 
several SER mutants with much fewer crystallisation conditions, however, led to 
obtaining crystals of SER2-15Ea, the first phytochrome crystal purely in the form which 
represents the photoconverted state. Structural determination was not possible due to the 
low quality of collected diffraction images, and attempts to extend screening by 
producing SER23 and SER236 mutants failed due to low yields. It is plausible, however, 
for SER2-15Ea to serve as a basis for carrying out further modifications to the construct 
in the hope to obtain better crystals. Possible modifications include a conventional 
optimisation route of removing the C-terminal hexahistidine tag and the preceding “LE” 
motif derived from the XhoI restriction site. Additionally, several amino acids with low-
conformational entropy are found at the C-terminus (501 KTEE 504), and removing 
these residues may improve the crystallisation propensity of the protein. Furthermore, 
introducing an Arg residue conserved in many phytochromes, a residue believed to play 
a key role in mediating parallel dimer formation in phytochromes (RpBphP3 Arg 150, 
the equivalent residue in Agp1 is Thr 131) may improve the crystal formation, because 
a correlation between dimerisation and the crystallisation propensity has been suggested 
(Bellini and Papiz, 2012a). Introduction of the dimer-mediating Arg will alter the KD of 
dimer formation by Agp1, but given the wide presence of this Arg residue in other 
phytochromes, the structure of Agp1 with the Thr 131 Arg mutation will still be a good 
representative for classical bacteriophytochromes in the Pfr-form. An alternative 
approach in gaining functional insights into phytochrome is to carry out structural 
analysis on a bathy-phytochrome in its ground state (Pfr) and its adduct with 15Za, 
another locked chromophore which mimics the configuration of BV in the Pr-form 
(Inomata et al., 2006). 
Should the crystal structure of Agp1 in the Pfr-form be solved in the future, the 
information regarding its inter-domain orientation must be interpreted carefully. It was 
shown in Section 3.10.2 that alternative crystal packing causes a difference in inter-
domain orientation between the WT and the SER26 mutant Agp1 structures, and a 
similar effect is also found in Cph1 (Mailliet et al., 2011) and PaBphP (Yang et al., 
2009). Since the crystal packings differ for each crystal form, it may be harder to 
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deduce the mechanism of signal transduction from crystal structures of a phytochrome 
in the Pr- and the Pfr-form than initially expected. For this reason, the full-length 
structure of a phytochrome in combination with results obtained by complementary 
techniques such as electron paramagnetic resonance (EPR) spectroscopy in combination 
with spin labelling may better shed light on the mechanism of phytochrome in the future. 
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Chapter 5: Assessment of the effects of the surface entropy reduction 
strategy 
5.1 Overview 
Introducing mutations involving charge alteration could result in destabilisation or 
unfolding of the protein. Concerns about a decrease in protein solubility and stability by 
SER mutation have been raised in the past. Four mutants of RhoGDI were reported to 
have lower solubility than the WT protein. The mutation comprised replacing the SER 
target residues (Glutamate, lysing or glutamine) with alanine, threonine, or tyrosine 
(Derewenda, 2011). The type of mutations and the magnitude of the decrease in 
solubility were overall consistent with a systematic study on the effect of the type of 
mutation on the solubility of ribonuclease (Trevino et al., 2007). A decrease in protein 
stability was observed in most of single and double SER mutants of RhoGDI, albeit the 
E87A mutant exhibited higher stability than E87D, therefore protein stability appears to 
be not directly correlated with the charge of the amino acid on the surface of the protein 
(Mateja et al., 2002). 
Human RhoGDI is the most extensively characterised protein with regards to the effect 
of SER mutations on crystallisation (Cooper et al., 2007, Keep et al., 1997, 
Longenecker et al., 2001, Mateja et al., 2002). The effect of SER mutation on the 
protein conformation was tested by carrying out structural superpositioning between the 
structures of the WT and SER mutants, and also between different SER mutants (Table 
5.1). Overall no major conformational difference was found between the WT proteins 
and SER mutants, and between one SER mutant to another, hence a SER mutant 
structure may be regarded as a good representative of that of the WT.  
Human vaccinia-related kinase 1 protein is an extreme case where crystallographic 
structural determination was only possible following extensive SER mutations (PDB 
entry 3OP5, Allerston et al., to be published). Eleven SER mutations were introduced 
across four surface patches, which accounts for 3.02% of the primary structure. SER 
mutation is introduced at a more moderate degree in the range from 0.40% for SER2 (2 
mutations / 504 residues) to 1.39% for SER236 (7 mutations / 504 residues) in the 
present study, therefore a less adverse effect, if any, is expected. In the following 
sections, the effects of SER mutations of Agp1 on biochemical properties and 
crystallisation propensity are discussed. 
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5.2 Effect of surface entropy reduction mutation on the solubility of the 
proteins 
The decrease in solubility caused by SER mutations was expected since the 
corresponding structural changes involve replacing the charged residues (Glu and/or 
Lys) with the non-polar Ala (Derewenda, 2011). The yield of soluble protein from 
affinity purification may be regarded as an indication of solubility of the protein the 
cytoplasm of E. coli, but the yield is also affected by multitudes of other factors. To this 
end, an objective study was undertaken to compare the solubility of the WT and mutants 
of Agp1 proteins. Since Agp1 proteins have high solubility in the SEC buffer (Section 
2.2.3.7.6), the relative solubility of the proteins were compared under the presence of 
1.2 M (NH4)2SO4 to emulate the method described in Trevino et al. (2007) as described 
in Section 2.2.4.6. The result is shown in Figure 5.1. SER2-BV and SER3-BV have 
lower solubility than that of the WT M15-BV, with SER3-BV being marginally less 
soluble than SER2-BV. SER6-BV has a higher solubility than the WT M15-BV. The 
presence of the SER6 mutation increases the solubility even in the presence of other 
SER mutation clusters, SER2 and SER3. Solubility of SER26-BV and SER36-BV are 
higher than that of SER2-BV and SER3-BV, respectively. Relative solubility of SER26-
BV and SER36-BV are the same as when those proteins are without the SER6 mutation, 
with SER26-BV being more soluble than SER36-BV.  
The pI is known to influence the solubility of a protein (Tan et al., 1998, Wu et al., 
2010). When the pH of the buffer is equal to the pI of a protein, the net charge of the 
protein is zero. The attractive electrostatic forces due to the dipole moment of the 
protein promote non-specific self-aggregation between proteins. Conversely, charged 
protein will resist aggregation by the repulsive electrostatic force. According to this 
rationale, a mutant protein with a lower pI than Agp1 M15s (pI 5.80) should have 
higher solubility than the WT protein. This will lead to a prediction that a EA 
mutation will impact the solubility while KA mutation will promote solubility by the 
virtue of lowering the pI. Correlation between the calculated pI of proteins and their 
solubility is difficult to establish, however. According to the above rationale, the SER3 
protein (E96A/K97A/K98A) should feature a higher solubility than the SER6 protein 
(E336A/K337A) by the virtue of an additional KA mutation, but SER6-BV had a 
higher solubility even than the WT M15-BV. Solubility of SER23-BV and SER236-BV 
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could not be tested due to being unable to obtain sufficient amount of purified 
apoprotein within the duration of the present study. This could imply that the 
simultaneous presence of SER2 and SER3 mutations, the two mutations that reduces the 
solubility of the protein, synergistically reduced solubility of the proteins to 
significantly reduce the proportion of soluble protein in the E. coli cytoplasm. The 
combination of the two sets of mutations is hypothesised to synergistically create a high 
concentration of hydrophobic residues on the protein surface which impacts solubility 
more than when SER mutation clusters are introduced singly in a limited region. As of 
now little is understood about how a local effect like the interaction between an amino 
acid side chain and the solvent determines a global property such as the solubility of a 
protein. 
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Figure 5.1 The calculated pI and the solubility of BV adducts of Agp1 proteins. A) The 
pI of Agp1 protein variants calculated by Protein Calculator 
(http://www.scripps.edu/~cdputnam/protcalc.html). B) Solubility of Agp1 protein 
variants as quantified spectrophotometrically under the presence of 1.2 M of (NH4)2SO4. 
Introduction of single cluster SER mutations reduces the yields of apoprotein in varying 
degrees depending on the location of the mutation site. 
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5.3 Biochemical verification of the SER mutants 
5.3.1 UV-vis absorption spectroscopy 
The ability to undergo photoconversion is a key aspect of phytochrome function. In 
order to verify their functionality, BV adducts of the SER mutants were tested for the 
ability to form the Pfr-form in response to red light. 
15Ea adducts of Agp1 representing the Pfr-form were omitted from the test, as they do 
not undergo photoconversion. Absorption spectra of 15Ea adducts of SER mutants are 
shown in Section 4.5.1, and they are indistinguishable from the WT holoprotein. 
Absorption spectra of BV adducts of M15s as WT, SER2, SER3, SER6, SER26, and 
SER36 at about 0.1 mg/ml were taken in the Pr-form, the dark adapted from. The ability 
of SER mutants to undergo photoconversion similarly to the WT holoprotein was 
confirmed by illuminating the sample with a red laser (650 +/- 20 nm) until no further 
change in absorption spectrum was observed. In all cases, BV-adducts of all SER 
mutants produced absorption spectra indistinguishable from the WT in both Pr (Fig. 
5.2) and Pfr-forms (Section4.5.1), except for SER36-BV. The slightly different 
spectrum of SER36-BV in the Pfr-form may be attributed to the heterogeneity of the 
sample. The experiment proves that the spectrophotometric properties are not affected 
in most SER mutants. 
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Figure 5.2 UV-vis absorption spectra of BV adducts of SER mutants in the Pr-form and the Pfr-
form. Dark adapted protein samples in the Pr-form were measured first (blue line), then the protein 
solution in the cuvette was exposed to red laser light until no further changes in the spectra was 
observed (red line).  
 
 
  
Chapter 5: Assessing the effects of surface entropy reduction strategy 
222 
 
5.3.2 Size exclusion chromatography 
The tertiary and quaternary structures of the SER mutants were probed with SEC. 
Protein concentrations of the holoproteins (M15s-BV, SER2-BV, SER3-BV, SER6-BV, 
SER26-BV, SER36-BV, M15s-15Ea, and SER2-15Ea) were adjusted to 1 mg/ml. 100 
l of the samples were injected into a 250 l sample loop, and subjected to analytical 
SEC on a Superdex200 column with SEC buffer (Section 2.2.3.7.6). In all cases the 
elution volumes of all SER mutants were similar to that of the WT, therefore the SER 
mutations did not alter the tertiary and quaternary structure significantly (Fig. 5.3). 
Additionally, the SEC elution volume of the 15Ea adducts of the SER mutants were 
smaller than those of the BV adducts. This form-dependence in SEC elution volume is 
in accordance with previous publications for the WT protein (Inomata et al., 2005, 
Noack et al., 2007), and confirms that the SER mutations do not cause major structural 
changes. 
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A 
WT M15s-BV 
 
B 
SER2-BV 
 
C 
SER3-BV 
 
D 
SER6-BV 
 
E 
SER26-BV 
 
F 
SER36-BV 
 
G 
WT M15s-15Ea 
 
H 
SER2-15Ea 
 
Figure 5.3 Elution profiles from analytical SEC on SER mutant holoproteins. Regardless of the 
protein, the elution volume given in ml in each panel is influenced by the chromophore (BV or 
15Ea), suggesting that SER mutation does not alter the tertiary and quaternary structures of the 
holoprotein. Chromatograms were obtained by monitoring absorption at 280 nm. A) M15s-BV; B) 
SER2-BV; C) SER3-BV; D) SER6-BV; E) SER26-BV; F) SER36-BV; G) M15s-15Ea; H) SER2-
15Ea. 
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5.3.3 Circular dichroism spectroscopy of SER holoproteins 
The effect of the SER mutations on the secondary structures of the holoproteins was 
investigated by circular dichroism (CD) spectroscopy in the far-UV range (190 – 260 
nm). Concentrated holoprotein samples at typically 20 mg/ml in IEX start buffer were 
diluted with CD buffer to 0.1 mg/ml. The absorption at 280nm was taken immediately 
prior to the CD measurement, in order to calculate the molar circular dichroism () 
afterwards.  
The results indicate that the proportions of secondary structure elements are comparable 
within the holoproteins with the same chromophore, thus indicating that SER mutations 
do not alter the secondary structure content of the protein (Fig. 5.4). The CD-spectrum 
of SER26-BV stands out from other BV-adducts, but this may be attributed to an 
experimental error during the quantification of the protein concentration. The secondary 
structure content calculated from the structure by DSSP is more consistent with the 
values obtained for other BV-adducts, as calculated from CD spectra.  
There are slight differences in the CD-spectra of adducts of BV and 15Ea. Peaks at 
approximately 193 nm in the spectra of 15Ea adducts are higher than those of BV 
adducts. Additionally, the relative intensities of the two minima (approximately at 210 
nm and 224 nm) in spectra of BV and 15Ea adducts are different i.e. the relative 
intensity of the minimum at 224 nm is higher for the 15Ea adducts. Secondary structure 
content calculated from these spectra reveal no obvious difference between the BV and 
15Ea adducts, however. 
Difference in the secondary structure content of BV and 15Ea adducts of the WT 
protein is discussed in Section 6.4.2. 
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C 
 
Figure 5.4 CD spectra of M15s holoproteins as BV and 15Ea adducts. A) Molar circular dichroism 
() of several holoproteins studied in this thesis. B) Secondary structure content calculated from 
CD-spectra with Dichroweb. C) Secondary structure content of SER26-BV structure, calculated with 
DSSP (Joosten et al., 2011). The proportion of each secondary structure element is given with 
respect to the number of modelled residues.  
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5.4 Correlation between crystal contact mediating epitope and possible 
crystal form 
It was noticed during crystallisation screening that all BV adducts of SER mutants 
produced positive signs of crystallisation under conditions similar to the one which 
leads to crystallisation of the WT M15(s)-BV. Herein, a positive sign of crystallisation 
is subjectively defined as green crystalline precipitate (score 5 in a scheme put forward 
by Benvenuti and Mangani, 2007) or better. In Section 3.7.3, SER3-BV and SER36-BV 
are described to crystallise under the same condition to form the same crystal form, but 
this condition and the crystal form are distinct from those of the WT crystal. This and 
other observations led to hypothesising a correlation between the presence of a 
particular epitope and the possible crystal form of the Agp1 proteins. To this end, 
crystallisation experiments were carried out. It must be noted however, that the 
formation of a nucleus in a crystallisation drop is a stochastic event, therefore a negative 
result does not necessarily prove the inability of a protein to crystallise under a given 
condition. 
Firstly, the solution of the BV adducts of the WT and some SER mutants were adjusted 
to the identical concentration of 25 mg/ml, and subjected to crystallisation under the 
same crystallisation condition as used for the WT M15(s)-BV protein. The results 
indicate positive signs of crystallisation for all holoproteins, albeit with varying degree 
in crystal quality (Fig. 5.5). This shows the capacity of all SER mutants tested in the 
present study to crystallise with what is assumed to be the same form as the WT. If the 
structural information from the WT crystal is reliable, it would have been interesting to 
investigate if the residues participating in the crystal contact of the WT crystal form are 
also conserved in the SER mutants in terms of the structure.  
A similar test was carried out, where SER3-BV, SER36-BV and WT M15s-BV were 
subjected to crystallisation under conditions derived from the (NH4)2SO4-based 
condition identified for SER36-BV. The trial resulted in successful crystallisation of 
SER3-BV and SER36-BV, but not of the WT protein (Fig. 5.6). This is attributed to the 
common presence of the SER3 mutated epitope (E96A/K97A/K98A) to mediate a 
crystal contact that allows for this particular crystal form to appear under (NH4)2SO4-
based conditions. 
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A crystallographic trial to test if the simultaneous presence of SER2 and SER6 
mutations were necessary for the crystallogenesis of SER26-BV protein in a novel form 
would have been interesting. Crystallisation of SER2-BV or SER6-BV with the same 
crystallisation condition as for SER26-BV could not be tested due to the limited time 
available for the present study, but an analysis using the crystal structure of SER26-BV 
is described in Section 5.5. The conclusion from the analysis would mean that the 
simultaneous presence of SER2 and SER6 mutations is necessary for the 
crystallogenesis of SER26-BV. 
Conversely to the above observations, SER26-15Ea crystals were never observed under 
the condition which facilitates the growth of SER2-15Ea. This is different from the 
above cases since an additional SER cluster seems to prohibit the formation of crystals. 
The unexpected absence of SER26-15Ea crystal formation may be due to reasons other 
than the crystallisation propensity of the protein (e.g. sample heterogeneity). An 
alternative proposal is that an additional SER6 cluster might be involved in a formation 
of a new interface between monomers, therefore the equilibrium of thermodynamically 
favourable crystal packing from is slightly shifted from one form to the other, thereby 
inhibiting continuous crystal growth with a consistent lattice. 
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Figure 5.5 Positive signs of crystallisation of the WT and SER mutants. All BV adducts were 
subjected to crystallisation under the optimal crystallisation condition for the WT M15(s)-BV 
protein. A) M15s-BV. B) SER2-BV. C) SER3-BV. D) SER6-BV. E) SER26-BV. F) SER36-BV. In 
all cases, the trial resulted in crystalline precipitate or better. The crystalline precipitates are unlikely 
to be denatured aggregate, since the precipitates samples still retain the green colour, indicative of 
conservation of the tertiary structure in Agp1 holoproteins. 
 
 
  
Figure 5.6 Crystals of SER3-BV and SER36-BV. A) SER3-BV and B) SER36-BV crystals. Both 
crystals were obtained by minor variation of the condition identified for SER36-BV as described in 
Section 3.7.4. 
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5.5 Effect of SER mutation on the crystal packing 
Introduction of SER mutations resulted in crystallisation of M15-BV in alternative 
crystal forms, and the correlation between the presence of a particular epitope and a 
specific crystal form was discussed in Section 5.4. The effect of Ala substitution of 
Glu/Lys residues on crystallogenesis of SER26-BV was investigating by simulating 
simple mutagenesis using the crystal structure of SER26-BV (Fig. 5.7). The “simple 
mutate” function of Coot was used to revert the SER mutations (Site 2, Ala86Glu / 
Ala87Glu; Site 6, Ala336Glu / Ala337Lys), followed by idealization of the geometries 
of the modified residues. Inspection of the two reverted sites in the SER26-BV structure 
indicates that in either case, the original WT residues could cause electrostatic repulsion 
with the residues of symmetry related molecules. The closest distances between Glu 86 
and Glu 87 of one molecule and Glu 489 of a symmetry related molecule are 5.5 and 3.5 
Å, respectively, and the closest distance between Lys 337 of one molecule and Lys 220 
of another symmetry related molecule is 4.8 Å. These observations suggest that 
electrostatic repulsion between equally charged residues in the case of WT M15s-BV 
prevented formation of the novel crystal form that was observed for SER26-BV. 
The rationale behind Ala substitution on Glu/Lys residues in the surface entropy 
reduction strategy is to decrease the surface conformational entropy, but successful 
crystallogenesis of SER26-BV in a new crystal form may also be attributed to resolving 
electrostatic repulsion. 
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Figure 5.7 Possible beneficial effects of SER mutations on crystallogenesis of SER26-BV protein. 
Mutation of SER sites with the original Glu/Lys residues were simulated, followed by idealisation of 
the geometry of the mutated residues with Coot. A) Overview of the locations of the SER mutation 
sites 2 and 6 in the SER26-BV crystal structure. B) Close-up view of SER mutation site 2 
(Glu86Ala/Glu87Ala), C) and of the corresponding site in the WT model. The presence of Glu 
residues in SER site 2 may cause electrostatic repulsion with Glu 489 of a symmetry related 
molecule. Short distances are indicated by broken lines. D) Close up view of SER mutation site 6 
(E336A/K337A), E) and of the corresponding site in the WT model. The presence of Lys in 337
th
 
position may cause electrostatic repulsion with Lys 220 of a symmetry related molecule. 
A 
B 
Site 2 in SER26-BV C 
Site 2 with the WT sequence  
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5.6 Discussion 
A correlation between the presence of an epitope and the form in which Agp1 can 
crystallise was described (Section 5.4). It is difficult to implement this information to 
predict the outcome of a crystallisation experiment ab initio, because at present it is 
impossible to predict the ability of a protein to crystallise in a novel from the amino acid 
sequence alone (e.g. SER26-BV). Nevertheless, it may be an effective approach to carry 
out crystallogenesis optimisation by exploring the SER mutants with common SER 
mutations to the one for which a positive sign of crystallisation has been identified. 
Inspection of the SER mutation site at the molecular level suggests that the successful 
crystallisation of SER26 in a novel crystal form is possibly due to resolving electrostatic 
repulsions, rather than solely to reducing the conformational entropy. This example 
shows that it is difficult to predict the exact effect mutations will impose on 
crystallisation, especially when a change in crystal form is involved. Nevertheless, 
surface entropy reduction and other similar techniques that directly address the 
“crystallisability” of the protein will play increasingly important roles in the future. It 
has been suggested that proteins evolved the “entropy shield” to help retain biological 
function by avoiding non-specific aggregation (Doye et al., 2004). Such notion is in 
accordance with the first of two major bottlenecks which were identified in statistical 
studies from structural genomics; the first of which is to obtain crystals of the target 
protein and the second one is to obtain useful diffraction data which leads to structure 
determination (Terwilliger et al., 2009, Bergfors, 2009: p313). In the present thesis, the 
potential of the surface entropy reduction strategy to tackle both types of bottlenecks 
was demonstrated for two types of holoproteins. The problem of obtaining crystals 
where no previous lead condition has been identified, described as the first bottleneck, 
was solved for the first time by using SER2 to crystallise an Agp1 holoprotein 
containing the locked 15Ea chromophore. While the diffraction datasets of SER2-15Ea 
crystals did not result in the determination of their structure, the success of growing 
crystals at least opens a new avenue for further modification and optimisation to be 
carried out on SER2-15Ea. A solution to alleviate the second bottleneck was 
demonstrated by changing the crystal form of M15s-BV as demonstrated with SER3-
BV, SER36-BV, and SER26-BV. Retrospectively, only one of two novel crystal forms 
of the BV adducts resulted in successful structure determination, and this highlights the 
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importance of carrying out extensive crystallisation trials where the protein itself may 
also regarded as an experimental variable (Longenecker et al., 2001).
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Chapter 6 Biochemical characterisations of Agp1 in different forms 
6.1 Overview 
Structural characterisation of Agp1 in the Pr-form is described in Chapter 3. While the 
present study has led to successful structure determination of this form, the original aim 
of performing an unbiased comparative study on Agp1 structures in two forms was not 
possible because the crystals of the 15Ea-adduct were of insufficient quality for 
structure determination (Chapter 4).  
Furthermore, structural information on phytochrome apoproteins is currently limited. 
All previous attempts to crystallise the WT Agp1 M15 apoprotein failed (N. Krauss, 
personal communication), therefore apoproteins of SER2, SER3, and SER26 mutants 
were screened with JCSG+, PACT-premier, and Morpheus kits (Molecular Dimensions), 
but no lead condition was identified. 
In this chapter, analysis on phytochromes in three forms – apoprotein, BV adduct (Pr-
form) and 15Ea adduct (Pfr-like form) with multitudes of biochemical techniques are 
described in an attempt to characterise the conformational differences between these 
forms. 
6.2 Ion exchange chromatography 
Previously, SEC has been successfully employed to study the conformational change 
associated with the photoconversion of phytochromes (Inomata et al., 2005, Inomata et 
al., 2006, Lamparter et al., 2001). SEC separates molecules according to their Stokes 
radius which depends on the molecular weight and the conformation of the protein, but 
knowledge of only this property could lead to difficulties in differentiating the 
alternative forms of the same protein, even with a column with high-resolving resin 
with appropriate selectivity within a relevant molecular weight range. For example, no 
difference in elution volumes was reported for full-length Agp1 in the Pr and Pfr-forms 
(Inomata et al., 2005). This is because the conformational change was insufficient to 
cause significant difference in the mobility of each form. 
IEX differentiates between proteins according to their net surface charge. It was 
hypothesised that IEX may be more suitable to detect the conformational change that is 
indiscernible by SEC if a conformational change involving a small change in Stokes 
radius results in an altered net surface charge. The use of IEX will not only enable to 
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investigate the presence and the nature of a subtle conformational change, but as a 
practical implication also to purify a conformationally homogeneous species.  
6.2.1 M15 and M20 as apoprotein and BV adduct 
The process of bilin assembly whereby phytochromes acquire the ability to 
photoconvert is not well characterised. Conformational differences between apoprotein 
and holoprotein of Agp1-M15 and Cph1 proteins have been demonstrated with SEC 
(Inomata et al., 2005, Lamparter et al., 2001), but the nature of the conformational 
change associated with the assembly process has not been well characterised. To this 
end, Agp1 M15 and M20 proteins were subjected to IEX using a linear gradient elution 
either as apoprotein or BV adduct. Differences in the elution volume between 
apoprotein and holoprotein were interpreted as to indicate the presence and the quality 
of the conformational change. Additionally, the degree of shift in elution volume 
between M15 and M20 will delimit the location of the conformational change, because 
M20 is shorter than M15 due to the lack of the PHY domain. Such interpretation is 
based on the hypothesis that the nature of the conformational change during the bilin 
uptake is similar between M15 and M20. The hypothesis is deemed plausible given the 
similar increase in the absorbance in the Q-band during the chromophore assembly by 
both M15 and M20 proteins and the structural similarity between SER26-BV (PAS, 
GAF and PHY domains) and DrBphP (PAS and GAF domains) (Chapter 3). 
The GAF domain was hypothesised to be the major site of conformational change as it 
contains the bilin-binding pocket, the major site of protein-chromophore interaction. It 
is immediately obvious by observing the Agp1 and other phytochrome structures that 
the bilin is shielded from the solvent (Fig. 3.27). Similar elution volumes of holoprotein 
and apoprotein of Agp1-M15 protein in SEC rule out an extreme conformational 
difference between the two forms (Inomata et al., 2005), but clearly the apoprotein must 
adopt a different conformation from that of the holoprotein in order to allow for the 
initial uptake of the bilin into the pocket. 
9000 mAU×ml (Section 2.2.3.7.4) of affinity purified M15 and M20 apoproteins were 
prepared either as apoprotein or BV-adduct (Section 3.4.1 and 3.2.1, respectively). 
M20-BV used in this experiment had not been further purified by IEX. Each protein 
was applied to a HiTrap Q column and eluted by a linear gradient from IEX Buffer A to 
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IEX Buffer B over 15 CV with a constant flow rate at 3.5 ml/min (Section 2.2.3.7.4), 
resulting in the chromatograms shown in Fig. 6.1. 
Both M15 apoprotein and holoprotein eluted as two peaks. The earlier main peak and 
the second minor peak were found to consist of monomer and dimer, respectively, as 
shown independently by a native-PAGE and dynamic light scattering (DLS) (Fig. 6.1), 
as well as UV-vis absorption spectroscopy (Fig. 6.2). It is interesting that the proportion 
of the dimer is higher in the apoprotein, which is discussed in more detail in Section 
6.2.2. The elution volumes of both monomer and dimer peaks are lower in case of M15-
BV compared to the apoprotein. This indicates that the BV assembly process involves a 
reduction of the net negative charge on the protein surface in both monomer and dimer. 
The elution profiles of M20 proteins are different from that of M15. The M20 
apoprotein eluted as the dimer in a single peak only, and the equivalent peak is also 
present in the chromatogram of M20-BV (Fig. 6.1). The constituent of the peaks were 
analysed by UV-vis absorption spectroscopy (Fig. 6.2). The presence of the apoprotein 
peak in the chromatogram of the holoprotein indicates that the BV assembly process is 
inefficient in M20. M20-BV eluted in two peaks, but both peaks were found to consist 
of the monomeric form. This indicates that M20-BV exists predominantly in the 
monomeric form, whereas the apoprotein has a strong propensity to form a dimer even 
more effectively than M15. This is surprising because the shorter M20 has a smaller 
dimer interface area than M15, but its strong propensity to form a dimer may be 
rationalised by formation of an inter-molecular disulphide bond which is discussed in 
Section 6.5.1. The difference in the elution volumes of apoprotein and holoprotein is of 
practical importance as it enables the separation of apoprotein and holoprotein of M20, 
a protein whose BV assembly is inefficient. In terms of conformational difference 
between apoprotein and holoprotein of M20, no direct comparison could be made based 
on their elution volumes because the oligomeric state is different.  
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Figure 6.1 Conformational differences between Agp1-M15 and M20 in the apo- and holoprotein 
forms. Analytical ion exchange (IEX) chromatograms of (A) Agp1-M15 holoprotein, (B) Agp1-M20 
holoprotein, (C) Agp1-M15 apoprotein, and (D) Agp1-M20 apoprotein. Values indicated next to the 
peaks are elution volumes from the start of the linear gradient. (E) A native-PAGE gel showing the 
peak-containing fractions from the IEX analyses. Based on the relative migration rates of the bands 
and the molecular weight of the monomer of each protein, the oligomerisation state was assigned to 
each band. (F) Results from DLS of the peak fractions from IEX chromatography. The measured 
approximate values of the molecular weight are in agreement with the relative molecular weights 
determined by native-PAGE. The blue, brown, and green lines indicate the absorption (mAU at 280 
nm), conductivity (mS/cm), and buffer volume ratio A/B (%), respectively. 
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6.2.2 M15s as apoprotein, BV adduct, and 15Ea adduct 
IEX was also employed to probe the conformational change associated with 
photoconversion. To emulate the approach described in Section 6.2.1, Agp1 M15s 
fragments as apoprotein, BV-adduct or 15Ea adduct were subjected to analytical IEX. 
3000 mAU×ml of Agp1 M15s as either apoprotein, BV adduct, or 15Ea adduct were 
applied and subjected to analytical linear gradient elution as described in Section 
2.2.3.7.4. For the M15s apoprotein and the BV-adduct, qualitatively similar elution 
profiles to the previously observed ones (Section 6.2.1) were obtained (Fig. 6.3). 
Elution profiles of these proteins are characterised by the earlier main peak and the later 
minor peak that correspond to the monomer and the dimer, respectively. Both peaks of 
M15s-BV have smaller elution volumes than the corresponding peaks for M15s 
apoprotein. M15s apoprotein has a higher proportion of the later minor peak compared 
to M15s-BV. The elution profile of M15s-15Ea was characterised by a single peak with 
an elution volume of 58.73 ml which was presumed to correspond to the monomer peak 
of M15 apoprotein and the BV-adduct. In terms of the elution volumes, the difference 
between the 15Ea adduct and the apoprotein is smaller than the difference between the 
BV adduct and the apoprotein. Nonetheless, despite its low magnitude the difference in 
the elution volumes provides an opportunity to separate the 15Ea adduct from the 
apoprotein as demonstrated in Section 4.4.1. Overall, the differences in elution volumes 
of the main peaks amongst apoprotein, BV adduct, and 15Ea adduct are not drastic. 
The fact that the 15Ea adduct elutes as a single peak whereas the BV adduct and the 
apoprotein elute as in monomer and dimer may enable to rationalise the relative kinase 
activity in terms of the proportion of the dimer in the sample. It has been reported that 
the relative kinase activities of Agp1 as apoprotein, in the Pr-form, and in the Pfr-form 
are 130%, 100%, and 19%, respectively (Inomata et al., 2005). Agp1 is a histidine 
kinase and formation of a parallel dimer is essential for its kinase activity. 
Determination of the area of peaks in the chromatograms in Fig. 6.3 indicates that the 
dimer peaks of the apoprotein, BV-adduct, and 15Ea amounts to 28.21%, 13.67%, and 
0% of the total peak area, respectively. Interestingly, the decreasing order of the dimer 
peak proportions of these proteins accords with their relative kinase activities. Any 
model which describes the kinase activity derived from IEX data must be approached 
carefully, however. Firstly, these experiments were carried out with a truncated 
construct lacking the HK domain, and secondly the buffers of the protein samples were 
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adjusted to that of “IEX buffer A” with no salt prior to application to the IEX column. A 
buffer condition of low ionic strength with little physiological relevance may affect 
hydrophobic and/or ionic interactions at the dimer interface, therefore the proportion of 
dimer at the start of the analytical IEX may not reflect that in the in vivo condition. 
Therefore, while this idea is interesting, another technique must be employed to 
quantify the proportion of the dimer at biologically relevant ionic strength in order to 
make this hypothesis a valid one. 
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Figure 6.3 IEX elution profiles of Agp1 M15s proteins in three forms. A) M15s apoprotein, elution 
volume: 60.02 ml. B) M15s-BV holoprotein, elution volume: 57.46 ml. C) M15s-15Ea holoprotein, 
elution volume:58.73 ml. The blue, brown, and green lines indicate the absorption (mAU at 280 nm), 
conductivity (mS/cm), and buffer volume ratio A/B (%), respectively. 
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6.2.3 Full-length protein as apoprotein, BV adduct and 15Ea adduct 
Studies on conformational differences between forms of Agp1 with analytical IEX were 
extended to full-length Agp1. Full-length Agp1 includes a C-terminal HK domain 
which changes its activity according to the photochromic state of the phytochrome 
(Inomata 2005), therefore any conformational change in the HK domain may be 
detectable by IEX, especially since there was no major difference in the elution volume 
of the main peaks of M15 apoprotein, BV adduct, and 15Ea adduct. 
1500 mAU×ml of full-length Agp1 either as apoprotein, BV adduct, or 15Ea adduct 
were eluted by a linear gradient from a HiTrap Q column (Section 2.2.3.7.4). 
Composition of the peak-containing fractions were analysed by absorption spectroscopy 
and SDS-PAGE (Fig. 6.5). The apoprotein and the BV adduct eluted at similar volumes 
of 60.53 ml and 60.09 ml, respectively, whereas the elution volume of the 15Ea adduct 
was distinctly different (47.11 ml; Fig. 6.4). 
Given that no major differences in elution volumes were observed for three forms of 
M15s, the distinctly earlier elution of the 15Ea-adduct of full-length Agp1 is attributed 
to a unique property of the HK domain in the Pfr-form. The smaller elution volume of 
the 15Ea adduct may be caused either by a unique conformational change of the HK 
domain in the Pfr-form, altered oligomerisation state, or combination of both. In either 
cases the unique tertiary and/or quaternary structure of full-length Agp1 in the Pfr-form 
may help to rationalise its low kinase activity (19%) relative to the apoprotein (130%) 
and the Pr-from (100%) (Inomata et al., 2005).  
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Figure 6.5 SDS-PAGE analyses of the fractions containing the main peaks of the IEX on full-length 
Agp1 proteins in three forms. Lane 1, Apoprotein fraction A4; Lane 2, BV adduct fraction A4; Lane 
3, 15Ea adduct fraction B6; M, SN2 marker. 
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6.3 Native-PAGE 
In addition to IEX, a complementary technique was deemed informative to probe the 
oligomerisation properties of Agp1. A rudimentary analysis of the oligomerisation 
properties of Agp1 was carried out by subjecting fragments of Agp1 in varying lengths 
to native-PAGE (Fig. 6.6). M15 and M20 proteins were tested as apoprotein and BV 
adduct. The first observation is that oligomerisation is observed in all combinations, 
although the extent of orders of oligomerisation depends more on the construct type 
(M15 and M20) rather than the form of the protein (apoprotein and BV-adduct). An 
oligomeric state of a higher order than the dimer is observed for M15, and oligomeric 
states of one order higher (trimer?) and two orders higher (tetramer?) can be clearly 
identified for the BV-adduct and the apoprotein, respectively. An oligomeric state of a 
higher order than the dimer is not clearly visible for M20 proteins. 
Given the same construct and the same oligomeric state, the BV-adducts migrate faster 
for both M15 and M20 proteins under the same experimental condition (pH 8.8). This 
observation may be a contrast to the result of analytical IEX which suggested the net 
negative charges of apoproteins are greater than the BV-adduct in IEX buffers (pH 8.0) 
(Section 6.2.1). This apparent contradiction may be rationalised that in a native-PAGE 
gel, the rate of migration of proteins is affected by the protein conformation in addition 
to the net surface charge.  
The conclusion that can be drawn from the analysis with native-PAGE is that the 
conformational change associated with BV assembly and its effect on the mobility in a 
native-PAGE gel is conserved between M15 and M20, therefore the likely site of 
conformational change is common between them, within the CBD (PAS-GAF domains). 
 
Figure 6.6 Native-PAGE analysis on Agp1 fragments as apoprotein and BV adduct. The volumes 
correspond to the volumes of the samples (5 mg/ml) per lane. The volumes of sucrose loading 
solution per lane were constant at 2 l. 
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6.4 Hydrophobic interaction chromatography 
HIC, like IEX, is a technique where proteins are separated according to the affinity of 
the proteins to the stationary phase of the column. The affinity in case of HIC is 
determined by the hydrophobicity of the protein surface. The hydrophobic interaction 
increases with higher ionic strength, and the protein is eluted with a buffer of lower 
ionic strength. A conformational change may involve a change in net surface 
hydrophobicity as well as in net surface charge, therefore HIC was also anticipated to 
provide information regarding the nature of conformational differences of Agp1 in 
different forms. HIC was employed to purify the DrBphP holoprotein from an 
inhomogeneous mixture, where the separation of proteins was presumably based on the 
same principle as discussed above (Auldridge et al., 2012). 
6.4.1 M15s as apoprotein, BV adduct, and 15Ea adduct 
M15s fragments of Agp1 as apoprotein, BV adduct, or 15Ea adduct were eluted by a 
linear gradient from HIC Buffer A to HIC Buffer B using a HiTrap Phenyl HP column 
(Section 2.2.3.7.5). The elution profiles of these three forms of the M15s protein were 
essentially identical, with all of them eluting at 100% HIC buffer B (20 mM Tris-HCl 
pH 7.8 at 20C, 1 mM EDTA) (Fig. 6.7). The elution profiles indicate that the net 
surface hydrophobicities are equally high for all forms of the M15s protein. Similar 
elution volumes of the three forms of the M15s protein indicate that hydrophobicities of 
the protein surfaces of those proteins are similar despite conformational differences 
between them. 
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Figure 6.7 HIC elution profiles of Agp1 M15 proteins in three different forms. A) M15s apoprotein, 
57.15 ml, B) M15s-BV holoprotein, 56.47 ml C) M15s-15Ea holoprotein, 56.97 ml. The blue, 
brown, and green lines indicate the absorption (mAU at 280 nm), conductivity (mS/cm), and buffer 
volume ratio A/B (%), respectively. 
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6.4.2 Full-length protein as apoprotein, BV adduct and 15Ea adduct 
In IEX, similar elution volumes were observed for the main peaks of M15s as 
apoprotein, BV adduct and 15Ea adduct, but substantial differences were found when 
the experiment was repeated with the full-length Agp1 protein which was interpreted to 
reflect the conformational difference of the HK domain. In order to investigate if 
differences in net surface hydrophobicity exist between apoprotein, BV adduct and 
15Ea adduct of full-length Agp1, analytical HIC was also applied to full-length Agp1 
proteins in these three forms using a HiTrap Phenyl HP column(Section 2.2.3.7.). 
Similarly to the results from analytical HIC with M15s proteins, the three forms of full-
length proteins all eluted at 100% HIC Buffer B, thus indicating the absence of 
substantial difference in the net surface hydrophobicity (Fig. 6.8). Analytical HIC could 
not reveal a conformational difference amongst them in a way that IEX could, and no 
further effort was made in the present study to utilise HIC to probe the conformational 
difference of the proteins. 
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Figure 6.8 HIC elution profiles of Agp1 full-length proteins in different forms. A) Full-length 
apoprotein, B) Full-length-BV holoprotein, C) Full-length-15Ea holoprotein. The blue, brown, and 
green lines indicate the absorption (mAU at 280 nm), conductivity (mS/cm), and buffer volume ratio 
A/B (%), respectively. 
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6.5 Flexibility of the N-terminal region 
The N-terminal region was assumed to be involved in a conformational change during 
the bilin assembly process because it shields the bilin from the solvent in the 
holoprotein structure. The N-terminal region also has an additional role of supplying the 
conserved Cys residue for the formation of a covalent bond with BV in 
bacteriophytochromes. Analysis of the N-terminal region of Agp1 may reveal the 
difference in functional roles played by this region in bacterial and cyanobacterial/plant 
phytochromes. 
6.5.1 Apoprotein dimerisation via the N-terminal Cys residue  
During a quality check of purified proteins with non-reducing SDS-PAGE, it was found 
that M15 and M20 apoproteins migrate unusually as dimers, but only if the free thiol 
was available at Cys 20 (Fig. 6.9A). Under the same condition, M15-BV and M15 
C20A apoprotein migrate as monomers. The commonality between them is the lack of a 
free cysteine at the 20
th
 position. A small amount of dimer was observed for M20-BV 
which had not been purified by IEX, therefore the presence of M20 apoprotein was 
likely. The M20 apoprotein consists of higher proportion of dimers than the M15 
apoprotein. Interestingly, the persistence of the dimers under the presence of SDS 
indicates that a covalent bond mediates the dimerisation between the apoproteins. When 
the apoproteins that migrated as dimers under a non-reducing condition were subjected 
to reducing SDS-PAGE, both M15 and M20 apoproteins migrated as monomers, 
indicating that a disulphide bond mediates the dimerisation of apoproteins (Fig. 6.9B), 
thus confirming the earlier assumption that the free thiol group at the 20
th
 position is the 
prerequisite for the formation of the dimer. 
It was concluded that Agp1 apoproteins can dimerise via a disulphide bond at the 
conserved cysteine residue in the N-terminal region. The apoprotein dimerisation shown 
in Fig. 6.9 probably occurred as a result of gradual oxidation of the thiol group by 
oxygen during storage. The higher proportion of dimer in M20 than in M15 
preparations after storage over a comparable period may be explained by the mode of 
protein-protein interaction being dominated by a larger natural interface in M15 rather 
than via disulphide bond. Oxidation of the thiol group is slow, and to this end, the 
samples were incubated under the presence of an oxidising agent, Potassium 
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hexacyanoferrate (III) (potassium ferricyanide, K3[Fe(CN)6]) to accelerate the oxidation 
prior to investigating the effect of an oxidising agent on Agp1. 
Agp1 M15(s), the M15 C20A mutant, and M20(s) either as apoprotein or BV adduct at 
a concentration of 1 mg/ml were incubated for 15 minutes at 20C in darkness under the 
presence of either 3 mM potassium ferricyanide or DTT to oxidise or reduce thiol group, 
respectively. Proteins were analysed by non-reducing SDS-PAGE (Fig. 6.10). Those 
proteins incubated with DTT migrated as monomers, and a minor difference in 
migration rate between the M20s apoprotein and M20-BV is attributed to the lack of 
first nine residues by the N-terminus in the former. The M15s and M20s apoproteins 
incubated with potassium ferricyanide migrated as dimers, whereas the proteins which 
lack the free cysteine at the 20
th
 position migrated as monomers. The presence of a 
small amount of monomer in the oxidised M15 apoprotein is attributed to insufficient 
incubation time. It can be ruled out that an insufficient amount of oxidising agent was 
responsible for incomplete oxidation of the thiol groups, since potassium ferricyanide 
was present in high molar excess at 3 mM, compared to the M15s apoprotein at 0.0182 
mM. The presence of some dimer in the oxidised M20 holoprotein is attributed to a 
small contamination by some M20 apoprotein, as the sample used here had not been 
purified by IEX. 
It is in general difficult to estimate the purity of the phytochrome holoprotein in a given 
sample by absorption spectroscopy. Since the formation of dimers via disulphide bonds 
at the conserved cysteine residue is specific to the apoproteins, detection of dimers may 
be utilised as a method to directly prove the presence of apoprotein in a sample. This 
method will be advantageous compared to using the SAR value as a criterion for purity 
which does not allow for an explicit quantification of the amount of the apoprotein in a 
sample. In order to test the applicability of this method to Agp1 proteins of various 
lengths, apoproteins of M15, M20, and full-length Agp1 at a concentration of 1 mg/ml 
were incubated with 4 mM of either DTT or potassium ferricyanide for 30 minutes 
before being subjected to non-reducing SDS-PAGE. Apoproteins of M20, M15, and 
full-length all formed dimers under the presence of the oxidising agent, thus 
demonstrating the applicability of this method using potassium ferricyanide in detecting 
apoproteins of various Agp1 fragments (Fig. 6.11).  
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Figure 6.9 SDS-PAGE gels showing redox condition dependent migration patterns of by some Agp1 
proteins. 20 g of proteins were loaded per lane. A) Different forms of Agp1 proteins were subjected 
to SDS-PAGE with non-reducing SDS loading solution. Dimers of M15 and M20 apoproteins were 
detected despite the presence of SDS. Proteins with no free thiol group at Cys20 residue did not form 
dimer, except for M20-BV which contained an apoprotein contamination. B) Apoproteins of M15 
and M20 which formed dimers were subjected to SDS-PAGE using reducing SDS loading solution 
in increasing quantity. The numbers indicate the volume of 4 × SDS loading solution in l used per 
20 g of protein sample. 
 
 
Figure 6.10 Non-reducing SDS-PAGE gel showing the efficacy of potassium ferricyanide in 
inducing the formation of apoprotein dimers via disulphide bond formation. 5 g of protein was 
loaded with 2 l of 4 × SDS(non-reducing) loading solution per lane. MW marker, Applichem marker 3 
l. 
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Figure 6.11 Non-reducing SDS-PAGE gel showing the occurrence of apoprotein dimerisation in 3 
constructs of Agp1 of differing lengths. 5 g of protein per lane. MW marker, Applichem marker 5 
l. The contrast of the MW marker lane was altered to aid visibility. 
 
  
Chapter 6: Biochemical characterisation of Agp1 in different forms 
253 
 
6.5.2 N-terminal region and bilin binding 
To date, all phytochrome structures have been solved as the holoprotein. The 
holoprotein structures have in common that the GAF domain, and also the PAS domain 
if present, form the solvent shield round the bilin moiety, and it is obvious that the N-
terminal region of the apoprotein must be in a conformation different from that of the 
holoprotein to allow for the initial bilin binding to occur. The inter-molecular disulphide 
bond at the N-terminal region (Section 6.5.1) is in accordance with the notion that this 
region in the apoprotein is flexible. 
It is difficult to relate the conformational change of the N-terminal region and the 
mechanism of bilin assembly. The solvent exposed thiol side chain of Cys 20 may be 
hypothesised to recruit the bilin in the solvent by acting as the “bait”, akin to proteins 
that function by the “fly-casting” mechanism (Huang and Liu, 2009). The available data 
contradicts such a model, however. It was shown in Section 4.2.2 that assembly of 
M15-15Ea involves the initial binding between the apoprotein and the bilin, followed by 
slow formation of the covalent bond, of which the latter leads to an increase in the 
absorbance in the Q-band and red-shifting of the absorption peak. Assembly with 15Ea 
is not a good representative of the process in nature, but a similar observation was made 
during the assembly of a non-covalent adduct, between the M15 C20A mutant and BV, 
which exhibited a blue-shifted peak and lower absorbance in the Q-band than the 
equivalent adduct with a covalent bond. Therefore, the assembly process is likely to 
consist of the initial binding followed by the formation of the covalent bond. 
The role played by the N-terminal region has changed for some phytochromes during 
the course of evolution. In bacteriophytochrome, the N-terminal region shields the BV 
from the solvent as well as supplying the conserved Cys for the covalent bond. As the 
chromophore-binding Cys residue moved from the N-terminal region to the GAF 
domain in cyanobacterial and plant phytochromes, the N-terminal region was relieved 
from one of its functions. Sequence alignment of the N-terminal region reveals that the 
PG motif is unique to bacteriophytochromes (Fig. 6.12). This motif located beneath the 
“trefoil knot” (Wagner et al., 2005) may be functionally important for the binding 
between bacteriophytochromes and BV, but not for the binding of PB by plant 
phytochromes or PCB by cyanobacterial phytochromes. Structures of the region 
surrounding the PG motif in bacteriophytochromes and the equivalent in Cph1 reveal 
generally conserved molecular interactions despite dissimilar primary structure, 
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however. Interestingly, the PG motif is present in CEA001-RpBphP4, an achromo-
phytochrome, although it does not even form a non-covalent adduct with BV. This 
could be because the presently functionally redundant PG motif in CEA001-RpBphP4 
may not have been subjected to silent mutation yet. 
 
 
Figure 6.12 The PG motif in bacteriophytochromes. A) Sequence alignment of the PG motif and the 
interacting residues. In most cases, the molecular interactions are limited to main chain interactions 
and are mostly conserved between bacterial and cyanobacterial phytochromes. Functional 
importance of the PG motif in bacteriophytochrome is implied by its strong conservation, 
presumably because of its specific role in BV incorporation in bacterial, but not in plant and 
cyanobacterial phytochromes. The apparent lack of the equivalent interaction between Gly 29 and 
Leu 236 of Agp1 in PaBphP and RpBphP3 may be due to no mediating water molecule being 
modelled owing to their lower resolution data. Solid lines representing polar interactions are 
associated with a description of the type of interaction (direct or solvent mediated), and coloured 
alphabets indicate the atoms involved in the interaction. B) The PG motif in Agp1, shown as sticks 
along with the interacting residues. The protein is shown in cartoon representation. The PAS and 
GAF domains are coloured in red and blue, respectively.  
A 
B 
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6.6 Circular dichroism spectroscopy 
A conformational difference between the apoprotein and the holoprotein of M15 could 
be detected by IEX, but IEX could not delimit the region of conformational difference 
(Section 6.2.1). To investigate if the conformational change during the bilin assembly 
process is associated with a change in the secondary structure content, CD spectra were 
obtained for M15s and M20s proteins as apoproteins and BV adducts. Spectral 
differences between the apoprotein and the holoprotein would indicate a change in the 
secondary structure during the assembly process. Furthermore, by comparing the degree 
of the difference between M15 and M20, the site of conformational change may be 
narrowed down because M20s is shorter due to the lack of the PHY domain. CD 
spectroscopy is advantageous over IEX, because it is not directly affected by the 
oligomeric state of the protein. 
Also, based on the “context dependent conformation” of numerous conserved residues it 
was suggested in Chapter 3 that a dynamic conformational change is associated with the 
photoconversion from the Pr- to the Pfr-form. The hypothesis was tested by CD 
spectroscopic analysis of the M15s protein as BV and 15Ea adducts, representing the 
Pr- and the Pfr-forms, respectively. 
6.6.1 M15 and M20 as apoproteins and BV adducts 
CD spectra of M15s and M20s fragments of Agp1 as apoproteins and BV adducts were 
obtained in the far-UV range (185 – 260 nm). Differences in the spectra were observed 
between apoprotein and BV adducts for both M15s and M20s, but the degree and the 
quality of the change was not consistent between M15s and M20s (Fig. 6.13A). This is 
possibly due to the errors introduced during the quantification of the protein 
concentrations. 
Using the SER26-BV structure, the secondary structure contents of M15s-BV and 
M20s-BV were calculated, based on the assumption of structural isomorphism between 
the CBD and PCM fragments (Fig. 6.13C). A reasonable correlation was found between 
the secondary structure contents calculated from the CD spectra and the values 
calculated from the SER26-BV structure.  
Overall, the differences in the secondary structure content between the apoprotein and 
the BV-adduct of the same fragment (M15s or M20s) are less significant than between 
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M15 and M20. Therefore, according to CD spectroscopic analysis the Agp1 apoprotein 
have a comparable degree of secondary structure elements as the BV-adduct. 
 
 
 
Figure 6.13 Secondary structure analyses on Agp1 M15s and M20s proteins. A) CD spectra of M15s 
and M20s proteins as apoproteins and BV adducts. Molar circular dichroism () is plotted as a 
function of wavelength (nm). B) Secondary structure contents of these proteins calculated using the 
DICHROWEB server. C) Proportion of secondary structure elements of the structure of SER26-BV, 
and of the M20 equivalent part of the structure. The calculation was carried out with DSSP. 
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6.6.2 M15 as BV and 15Ea adducts 
In the crystal structure of phytochromes, conformational differences are found between 
those in the Pr- and the Pfr-form, for example the Tongue of the PHY domain comprises 
two anti-parallel -sheets in the Pr-form and coils and an -helix(ces) in the Pfr-form. 
Such differences manifest in the proportion of secondary structure elements in each 
structure (Fig. 6.14). The PaBphP structure in the Pfr-form features a lower proportion 
of -strands and a higher proportion of loops than those structures which are in the Pr-
form. The secondary structure content calculated from the structures, however, must 
only be regarded as a rough indication of the true proportion of the secondary structure 
elements. Crystallographic structures, especially the ones that were solved from lower 
resolution datasets often have un-modelled segments. The figures quoted in Fig. 6.14 
are always shown as percentage relative to the total number of modelled residues, so the 
accuracy depends on the degree of disorder of the crystal structures.  
If the conformations found in the Pr- and the Pfr-forms of phytochromes represent the 
two end points of the photoconversion trajectory, such changes may be detected by CD 
spectroscopy, and to this end, CD spectra of M15s as BV adduct and 15Ea adduct 
representing the Pr- and the Pfr-form, respectively, were collected (Fig. 6.15). 
Only slight changes in proportions of secondary structure element were found between 
the BV and 15Ea adducts of the M15s protein. The 15Ea adduct representing the Pfr-
form showed a 1% higher content of -helix, a 1% lower content of disordered regions, 
and the same proportion of -sheet structure when compared to the BV adduct. These 
data are difficult to relate to the differences in the secondary structure contents of 
phytochrome crystal structures in the Pr- and the Pfr-forms. Changes in the secondary 
structure contents by few per cents in a relatively large protein (Agp1 M15s = 54 kDa) 
are close to the limitation of CD-spectroscopy, because the results are greatly affected 
by an inaccuracy during the quantification of the protein concentration. 
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Figure 6.14 Proportion of secondary structure elements in phytochrome PCM structures. 
Calculations were performed with DSSP, and the proportion is relative to the total number of 
modelled residues. Care must be taken to interpret the secondary structure contents, because the 
degrees of disorder that affect the values differ between the structures. The structures used for the 
analysis and their PDB accession codes are as follows. Agp1 SER26-BV (N/A), PaBphP (3C2W and 
3G6O), Cph1 (2VEA and 3ZQ5). The PaBphP structure with PDB code 3IBR was omitted due to 
the lower quality of the data and a very similar proportion of secondary structures as in the structure 
with PDB code 3G6O. 
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Figure 6.15 Secondary structure analysis of the M15s protein in the Pr and the Pfr-like forms. A) 
CD spectra of M15s-BV and M15s-15Ea presented as molar circular dichroism () plotted as a 
function of wavelength (nm). Higher absolute values at   193 nm and   225 nm in the 15Ea 
adduct indicates a higher proportion of -helices. B) Secondary structure contents of M15s-BV and 
M15s-15Ea calculated using DICHROWEB server. 
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6.7 Discussion and future works 
6.7.1 Conformational differences between different forms of Agp1 
Combinations of biochemical approaches have revealed some aspects of conformational 
differences between Agp1 in different forms. The flexibility of the N-terminal region is 
suggested to facilitate the initial diffusion of BV into the bilin pocket. M15 fragments as 
apoprotein, BV- and 15Ea adduct did not show major differences in IEX elution 
volumes, but when the experiment was repeated with the full-length protein, the elution 
volume of the 15Ea adduct was distinctly different. This larger elution volume by the 
15Ea adduct is likely to be a conformational difference at the HK domain, and this in 
turn could explain the lower kinase activity by the Pfr-form compared to other two 
forms. 
CD spectroscopy on M15 and M20 fragments of Agp1 as apoprotein and BV-adduct has 
shown that no substantial difference in proportions of secondary structure elements is 
present between BV-adduct and apoprotein. This indicates that phytochrome apoprotein 
structure, which to date little detail is known, features similar secondary structure 
contents to that of the BV adduct, both as M20s and M15s fragments. The apoprotein 
therefore, is as well-folded as the BV-adduct holoprotein, and conformational 
differences detected by IEX is due to changes in the tertiary structure rather than the 
secondary structure. 
CD spectroscopy on M15 proteins as the BV- and the 15Ea-addcut did not indicate a 
major difference in the secondary structure content between them, at least not in the 
scale of the difference between phytochrome PCM crystal structures in the Pr- and Pfr-
form. This is experimental evidence against a hypothesis that phytochrome crystal 
structures in the Pr- and the Pfr-forms represent the end points of the photoconversion 
(Section 3.11.4). Perhaps the conformational change during the photoconversion 
involves changes at the tertiary structure level and relatively small changes in the 
secondary structure. Observations such as the difference in SEC elution volumes of 
phytochromes in the Pr- and the Pfr-forms (Section 5.3.2) may be rationalised by a 
difference in the global conformational differences (Section 3.10.2), but without a 
structural evidence, all proposals remain to be a mere speculation. Therefore it is ever 
more important to solve the structure of phytochrome in its photoconverted state as well 
as its ground state. 
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6.7.2 Oligomerisation properties of Agp1 
Analysis with native-PAGE indicated two aspects of the oligomerisation properties of 
Agp1. 
The first point is that the affinity between monomers is such that in a native-PAGE, a 
larger proportion of protein was found in the monomeric form than in the dimeric form. 
This is consistent with the result from IEX runs using M15 fragments (Section 6.2.1). 
Seemingly weak affinity between monomers to form a dimer may be correlated with the 
fact that Agp1 lacks an Arg residue at the 131th position which is implied to play a key 
role in dimerization (Bellini and Papiz, 2012a). 
Secondly, Agp1 M15 oligomers of clearly higher order than the dimer were observed. 
This is consistent with some previous observations (Noack et al., 2007, Scheerer et al., 
2010). Since the order of oligomeric states increases sequentially (Dimer, trimer and 
then tetramer, Noack et al., 2007), the observation is unlikely to derive from non-
specific inter-molecular aggregation. No functional role of the higher order oligomeric 
states of phytochrome has been characterised. Current lack of information regarding the 
molecular interface of higher order oligomers does not permit a study of the nature of 
the interface using an electrostatic surface potential of Agp1 (Figure 3.31). Since the 
experiment with a native-PAGE gel was carried out with the M15 fragments, the 
formation of higher order oligomers is mediated by the N-terminal region of Agp1. 
Higher order oligomers were observed in the M15 fragments in the present study, but 
neither the data presented here nor a study by Noack et al. (2007) exclude a possibly for 
the C-terminal HK to also mediate the formation of higher order oligomers in the full-
length Agp1 protein.  
6.7.3 Hydrophobic interaction chromatography 
No major differences in elution volumes were found between the apoprotein, BV adduct, 
and 15Ea adduct of Agp1 with HIC, regardless of the length of the protein used (full-
length or M15). Therefore it was not possible to purify the Agp1 holoprotein from the 
apoprotein with the HIC column, but this is in contrast from the reported case where BV 
adduct of DrBphP CBD was successfully purified with a HIC column with the same 
functional group (phenyl sepharose column, Auldridge et al., 2012). Difference between 
Agp1 and DrBphP may be attributed to the difference in the lengths of the proteins used 
during HIC purification, but it is also possible that the degree and the nature of the 
Chapter 6: Biochemical characterisation of Agp1 in different forms 
262 
 
change at the protein surface during bilin assembly to differ between phytochromes. 
This hypothesis may be confirmed by measuring the elution volume of Agp1 M20s 
protein as apoprotein and BV adduct. 
6.7.4 Disulphide bond formation 
Intermolecular disulphide bond formation was shown to form via Cys 20, but this mode 
of dimerisation was regarded to be physiologically irrelevant, at least in A. tumefaciens. 
Under the native condition in A. tumefaciens, the phytochromes are only expressed at 
low concentrations of 10 and 19 molecules per cell for Agp1 and Agp2, respectively 
(Oberpichler et al., 2006). Given the continuous production of BV by heam oxygenase, 
BV molecules are assumed to saturate the free thiol groups of apo-phytochromes. 
CEA001-RpBphP4, an achromo-phytochrome that functions as a redox-sensor which 
does not even form a non-covalent adduct with a bilin has been reported to undergo 
redox-state dependent oligomerisation via Cys residues (Vuillet et al., 2007). The way 
CEA001-RpBphP4 apo-phytochrome forms oligomer via disulphide bond is 
superficially similar to the intermolecular disulphide observed in Agp1 apoproteins, but 
functional role of oligomerisation by these two phytochromes are expected to be 
different. For example, the positions corresponding to Cys 472 and Cys 722, the Cys 
residues that are implied to be important for redox-state dependent oligomerisation in 
CEA001-RpBphP4 are usually occupied by Ser and Leu, respectively, in chromophore-
binding bacteriophytochromes including Agp1.
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Chapter 7: Overall summary 
In the present study, the structure of Agp1, a bacteriophytochrome, was solved as a 
photosensory core module fragment in the Pr-form. As far as is known, this is the first 
time that the entire photosensory core module fragment of a classical 
bacteriophytochrome has been structurally determined. 
The structure of Agp1 resembles the cyanobacterial phytochrome Cph1 in terms of its 
global conformation. The similarity is significant considering the differences between 
those two phytochromes with regards to the type of the bound bilin chromophore and 
the location of the chromophore-binding cysteine residue, and as expressed by the 
distance in molecular phylogeny. Therefore we can now be confident that the global 
conformations of these structures are valid representatives of the Pr-form of 
phytochromes as a whole. 
Molecular interactions found in Agp1, on the other hand, resemble the 
bacteriophytochrome DrBphP more closely than Cph1. This is thought to correlate with 
the functional differences between cyanobacterial phytochromes and 
bacteriophytochromes, such as the ability of bacteriophytochromes to undergo dark-
reversion from the photoconverted state into the dark-adapted state, which is absent in 
cyanobacterial phytochromes. 
An open question remains as to whether the bathy-phytochrome structures are suitable 
to represent key features of the photoconverted state of the classical phytochromes. 
There are now two representatives of bathy-phytochrome structures, and they too show 
structural similarities to each other despite a significant phylogenetic distance between 
them. Furthermore, some residues that stabilise their structures in the Pfr-form are not 
conserved. Structural similarities between two phylogenetically distant bathy-
phytochromes reinforce the notion that their global conformations represent the Pfr-
form for all phytochromes. The situation leaves open the possibility for an alternative 
hypothesis that the similarities between two bathy-phytochromes structures do not 
represent the photoconverted state of classical phytochromes and that the similarities are 
the result of convergent evolution. 
A comparison of the structures of phytochromes in the Pr- and the Pfr-forms reveals 
many instances of “context dependent conformation”, a phenomenon where residues 
conserved in both classical and bathy-phytochromes exhibit different conformations in 
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two forms. This observation supports the notion that a phytochrome whose structure is 
known in one form can assume the conformation of the other, and supports the first of 
the two hypotheses presented above – that the crystal structures that are currently 
available for the Pr- and the Pfr-forms truly represent the end points of the 
photoconversion event for all phytochromes in terms of their global conformation.
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Appendix 
Appendix 1: The safe-light 
The safe-lights consisting either of filters or and LED have the peak in transmission 
spectra and emission spectra, respectively, at the wavelength close to an absorption 
minimum of Agp1 sample (Fig. A.1). This in theory should minimise photoconversion 
from the Pr-form into the Pfr-form, and that was also the case as far as observed during 
this study. 
Appendix 1.1 Green filter 
Colour effect filters, Velvet green #735 and Twickenham green #736 (LEE filters) were 
used either by themselves or in combination to cover light emitting materials such as 
power indicator of instruments or monitor display in order to minimise the exposure to 
light at photoactive wavelengths by phytochrome samples. Those filters were also used 
to cover handheld torches (Halfords) (Fig. A.1), and to cover the lamp of a stereo 
microscope during inspection of crystallisation plates. 
Appendix 1.2 Green LED 
NSPG510AS, a green LED with the maximum emission at 525 nm (Nichia) was 
connected in serial with a register rated at 30 ohm, and then 10 of such combinations 
were connected in parallel and were powered by an adjustable AC/DC converter set to 
operate at 3.5 volts. The resulting safe lamp is shown in Fig. A.1 and the circuit diagram 
is shown in Fig. A.2. 
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Figure A.1 Safe lights that do not induce photoconversion used in the present study. A) Safe light 
constructed with a green filter and a torch. B) Safe light constructed with green LEDs. Transmission 
spectra of C) #735 Velvet green filter and D) #736 Twickenham green filter (Lee Filters). E) The 
emission spectra of NSPG510AS green LED (Nichia). F) Typical absorption spectra of Agp1-BV in 
the Pr-form. An absorption minimum is indicated by the vertical line, which is roughly at 517 nm 
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Figure A.2 The circuit diagram of the safe-light used in the present study. The photograph of the 
assembled equipment is shown in Fig. A.1. The emission spectrum of the green LED (Nichia 
NSPG510AS) has the peak at 525 nm which nearly coincides with a minimum of the absorption 
spectrum of Agp1-BV holoprotein (Fig. A.1). The resistors were rated at 30 . The total current 
during operation at 3.5 V is 0.143 A, which is below the capacity of the AC/DC converter (0.5 A). 
The current though each LED is 0.0143 A, which is below the maximum forward current of the LED 
(0.035 A). The diagram was created with BSch3V (Suigyodo). 
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Appendix 2: Generation of M20s plasmid construct 
Appendix 2.1 Polymerase chain reaction and T4 DNA ligation 
PCR reaction was carried out with pNM19a plasmid bearing the PAS, GAF and PHY 
domains as the template. pNM19a-M20F and pNM19a-M20R primers were used 
(Section 2.2.2.1). PCR primers were designed to frank the sequence to be omitted (the 
PHY domain) and to retain the C-terminal hexahistidine tag to enable affinity 
purification of the expressed protein (Fig. A.3).  
The amplified linear DNA fragment was purified with DNA purification kit and 
subjected to blunt end ligation with T4 DNA ligase at 20 °C for 1:30 hours. The ligation 
reaction was inactivated by incubation at 65C for 10 minutes. The sample was purified 
with DNA purification kit again prior to being subjected to DpnI digestion. Only the 
parental pNM19a plasmids, which had been purified from E. coli cells, are expected to 
be digested by DpnI enzyme due to their methylated state. E. coli XL1-Blue cells were 
transformed with the DNA sample and subjected to selection with LB-agar plate 
containing ampicillin. Several colonies were selected for plasmid DNA purification 
with Miniprep kit, and subjected to verification for the successful truncation. 
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Figure A.3 Generation of M20s construct. A) Schematics of strategy to generate the truncated 
construct. The entire plasmid was amplified with the primers designed to flank the region to be 
omitted. The linear DNA fragment was ligated by blunt end ligation to create circular plasmid again 
by T4 DNA ligase. B) Agarose gel electrophoresis of PCR amplified DNA. Lane 1, DNA markers 
(bp); Lane 2 and 3, PCR amplified linear DNA that were carried out in duplication. A single band of 
amplicon designed to be 6276 bp is visible. The colour of the gel is inverted. 
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Appendix 2.2 Verification of the plasmid construct 
Appendix 2.2.1 Restriction digestion 
Restriction digestion was carried out to assess the success of truncation of the construct. 
Protein coding sequence of Agp1 PHY domain contains a restriction site for XhoI 
(C/TCGAG), and no other XhoI site is present in the parental pNM19a plasmid, 
therefore if the product plasmid resists digestion by XhoI, it implies the successful 
truncation. Conversely if the truncation of the plasmid is unsuccessful, XhoI digestion 
will yield a single linear DNA. Plasmids purified from several colonies were tested with 
XhoI digestion along with parental pNM19a plasmid. The restriction pattern of the XhoI 
treated plasmids were visualised by agarose gel electrophoresis along with non-digested 
plasmids (Fig. A.4), and this led to identification of several candidate plasmids as being 
the successfully truncated construct, M20s. 
 
Figure A.4 Agarose gel electrophoresis of plasmid DNA before and after being subjected to XhoI 
digestion. Lanes 1 to 5, Candidate M20s plasmids; Lane 6, Parental pNM19a plasmid. U, 
Undigested with XhoI; C, Digested with XhoI. Lane 7, DNA markers (bp). Migration patterns of 
lane 2, 4 and 5 is similar to that of lane 6, where undigested plasmid migrates as several bands and 
XhoI digested plasmid appear as a single band. Only lane 3 clearly indicates a case where identical 
migration pattern is observed for both digested and undigested plasmid, indicating the lack of XhoI 
site. 
  
Appendix 
271 
 
Appendix 2.2.2 Test expression 
Integrity of the Agp1 M20s protein coding sequence in the plasmid which exhibited 
positive pattern with XhoI digestion test were checked by small scale expression trials. 
Expression of agp1 gene under an inducing condition will indicate the integrity of the 
gene and also enable to test for the success of truncation by analysing the molecular 
weight of the expressed protein. 
E. coli BL21 (DE3) cells were transformed with three candidates of M20s construct. 10 
ml LB-ampicillin cultures were treated with 100 M IPTG. Overnight cultures were 
collected by centrifugation and the cells were resuspended in 2 ml of 300 mM NaCl, 50 
mM Tris-HCl pH 7.8 at 20 °C, 5 mM EDTA, 14 mM 2-mercaptoethanol. The cells were 
disrupted by 2 cycles of freeze-thaw followed by sonication. The cell lysate was 
clarified by centrifugation, and soluble and insoluble fractions were analysed by SDS-
PAGE (Fig. A.5). The fact that the majority of the protein was found in the insoluble 
fraction may be attributed to incomplete cell disruption. 
  
 
Figure A.5 SDS-PAGE gel showing small scale expression trials of M20s. BL21 (DE3) cells were 
transformed with of candidate plasmids for M20s, a truncated M20 construct. Groups 1 to 3, Cells 
after overnight induction; Group 4, Negative control where cells transformed with the same plasmid 
as that of lane 1 was incubated overnight without induction; M, SN molecular weight markers 
consisting of M15 (55.8 kDa) and M20 (34.7 kDa) apoproteins. S: Soluble fraction, P: Insoluble 
fraction after cell disruption. Only the candidate in lane 2 indicates the production of the M20s 
protein with the expected molecular weight, 33.5 kDa. 
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Appendix 2.2.3 DNA sequencing by Sanger’s dideoxy method  
The gene of Agp1 M20s was judged to be intact following a successful expression of 
the protein with expected molecular weight and also by the success of affinity 
purification, which demonstrate that the coding sequence for hexahistidine tag was in 
frame. Finally the correctness of the protein coding sequence was checked with 
dideoxy-termination sequencing. A candidate plasmid exhibiting positive results in both 
restriction and expression tests was sequenced by dideoxy-termination sequencing in 
direction from 5’ to 3’ using a primer designed to bind to the T7 promoter region 
(Eurofins). 
Nucleotide sequence from the sequencing result was aligned with the reference 
sequence of Agp1 M20s for inspection (Fig. A.6). Many mismatches (69
th
, 70
th
, 71
th
, 
74
th
, and 77
th
 positions of the sequencing result) were found in the region immediately 
following the start codon, but these deviations from the reference sequence were not 
found to cause any change in the translated amino acid sequence (Fig. A.7). The 
following sequencing result perfectly matched to the reference sequence apart from five 
apparent insertion mutations at 765
th
, 864
th
, 903
rd
, 952
nd
, and 954
th
 of the sequencing 
result (Fig. A.6). The apparent insertion mutations were assumed to be errors during 
nucleotide sequence assignment. The point mutation at 969
th
 of the sequencing result is 
a silent mutation even if the sequencing result is true. Thus the entire sequence of M20s 
(Agp1 10-313 + hexahistidine tag) was deemed correct. 
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Sequencing result  61 ATATGAGTAGCCACACACCGAAACTGGATAGTTGCGGCGCAGAGCCCATCCACATTCCCG 120 
Agp1_M20_10_313    28 --ATGAGTTCACATACGCCGAAACTGGATAGTTGCGGCGCAGAGCCCATCCACATTCCCG 85 
                        ******   ** ** ******************************************* 
 
Sequencing result 121 GTGCTATTCAGGAACATGGAGCCCTTCTGGTTCTGTCCGCGCGGGAATTTTCCGTGGTGC 180 
Agp1_M20_10_313    86 GTGCTATTCAGGAACATGGAGCCCTTCTGGTTCTGTCCGCGCGGGAATTTTCCGTGGTGC 145 
                      ************************************************************ 
 
Sequencing result 181 AGGCGAGCGATAATCTCGCCAACTATATTGGTGTGGACCTGCCAATCGGGGCCGTTGCCA 240 
Agp1_M20_10_313   146 AGGCGAGCGATAATCTCGCCAACTATATTGGTGTGGACCTGCCAATCGGGGCCGTTGCCA 205 
                      ************************************************************ 
 
Sequencing result 241 CCGAAGCAAACTTGCCGTTCATCTCCGTACTGTCCGCCTGGTATTCCGGCGAGGAGAGCA 300 
Agp1_M20_10_313   206 CCGAAGCAAACTTGCCGTTCATCTCCGTACTGTCCGCCTGGTATTCCGGCGAGGAGAGCA 265 
                      ************************************************************ 
 
Sequencing result 301 ATTTCCGATATGCCTGGGCCGAAAAGAAACTCGATGTTTCGGCGCATCGATCCGGGACCT 360 
Agp1_M20_10_313   266 ATTTCCGATATGCCTGGGCCGAAAAGAAACTCGATGTTTCGGCGCATCGATCCGGGACCT 325 
                      ************************************************************ 
 
Sequencing result 361 TGGTTATTCTTGAGGTGGAAAAGGCAGGAGTGGGCGAATCCGCTGAAAAGCTGATGGGCG 420 
Agp1_M20_10_313   326 TGGTTATTCTTGAGGTGGAAAAGGCAGGAGTGGGCGAATCCGCTGAAAAGCTGATGGGCG 385 
                      ************************************************************ 
 
Sequencing result 421 AACTCACCAGTCTGGCGAAATATCTGAACAGCGCGCCGTCGCTGGAGGACGCGCTTTTTC 480 
Agp1_M20_10_313   386 AACTCACCAGTCTGGCGAAATATCTGAACAGCGCGCCGTCGCTGGAGGACGCGCTTTTTC 445 
                      ************************************************************ 
 
Sequencing result 481 GGACGGCGCAACTGGTGTCCTCGATCAGCGGTCATGACCGTACCCTGATCTATGATTTCG 540 
Agp1_M20_10_313   446 GGACGGCGCAACTGGTGTCCTCGATCAGCGGTCATGACCGTACCCTGATCTATGATTTCG 505 
                      ************************************************************ 
 
Sequencing result 541 GACTGGACTGGAGCGGCCATGTCGTGGCGGAAGCGGGAAGCGGGGCTTTGCCGTCTTATC 600 
Agp1_M20_10_313   506 GACTGGACTGGAGCGGCCATGTCGTGGCGGAAGCGGGAAGCGGGGCTTTGCCGTCTTATC 565 
                      ************************************************************ 
 
Sequencing result 601 TCGGCCTTCGCTTTCCGGCGGGCGACATCCCGCCGCAGGCGCGGCAGCTCTATACCATCA 660 
Agp1_M20_10_313   566 TCGGCCTTCGCTTTCCGGCGGGCGACATCCCGCCGCAGGCGCGGCAGCTCTATACCATCA 625 
                      ************************************************************ 
 
Sequencing result 661 ATCGCCTGCGGATGATTCCCGATGTCGATTATAAGCCCGTGCCGATCAGACCGGAGGTGA 720 
Agp1_M20_10_313   626 ATCGCCTGCGGATGATTCCCGATGTCGATTATAAGCCCGTGCCGATCAGACCGGAGGTGA 685 
                      ************************************************************ 
 
Sequencing result 721 ATGCGGAAACGGGAGCGGTGCTCGATATGAGCTTTTCACAGCTTTCGCAGCGTATCGCCG 780 
Agp1_M20_10_313   686 ATGCGGAAACGGGAGCGGTGCTCGATATGAGCTTTTCACAGCTT-CGCAGCGTATCGCCG 744 
                      ******************************************** *************** 
 
Sequencing result 781 GTTCATCTCGAATATATGCGCAATATGGGCACTGCCGCTTCGATGTCGGTGTCCATCGTC 840 
Agp1_M20_10_313   745 GTTCATCTCGAATATATGCGCAATATGGGCACTGCCGCTTCGATGTCGGTGTCCATCGTC 804 
                      ************************************************************ 
 
Sequencing result 841 GTCAATGGCGCTCTCTGGGGCTTTGATTGCCTGCCACCACGCGACACCGCATTCGGTATC 900 
Agp1_M20_10_313   805 GTCAATGGCGCTCTCTGGGGCTT-GATTGCCTGCCACCACGCGACACCGCATTCGGTATC 863 
                      *********************** ************************************ 
 
Sequencing result 901 CCCTTGCCGTACGTGAAGCCTGTGATTTTGCAGCGCAGCTCCTGTCGATGCCGAATCGCG 960 
Agp1_M20_10_313   864 CC-TTGCCGTACGTGAAGCCTGTGATTTTGCAGCGCAGCTCCTGTCGATGC-GGATCGCG 921 
                      ** ************************************************ * ****** 
 
Sequencing result 961 ATGGAGCAAAGTTCCCAGCACCACCACCACCCACCACTGGAAATCCGGCTGCTAACAAAG 1120 
Agp1_M20_10_313   922 ATGGAGCAGAGTTCCCAGCACCACCACCACCCACCAC----------------------- 947 
                      ******** ****************************                       
Figure A.6 Sequencing result of M20s. Sequence alignment was carried out between reference 
M20s sequence and the result from the sequencing with ClustalW 2.0.9 (Larkin et al., 2007) with the 
default settings. Apparent mutation in the result is highlighted in blue. 
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Figure A.7 Apparent mutations in the sequencing result. Mismatches between the sequencing result 
and the reference sequence are indicated by rectangles. A) Mismatches do not cause alteration in the 
translated amino acids. B) C) D) E) F) Apparent insertion mutation at 765
th
, 864
th
, 903
rd
, and 952
nd
 
positions are assumed to be error that had occurred during assigning sequence by the fluorescence 
detector, because these cases always occur on or next to a low quality region with consecutive same 
nucleotides. Apparent point mutations at 954
th
 and 969
th
 positions do not alter the translated amino 
acids. 
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Appendix 3: Generation of single cluster surface entropy reduction 
mutants 
Appendix 3.1 QuikChange mutagenesis 
Expression constructs for three mutants of Agp1-M15s were created using QuikChange 
site directed mutagenesis protocol (Agilent technologies). The mutagenesis reactions 
were carried out in PCR thermal cycler with pNM19a as the template DNA and the 
forward and the reverse primers for the corresponding mutation as indicated in Section 
2.2.2.9. Successful amplification of the plasmids were confirmed by agarose gel 
electrophoresis (Fig. A.8). Plasmids were purified from several E. coli XL1-Blue 
colonies bearing mutated pNM19a plasmids, and the candidate plasmids were verified 
for successful mutations as described below. 
 
 
Figure A.8 Agarose gel electrophoresis of plasmid DNA amplified during mutagenesis reaction. A) 
DNA amplified during SER3 mutagenesis. Lane 1, 50 ng template + 3% DMSO; Lane 2, 50 ng 
template + 1.5 mM MgCl2; Lane 3, 50 ng template + 3% DMSO + 1.5 mM MgCl2; Lane 4, 10 ng 
template + 3% DMSO; Lane 5, 10 ng template + 1.5 mM MgCl2; Lane 6, 10 ng template + 3% 
DMSO + 1.5 mM MgCl2. B) DNA amplified during SER2 and SER6 mutagenesis. Lane 1, SER2; 
Lane 2, SER6; M, DNA sizer III marker. Faint bands are visible for both SER2 and SER6 between 
21226 bp and 5148 bp. Colour of the gels are inverted for the visibility purpose. 
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Appendix 3.2 Verification of the plasmid constructs 
Appendix 3.2.1 Restriction digestion 
Successful mutations were first verified with restriction digestion. As well as the 
mutating the target residues into Alanines, the recognition sites of the following 
restriction enzymes were incorporated into the plasmids, and were used as a marker for 
successful mutagenesis - SER3: BglI (Fig. A9), SER2: NheI, and SER6: BglI (Fig. 
A.10). 
For SER3 test groups, all cases of undigested plasmids migrated as multiple bands 
indicating the numbers of alternative coiling state of the plasmids. Restriction pattern of 
candidate number 3 and 4 are similar to that of the WT plasmid that two bands are 
present at the expected fragment sizes. Restriction patterns of candidate number 1, 2, 5, 
and 6 were in accordance with expected fragment sizes of BglI digested SER3 plasmids. 
The upper band was assigned to be 2654 bp fragment while the lower band comprises 
both 2050 bp and 2151 bp fragments with similar migration rate on a gel at the 
resolving capacity of 0.7% agarose gel. 
For SER2 test group, the migration pattern of the parental plasmid was identical for 
both undigested plasmid and the plasmid subjected to NheI digestion. This indicates the 
lack of NheI restriction site in the WT plasmid as expected. All three candidates 
digested by NheI migrated as a single band at the expected size of 6855 bp, indicating 
successful SER2 mutagenesis. 
All three candidates digested with BglI in SER6 test group exhibited restriction pattern 
distinct from that of the WT plasmid. The upper band was assigned to be 2868 bp 
fragment while the lower band comprises both 2050 bp and 1937 bp fragments with 
similar migration rate on a gel at the resolving capacity of 0.7% agarose gel. 
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BglI digestion 
WT 2050 bp 
 4805 bp 
  
SER3 2050 bp 
 2151 bp 
 2654 bp 
 
Figure A.9 Restriction digestions to evaluate the success of SER3 mutagenesis. A) Agarose gel 
electrophoresis of BglI restriction digested plasmids (C) and undigested plasmids (U) carried out 
with a 0.7% agarose gel. The colour of the gel is inverted for the visibility purpose. Plasmids from 
six colonies tested for successful SER3 mutagenesis is represented by the number after the decimal 
point. WT: Parental WT plasmid was also included as the negative control. M: Molecular weight 
marker (bp). B) Schematic diagram of the parental plasmid with the BglI sites indicated. SER3 site is 
also shown, where an additional BglI site is incorporated. C) Expected sizes of the fragments of WT 
and SER3 plasmids following BglI digestion. 
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C 
NheI digestion 
  
WT 
No restriction site 
available 
  
SER2 6855 bp 
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BglI digestion 
  
WT 2050 bp 
 4805 bp 
  
SER6 1937 bp 
 2050 bp 
 2868 bp 
Figure A.10 Restriction digestions to evaluate the success of SER2 and SER6 mutagenesis. A) 
Plasmids digested with restriction enzymes and undigested plasmids were separated by 0.7% agarose 
gel electrophoresis. NheI and BglI were used for identifying successful SER2 and SER6 
mutagenesis, respectively. The colour in inverted for the purpose of visibility. Plasmids from three 
colonies were tested for successful SER2 and SER6 mutagenesis each, and are represented by the 
number after the decimal point. Schematic diagram of the plasmid and the locations of the 
restrictions sites. B) A NheI site is introduced by SER2 mutation. C) Expected sizes of the fragments 
of WT and SER2 plasmids following NheI digestion. D) A BglI site is introduced by SER6 
mutation. E) Expected sizes of the fragments of WT and SER6 plasmids following BglI digestion. 
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Appendix 3.2.2 Test expression 
For those plasmids indicated to be successfully mutated by restriction digestion were 
tested for the integrity of the Agp1 sequence and ability to express protein. Purified 
plasmids were transformed into E. coli BL21(DE3) cells and small scale test 
expressions were carried out. 
Each SER plasmid candidate was subjected to small scale test expression with 5 ml of 
LB-Amp media according to the Section 2.2.3.6.1. The soluble lysate and the insoluble 
pellet of each candidate was analysed by SDS-PAGE for each candidate (Fig. A.11). 
For SER2 mutation only candidate number 2 successfully resulted in production of the 
target protein while four and two candidates resulted in production for mutations SER3 
and SER6, respectively. Molecular weights of the overproduced proteins form the 
successful candidates were the same as that of the WT M15 protein. In majority of the 
cases, the overproduced proteins were only identified in the insoluble fraction of lysate, 
even in the case of expression of WT M15 protein. Unpredictable presence of the target 
protein in the soluble fraction was attributed to incomplete cell lysis. 
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Figure A.11 SDS-PAGE gel showing the small scale expression trials with the SER mutant 
candidate plasmids. Cells bearing WT plasmid was also tested as the control. A) No indication of the 
SER2 protein overproduction is present in the candidate 1. SDS-PAGE of SER2 test group. 
Candidate 2 produces protein of the same molecular weight as the WT protein. Molecular weight of 
the protein produced by candidate 3 appears larger than the WT. B) All 4 SER3 candidates produced 
protein of the same molecular weight as the WT protein. C) SDS-PAGE of SER6 test group. 
Candidate 1 and 2 produced protein of the same molecular weight as the WT protein, while no 
protein overproduction was evident for candidate 3. M, molecular weight marker consisting of 
purified M15 apoprotein and M20 apoprotein. WT+, WT induced; WT-, WT uninduced. 
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Appendix 3.2.3 DNA sequencing by Sanger’s dideoxy method 
Successful mutagenesis was finally verified with DNA sequencing. Plasmid candidates 
SER2.2, SER3.5, and SER6.2 were selected for sequencing with T7 forward primer for 
SER2 and SER3, while T7 reverse primer was selected for SER6 (Section 2.2.2.10). 
Successful mutagenesis was confirmed for all SER mutants under high quality regions 
(Fig. A.12). 
 
 
 
Figure A.12 Dideoxy-termination sequencing of SER mutant plasmids. Translated amino acid 
sequences in the correct reading frame are annotated with the residue number. A) SER2 
(E86A/E87A). B) SER3 (E96A/K97A/K98A). C) SER6 (E336A/K337A). T7 reverse primer was 
used for sequencing this mutant. Complementally nucleotide sequence is also shown to ease the 
identification of the translated amino acid sequence, shown in reverse order.  
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Appendix 4: Sequencing result of double cluster SER mutants 
Appendix 4.1 Verification of the plasmid constructs 
Appendix 4.1.1 Restriction digestion 
Successful mutagenesis was firstly tested by restriction digestion. Candidates for SER26 
were digested by NheI to confirm the successful introduction of SER2 mutation to 
parental the SER6 plasmid, which like WT pNM19a doesn’t contain any NheI site. 
Candidates for SER36 were digested by BglI to confirm the successful introduction of 
SER3 mutation to the parental SER6 plasmid. SER3 mutation introduces an additional 
BglI site to SER6 plasmid which has 3 BglI sites, of which one of them is as a result of 
SER6 mutation. All candidates for both mutations indicated successful mutagenesis 
exhibiting expended band sizes on an agarose gel (Fig. A.13).  
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No restriction site 
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BglI digestion 
SER6 1937 bp 
 2050 bp 
 2868 bp 
  
SER36 2151 bp 
 2050 bp 
 1937 bp 
 717 bp 
 
Figure A.13 Restriction digestions to evaluate the success of SER26 and SER26 mutagenesis. A) 
Agarose gel electrophoresis of plasmids digested with restriction enzyme. The colour of the gel has 
been inverted.  
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Appendix 4.1.2 Test expression 
Test expression was carried out on the constructs with positive sign of mutagenesis to 
test for the integrity of the protein coding sequence. Based on an SDS-PAGE gel (Fig. 
A.14), the constructs SER26.2 and SER36.3 were selected for further verification. 
 
Figure A.14 SDS-PAGE gel showing the small scale expression trial of the double cluster SER 
candidate plasmids. S, Soluble fraction; P, Insoluble fraction of the cell lysate. WT+, positive control 
with the construct for WT M15s protein. 
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Appendix 4.1.3 DNA sequencing by Sanger’s dideoxy method 
Successful mutagenesis was finally verified with DNA sequencing. Plasmid candidates 
SER26.2 and SER36.3 were selected for sequencing with T7 forward primer for both 
SER26 and SER36 (Fig. A15). Verification of the SER6 mutation was deemed 
unnecessary since the mutagenesis of SER26 and SER36 plasmids were based on 
SER6.2, whose sequence has been verified (Appendix 3.2.3). 
 
 
Figure A.15 Dideoxy-termination sequencing of double cluster SER mutant plasmids. Translated 
amino acid sequences in the correct reading frame are annotated with the residue number. Since a 
successfully mutated SER6 was used as the template for generation of both SER26 and SER36, only 
unique mutation sites are shown here. A) SER26 (E86A/E87A/E336A/K337A). B) SER36 
(E96A/K97A/K98A/E336A/K337A).  
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Appendix 5: Calibration of Superdex 200 column 
To enable correlation between the elution volumes and the molecular weight of the 
eluate, calibration was carried out with two model proteins, human serum albumin 
(HSA) and hen egg white lysozyme (HEWL) (Table A.1).  
Calibration of the Superdex 200 column was carried out for buffers at several NaCl 
concentrations. Superdex 200 column was equilibrated with SEC buffer (20 mM Tris-
HCl pH 7.8 at 20C, 1 mM EDTA) containing either 500, 330, 170, or 5 mM of NaCl. 
100 l of protein solutions containing 450 mAU×ml of each protein were prepared in 
SEC buffer of the same NaCl concentration as the buffer used in the calibration run. The 
mixtures were subjected to isocratic elution with S200 column, and the chromatograms 
are shown in Fig. A.16. 
HSA eluted in two peaks, and the elution volumes increased with increasing NaCl 
concentration. HEWL eluted in a single peak, and the elution volume decreased with 
increasing NaCl concentration. NaCl concentration dependent mobility of the elution 
peak indicates slight degree of hydrophobic interaction and ionic interaction with the 
stationary phase for HSA and HEWL, respectively. The first minor peak of HSA was 
attributed to be its dimer as judged by SDS-PAGE gel (data not shown) and the by the 
calibration curve drawn by other two peaks. Majority of HEWL failed to elute with 
eluent containing 5 mM NaCl, likely due to non-specific interaction with the stationary 
phase. A very minor peak, indiscernible at the scale of presentation in Fig. A.16 was 
detected at 19.68 ml, but since this value is against the trend of decreasing elution 
volume with increasing NaCl concentration, it was omitted as an anomaly, and instead 
the elution volume of HEWL at 170 mM NaCl was used for calculating the calibration 
curve for 5 mM (Fig. A.17). 
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Protein Human serum albumin 
(HSA) 
Hen egg white lysozyme 
(HEWL) 
Source Sigma A3782-5G Fluka 62970 
MW specified by the supplier 66478 Da / monomer 14300 Da / monomer 
Seq. accession number used AAA98798 ACL81750.1 
The following was calculated by Protein calculator 
MW (Da) 69366.4844 16162.5049 
pI 6.29 9.09 
# of Cys (# of disulphide bonds) 35 (17) 9 (4) 
280 with disulphide bonds 37740 37180 
Table A.1 Biochemical information of two model proteins used for calibration of Superdex 200 
column.  
 
 
 
B 
 
Figure A.16 Chromatograms from calibration of Superdex 200 SEC column. A) Chromatograms of 
HSA and HEWL in eluent under various NaCl concentrations. B) Elution volumes of the peaks 
observed during the Superdex 200 calibration. Units of the elution volumes are in ml. The value for 
HEWL at 5 mM NaCl is indicated by grey highlight. It was omitted as an anomaly against the trend, 
and was replaced by the value for 170 mM for calculating the calibration curve for 5 mM. 
Chromatograms were obtained by monitoring absorption at 280 nm. 
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B 
5 mM NaCl 
                 
 
170 mM NaCl 
                 
 
330 mM NaCl 
                 
 
500 mM NaCl 
                 
Figure A.17 Calibration curves from calibration of Superdex 200 SEC column. A) Calibration 
curves with elution volumes (x-axis) and log of molecular weight of eluates (y-axis). B) Calculated 
calibration curves for each NaCl concentration, which were used for estimating the molecular 
weight of the eluate during analytical SEC. y = log of molecular weight of the eluate, and x = elution 
volume (ml). 
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Appendix 6: Calibration of dynamic light scattering 
Accuracy of the DLS was verified by taking measurements of two model proteins, HSA 
and HEWL. Solution of each protein was prepared at 1.0 mg/ml in SEC buffer with 170 
mM NaCl, and 20 measurements were taken from which average peaks were obtained 
(Figure A.18). There were good agreement between the molecular weight information 
supplied by the manufacturer and the calculated molecular weight from DLS, thereby 
verifying the use of DLS to probe the apparent molecular weight of the protein in 
solution. 
Human serum albumin 
 
Hen egg white lysozyme 
 
C 
 
 
Figure A.18 Verification of DLS measurements. A) HSA and B) HEWL were subjected to DLS, 
which returned the values similar to the molecular weight of the samples (HSA 66478 Da and 
HEWL 14300 Da). C) Tabulated results. R, radius; Pd, polydispercity; MW, molecular weight; Int, 
intensity. The peak with the highest % intensity value is highlight in grey. Values in the table are 
when the plots are made with % Intensity as the Y-axis and the solvent is set as PBS. 
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